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ABSTRACT 
 
DEVELOPMENT OF MULTIVARIATE POWDER X-RAY DIFFRACTION 
TECHNIQUES AND TOTAL SCATTERING ANALYSES TO ENABLE 
INFORMATIC CALIBRATION OF SOLID DISPERSION POTENTIAL 
 
 
By 
Michael D. Moore 
December 2010 
 
Dissertation supervised by: Peter L.D. Wildfong, Ph.D. 
 The objective of this work was to introduce a novel method for predicting solid 
dispersion potential enabled by the ability to differentiate phase-separated co-solidified 
products from amorphous molecular solid dispersions.  The central hypothesis states that 
a combination of materials properties exists that defines the propensity of an active 
pharmaceutical ingredient to form a binary amorphous molecular solid dispersion with 
polyvinylpyrrolidone:vinyl acetate copolymer using a melt-quench procedure.  Testing 
this hypothesis required execution of specific aims directed to address issues inherent to 
characterizing amorphous materials.  The work herein is presented with respect to two 
separate subjects: (1) analytical development and (2) theoretical applications.  In the first 
few chapters, advanced powder X-ray diffraction data processing techniques are explored 
and adapted to composite pharmaceutical systems.  Specific emphasis will be placed on 
iv 
 
total scattering data manipulations and their benefits over traditional practices.  The 
concluding part of this work is devoted to illustrating the use of materials informatics in 
modeling solid dispersion potential, ultimately afforded by implementing the materials 
characterization methodologies developed in the initial stages.  Molecular descriptors, 
commonly employed in quantitative structure-property relationship assessment, were 
tested for correlation to dispersion potential across a library of small molecule organic 
compounds.  The final model accurately predicted dispersion potential for all 12 
calibration compounds and three test compounds. 
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Chapter 1: Introduction 
 
 
1.1 Statement of Problem 
 
 The development of small molecule organic (SMO) new chemical entities (NCE) 
for use in therapeutic products is a complex process involving effort from a diverse 
multidisciplinary scientific team.  Charged with the formidable task of formulating 
chemically/physically stable, manufacturable, and bioavailable dosage forms, scientists 
have traditionally relied on highly empirical tactics for solving the most daunting 
developmental issues.  Instances where first-principles approaches are not available for 
troubleshooting problematic materials-based deterrents seldom precipitate empirically-
derived predictive models largely due to analytical limitations.  As a result, innovation in 
the areas of pharmaceutical pre-formulation and formulation development are often 
precluded by advancements in materials characterization. 
 In the area of solid oral dosage form development, solubility of a solid material in 
the aqueous environment of the gastrointestinal fluid and subsequent permeability of 
active pharmaceutical ingredient (API) molecules through epithelial cellular membranes 
are two principal biopharmaceutical properties given significant consideration when 
deciding the fate of a NCE in the pharmaceutical development process.  Molecules 
having acceptable aqueous solubility and permeability, i.e., biopharmaceutical 
classification system1 (BCS) I compounds, are desirable owing to typically higher in 
vitro-in vivo correlation (IVIVC), but are encountered less frequently among emerging 
NCEs.  Therefore, modifications to APIs intended to improve biopharmaceutical 
properties inherent to successful development are becoming routinely necessary.   
 1
 Tactics commonly employed in permeability enhancement of NCEs often require 
alteration of intramolecular functional groups, thereby manipulating properties, including 
reduction of ionization potential under physiological conditions and lipophilicity.  These 
modified functional groups, however, often influence other physicochemical and 
pharmacological properties, such as aqueous solubility and receptor binding efficiency.  
Consequently, molecules that lack adequate permeability (BCS Class III, IV) are often 
dismissed as viable development candidates.  As aqueous solubility enhancing 
approaches are developed, BCS Class II compounds (low aqueous solubility, high 
permeability) exhibit greater potential for successful development.  With the decline in 
“blockbuster” drug development in the last decade, methods for optimizing 
biopharmaceutical properties of SMO compounds are becoming increasingly important. 
 The solubilization of a solid material in an aqueous medium is a complex, 
equilibrium process that can be broken down into three general steps.  The first step 
involves removing a molecule from the bulk solute particle.  This is achieved by 
breaking/overcoming the cohesive inter-molecular non-bonded interactions (NBI) 
responsible for maintaining the crystal lattice.  Half of the work committed in this process 
is regained from “closing” the hole created from the departure of the molecule.  The 
second step is called pre-solvation and is the work of breaking cohesive solvent:solvent 
interactions to create a “hole” sufficient to accommodate the solute molecule.  The final 
step, solvation, is the insertion of the solute molecule into the solvent “hole” and 
subsequent formation of adhesive interactions.  The final step represents an overall gain 
in work (or decrease in potential energy) due to: (1) the formation of adhesive 
 2
interactions between the solute molecule and surrounding solvent molecule(s); and (2) 
the “hole” created in step two is sealed.2
 Techniques that may be used to enhance the aqueous solubility and/or dissolution 
rate of NCEs can be broken down into two subgroups: (1) chemical and (2) physical 
modifications.  Conventional chemical modifications include prodrug development3 and 
salt screening/selection.4,5  Though successfully applied to commercially available 
therapeutic agents,2 these methods have their shortcomings.  Synthesizing an appropriate 
prodrug through the addition of an optimal physiologically cleavable functional group is 
not trivial.  Further, chemical modifications also possess the potential to unpredictably 
alter other biopharmaceutical properties, such as permeability, toxicological potential and 
pharmacological action.  Specifically, a molecular modification resulting in the greatest 
aqueous solubility enhancement may increase the toxicity of the molecule, e.g., in the 
case of quaternary ammonium prodrugs of tertiary amine containing compounds.6  
Further, salt formation of a compound is only a viable option when the NCE possesses an 
ionizable group, and oftentimes results in a material that has sub-optimal physical 
properties for manufacturing and stability.   
 Physical modifications, on the other hand, are more generally applied in the 
pharmaceutical industry relative to their chemical counterparts.  From classical 
dissolution theory, such as Noyes-Whitney,7 various materials properties can be altered, 
theoretically resulting in enhanced aqueous dissolution.  The inverse relationship between 
particle size and dissolution rate has enabled the exploitation of particle size reduction as 
a method of enhancing aqueous dissolution.8  Impact mills and fluid-energy mills are 
commonly used for reduction of particle size, however, the high-energy input of these 
 3
methods imparts the ability to induce phase changes (i.e., polymorphism,9 
amorphization,10,11 etc.,) with implications of physical instability.12   
 Other physical strategies, such as the formation of non-covalent inclusion 
complexes using cyclodextrins, provide solubility advantages over the un-manipulated 
drug.13  The prediction of solubilization potential with cyclodextrins, however, remains 
highly empirical, and is limited to appropriately sized, chemically compatible molecules.  
Solubility enhancement can be achieved through the use of formulation additives such as 
surfactants, however, drug:excipient compatibility becomes an issue.14  Despite the extent 
of viable options described herein, it has still been estimated that more than 40% of 
highly potent NCEs fail to reach clinical trials owing to their poor aqueous solubility.15  
Therefore, alternative methods need to be rigorously explored, and more fundamentally 
understood. 
 Controlled solid state modifications comprise an additional tactic for aqueous 
solubility enhancement on the principle that different solid forms have different 
physicochemical properties.  Adoption of metastable forms, however, is limited by their 
potential to convert to a more thermodynamically stable form in pharmaceutically-
relevant time-frames.12  Formation of binary amorphous molecular solid dispersions 
offers a method for physically stabilizing the amorphous phase of a drug substance.  
Generally speaking, amorphous molecular solid dispersions are formed by the co-
solidification of a drug and polymer, in a specific ratio, producing an overall amorphous 
phase displaying short-range order unique from that of either amorphous component.  
These systems, coupled with other composite entities (e.g. eutectics and solid solutions) 
are commonly implemented in manufacturing in the areas of metallurgy,16 
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microelectronics, and superconductor technology, where their controlled formation is 
well understood in the optimization of specific materials properties (other than solubility 
enhancement).17,18   
 The application of composite systems to pharmaceuticals is highly empirical, 
where solid dispersion potential screening may involve multiple concentration points (i.e. 
drug to excipient ratios), various excipient (e.g. polymers) materials, and different 
methods of preparation.  The raw material requirement involved with this assessment in 
early drug development stages remains an impediment for producing viable dosage forms 
from this technology.  Given this, the commercial availability of these systems in 
currently marketed pharmaceutical dosage forms is limited.8,19   
 Predicting drug:polymer solid dispersion compatibility/stability presents a 
difficult task, which suffers from the absence of universally applicable rules describing 
the molecular requirements for physically stabilizing amorphous therapeutic agents.  
Attempts to empirically model solid dispersed systems have yielded conflicting accounts, 
which are seemingly due to the dependency of specific stabilization effects on the 
particular components in the system, as well as inconsistencies in analytical 
characterization.  The insensitivity to structure at the short-range order level frequently 
impedes identification of miscible products from phase-separated products.  Additionally, 
variable reports on the presence of adhesive drug:excipient interactions oftentimes 
prevents accurate modeling/calibration of dispersion potential.   
 The random orientation of molecules in a molecularly dispersed system, as well 
as the indiscriminate specific/non-specific bonding schemes, implies that miscibility-
indicating features may be specifically related to properties of the individual molecules.  
 5
Through in silico modeling, various molecular properties and descriptors can be 
calculated from the compound’s atomic crystallographic coordinates.  With the enormous 
number of molecular properties available for modeling, a method for sorting through 
multi-dimensional data is required.  Materials informatics provides a statistically-robust 
method for surveying multi-scale data to seek specific structure-property relationships 
through linear/non-linear modeling.  Coupled with identification of successful amorphous 
molecular dispersion formation, this may ultimately provide an answer to determining 
molecular requirements for successful formation of amorphous molecular solid 
dispersions.  The ability to predict the miscibility between a drug and polymer and 
thereby limit the overall resource burden would significantly enhance the appeal of solid 
dispersion technology.   
 
1.2 Hypothesis and Objectives 
 The central hypothesis of this dissertation is that a combination of materials 
properties exists that defines the propensity of an API to form a binary amorphous 
molecular solid dispersion with polyvinylpyrrolidone:vinyl acetate (PVPva) copolymer 
using the melt-quench process.  In order to test this hypothesis, the following specific 
aims were proposed and executed: 
1.  Due to the considerable complexity of composite materials relative to single 
component systems, the quantitative ability of multivariate PXRD techniques 
will be compared with traditional univariate methods to support the use of 
full-pattern analyses on composite samples. 
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2.  The sensitivity of the PDF transform to subtle alterations in interatomic 
distances of an API:excipient composite mixture induced by high compaction 
pressures will be demonstrated with the goal of illustrating the potential of 
finite phase differentiation using the short-range structural order. 
3.  A statistically-relevant method for interpreting PDF difference plots based on 
the propagation of an initial PXRD error estimate will be derived and applied 
to classification schemes for solid dispersion systems. 
4.  An informatics calibration from a molecular descriptor database will be 
created to predict the potential of a compound to form an amorphous 
molecular solid dispersion with a given polymeric carrier using a single 
preparation method. 
 The purposes of the previous specific aims are: (1) to support the use of advanced 
analytical techniques to improve the characterization of complex pharmaceutical systems; 
and (2) to replace traditional empirical methodologies with advanced in silico modeling.   
1.3 Literature Survey 
1.3.1 Powder X-ray Diffraction 
 The discovery of X-radiation occurred in 1895 by W.C. Röntgen.  It was not until 
1912 when Max von Laue confirmed the wave character of X-rays from his single crystal 
diffraction experiments that the birth of the X-ray crystallography field commenced.  
Following von Laue’s three-vector dot-product description of X-ray diffraction, William 
Henry Bragg and his son William Lawrence Bragg derived a simpler method for 
understanding and predicting this phenomenon, thereby arriving at the well-known Bragg 
equation (Equation 1.1): 
 7
θλ sindn 2=  (1.1) 
where λ is the wavelength of X-radiation, n is the integer value of wavelength 
displacement satisfying constructive interference criteria, d is the interplanar spacing 
between a pair of Miller indices, θ is equal to 2θ/2 and 2θ is the angle between incidence 
and diffracted beams.20
 According to Equation 1.1, when a particular set of molecular planes is oriented 
toward an X-ray beam, X-rays will be diffracted at an angle (2θ) satisfying a particular 
distance between planes.  Although initially derived for single crystal samples, 
applications of X-ray crystallography principles to powders (i.e. polycrystalline material) 
provide the ability to study structural order without isolating a single crystal specimen.  
The powder diffraction pattern arises from the assumption that a large number of 
polycrystalline aggregates have crystallites in all possible orientations permitting the X-
ray beam to see all intermolecular planes.  Powder X-ray diffraction (PXRD) has become 
particularly useful practically, as structure-sensitive analyses may be applied to samples 
obtained from all stages of various manufacturing unit operations. 
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 Figure 1.1.  Example PXRD focusing arrangements (after Zevin and Kimmel21, with 
modifications): (a) diverging incident radiation converges upon diffraction in reflectance 
geometry; (b) converging incident radiation diverges upon diffraction in reflectance 
geometry; (c) diverging incident radiation diverges upon diffraction in transmission 
geometry; and (d) converging incident radiation converges upon diffraction in 
transmission geometry. 
 
 Fundamentally, there are two primary geometric modes of PXRD analysis: (1) 
reflectance and (2) transmission.  Differences between the two setups involve the 
convergence-divergence of the X-ray beam.  In reflectance, the sample itself either: (a) 
changes a divergent beam into a convergent beam or (b) changes a convergent beam into 
a divergent beam.  In transmission mode, an incident diverging beam remains divergent 
upon diffraction and vise versa.  From these definitions, four types of focusing 
arrangements may be envisioned.  The first scheme involves a reflectance orientation 
where incident X-rays diverge with subsequently diffracted convergence and is 
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commonly referred to as Bragg-Brentano parafocusing geometry (Figure 1.1a).  The 
second reflectance setup produces converging incident X-radiation with subsequent 
diffracted divergence and is known as Seeman-Bohlin focusing geometry (Figure 1.1b).  
The first transmission mode produces converging X-rays that display convergence upon 
diffraction and is named for Guinier (Figure 1.1d).  The second transmission mode, 
which is much less common relative to the Guinier geometry, is divergent incident 
radiation with subsequent divergent diffracted radiation (Figure 1.1c).21  Both reflectance 
and transmission geometries have their own advantages and disadvantages that may be 
ultimately reconciled into instrumental and chromatic effects.  
 The most commonly employed focusing scheme, Bragg-Brentano reflectance, 
suffers from both instrumental and chromatic aberrations.  Each error source has 
scattering angle dependence, where instrumental effects decrease with increasing 
scattering angle and chromatic effects increase with increasing scattering angle.  There 
are four inherent instrumental errors of particular significance that are largely a 
consequence of the geometrically-imposed parafocusing circle.  They include the axial-
divergence error, flat specimen error, sample transparency error, and sample 
displacement error, where the latter two are closely related.  
 The axial-divergence error arises from the divergence of X-rays within the plane 
of the specimen, orthogonal to the theta angle.  This anomaly produces asymmetric 
broadening of Bragg diffraction peaks in the low two-theta direction.  Additionally, it 
introduces a decreasing negative error in two-theta up to 90°, then an increasingly 
positive error beyond.  To combat this issue, collimator slits comprised of a metal (i.e. 
molybdenum for copper radiation), cut to a specific length, and evenly spaced apart are 
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placed in between the source and sample, as well as, the sample and detector, to axially 
focus the X-ray beam.20   
 The flat-specimen error, as indicated by the name, is due to the inability of the 
entire irradiated sample to be co-concentric with the parafocusing circle.  The sample 
surface forms a tangent to the circle, where a different apparent irradiation distance for 
specimen extremities results in diffraction at an angle lower than expected.  The overall 
pattern aberration is a broadening of Bragg peaks due to a distortion of the average radius 
of the parafocusing circle.  Assuming a fixed incident divergence slit, the magnitude of 
the error is highly dependent on scattering angle, where decreasing divergent slit sizes 
result in smaller errors.20
 The principles associated with errors from sample transparency and sample 
displacement are very similar, where both are a result of instances where the effective 
diffraction surface lies above/below the focusing circle.  Pharmaceutically-relevant SMO 
compounds are effectively “transparent” to X-radiation, as the mass-attenuation of atoms 
comprising these molecules is relatively low.  The specimen-transparency error arises 
when X-rays penetrate to layers below the surface with subsequent diffraction from 
planes well below the focusing circle.  It has been reported that decreasing linear 
attenuation coefficients result in as much as a tenth of a degree peak shift and substantial 
angular asymmetry.22  Practical difficulties associated with placing a specimen directly 
co-concentric to the focusing circle lead to sample-displacement errors.  Pattern 
aberrations attributable to this error include low two-theta asymmetric peak broadening 
and absolute peak shifts equivalent to 0.01°2θ for every 15 μm displacement.20
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 To understand chromatic aberrations, an explanation of X-ray generation is 
warranted.  The production of X-rays is a highly inefficient process with respect to both 
substantial heat generation and emission of polychromatic radiation.  Copper X-radiation 
is produced as a result of the displacement of electrons from its inner electron shell and 
the concurrent replacement of those electrons from an outer electron shell.  The demoted 
electron releases energy equivalent to the energy difference between each orbital, which 
is on the order of the wavelength of X-radiation.  Typically, high current voltage is 
passed through a tungsten filament, which is encased in a glass housing that possesses an 
overall negative potential.  As high current passes through the filament, electrons are 
generated and subsequently directed towards the copper anode.  When they collide with 
the copper anode, electrons are displaced from the inner electron shell (normally 1s) and 
subsequently replaced by an electron from an outer shell (2p→1s).  This particular 
transition produces Kα radiation.  Also, a transition of electrons from the 3p shell (3p→1s) 
results in radiation (termed Kβ) of shorter wavelength.  Depending on the combination of 
the angular quantum number and spin quantum number of the electron which transitions 
from the outer shell, different wavelengths of radiation may be produced (Kα1/ Kα2 or Kβ1/ 
Kβ3).23
 Nickel has an absorption edge at 1.488Å with mass attenuation coefficients for Kβ 
and Kα radiation of 286 cm2/g and 49.2 cm2/g, respectively.  By controlling the thickness 
of a Ni filter in the path of incident/diffracted X-rays, considerable attenuation of Kβ 
radiation with minimal affect on Kα intensity is possible.  It is common practice to use Ni 
filters, where 15 μm results in an integrated intensity ratio of Kα / Kβ = 50:1.20  Given this, 
the bulk of chromatic aberrations are due to the inability to discriminate between Kα1 and 
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Kα2. At large scattering angles, the Kα1/Kα2 doublet results in significant Bragg peak 
broadening unless otherwise resolved.  The use of a monochromator to remove Kα2 
radiation is the most effective method; however, mathematical “stripping” may be carried 
out through data processing, having knowledge of each respective profile (i.e. shape, 
magnitude).24  Inaccuracies associated with the estimation of each wavelength’s 
contribution to the overall diffraction peak when mathematically stripping Kα2, however, 
may result in the introduction of substantial error into the data.  
 The transmission technique where a constant specimen-detector distance is 
employed creates an analog similar to the back-reflection of the aforementioned Bragg-
Brentano scheme.  Given the conceptual similarities, it may be envisioned that a certain 
likeness exists between errors encountered using Bragg-Brentano and transmission 
schemes.  Generally speaking, both instrumental and chromatic aberrations are much 
lower in transmission geometry relative to reflectance, largely due to the focusing circle 
placement at θ - 90°.  This emulates back-reflection characteristics, and as previously 
discussed, is approximately where instrumental aberrations decrease in Bragg-Brentano 
setups.  Chromatic aberrations are largely eliminated due to competitive dispersion 
elements arising from the specimen and/or the mechanism used for incident X-ray 
convergence, e.g. elliptical mirror.  These factors largely reduce the separation between 
the Kα1 and Kα2 components.21  In addition to lower instrumental and chromatic 
aberrations, constant depth-of-penetration in transmission geometry results in increased 
robustness to particle size, preferred orientation, and stress/strain aberrations relative to 
traditional Bragg-Brentano reflectance, where depth of penetration varies with diffraction 
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angle thereby amplifying these effects.  When significant sample absorption is not an 
issue, transmission geometry affords superior performance. 
1.3.1.1 Quantitative Powder X-ray Diffraction 
 Ranging from univariate to full-pattern approaches, quantitative powder X-ray 
diffraction (qPXRD) techniques have long been plagued with errors attributable to the 
physical characteristics of the sample.  Paramount to the list is the issue of sample 
absorbance, where the electron density of the atoms comprising the specimen may result 
in considerable radiation attenuation.  The implementation of full-pattern multivariate 
quantitative modeling will be discussed, specifically in the context of the aforementioned 
instrumental and chromatic pattern aberrations. 
 The interaction between the radiation and matter is fairly complex, where 
“absorbed” radiation may have been subjected to various other transformations.  Total 
absorption or energy loss as a function of passing through matter is due to a combination 
of scattering and the photoelectric effect.  General scattering occurs when radiation 
interacts with matter, retains the initial energy/wavelength, but scatters at an angle not 
defined by Bragg’s law (Equation 1.1).  An instance where a decrease in energy of the 
radiation occurs in addition to the previously described situation is commonly referred to 
as Compton scattering.  Radiation can be absorbed by atoms according to the 
photoelectric effect, where the atom is excited and an electron is ejected.  When the atom 
returns to its ground state, another electron (Auger effect) or fluorescent radiation can be 
emitted.25  The methods for absorption corrections in qPXRD applications range from 
first principles estimations to empirical assessments with respect to a reference 
material(s).  The principles originally developed by Alexander and Klug26 for quantitative 
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analysis of powder mixtures with respect to the absorptive properties of the sample are 
the foundation for the forthcoming discussion. 
 The oldest method for absorption correction in qPXRD applications is a 
univariate approach known as the internal standard technique.21  The specimen is spiked 
with a known amount of a pure reference phase and subsequently analyzed as a mixture.  
The ratio of unknown phase intensity to the internal standard intensity can be used to 
determine the concentration of the unknown phase, as the ratio of intensity values are 
independent of sample absorption.  Analyte concentration values are, therefore, obtained 
from a single experiment negating the need for a calibration.  The weight fraction of a 
phase j is given by: 
hs
ij
j I
I
Hc =  (1.2) 
where Iij is the intensity value for the unknown phase, Ihs is the intensity value for the 
internal standard, and H is a constant determined from knowing the weight of the internal 
standard.  In this analysis, intensity is taken as the peak height or integrated intensity.   
 In selecting an internal standard, a few considerations must be made.  First, the 
standard is desired to possess high symmetry, thereby producing a small number of 
highly intense Bragg peaks.  Additionally, sufficient isolation of the peak(s) used for the 
unknown phase from that of the standard is also a necessity.  The density of the internal 
standard should be close to that of the unknown phase as to permit a homogeneous 
distribution upon mixing.27  Finally, the standard material should be chemically stable in 
the analytical environment. 
 The internal standard method is insensitive to unknown phases and therefore may 
be implemented to analyze any crystalline material in a multiphase matrix.  Lithium 
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fluoride was used to aid in simultaneously quantifying an enantiomeric material and 
racemic compound mixture of ibuprofen, where limits of quantification were around 
three percent.28  A potential disadvantage involves the physical addition of an internal 
standard to the sample matrix.  Errors in weighing and inhomogeneous distribution of the 
standard may increase the uncertainty associated with the measurement.  Further, the 
methodology prevents analysis of composite samples intact, as the sample must be 
destroyed and blended with the standard. 
 The most direct method for absorption correction is afforded through knowledge 
of the mass absorption coefficient.  This may be determined using a simple calculation 
from the chemical composition23 or any direct experimental technique, provided the 
determination is independent of the diffraction measurement.  Born from this approach is 
the diffraction-absorption method, where calibrations are created from correlating 
standard samples to corrected intensity(s).  If it is assumed that the absorption coefficient 
for the unknown phase is the same as that for the entire sample matrix, the concentration 
of phase j is given by: 
ijijj Ic χ=  (1.3) 
where Iij is a measured intensity value and χij is a calibration constant obtained by 
analyzing any mixture with a known concentration of phase j.  The use of a single 
intensity value in this application may introduce significant error into the analysis due to 
many of the systematic aberrations described previously.  Variations in the lattice strain 
and particle size, which commonly influence Bragg peak shape, are avoided by using the 
integrated intensity.27   
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 Adaptations for constant and variable absorption coefficients have been 
developed for multiphase analysis.  Unfortunately, sources of nonlinearity other than 
absorption can introduce errors into this type of calibration, including microabsorption, 
extinction, and preferred orientation.  The effect of preferred orientation may be 
substantially different in a composite system than that exhibited by the pure phase, as 
powder consolidation has been shown to induce preferred orientation.29  A qPXRD study 
by Tiwari et al. to quantify polymorphs of a specific drug showed particle size and 
preferred orientation errors significantly affected the number of identifiable peaks and 
their respective integrated areas.30  To increase the accuracy and precision of their 
method, substantial parameter and sample optimization was required beforehand, thereby 
increasing raw material demands and other costly resources. 
 Full pattern techniques are particularly useful when peak overlap between 
components occurs in a mixture.  The most popular full pattern method for quantification 
of crystalline phases was introduced by Rietveld,31,32 which was originally developed for 
crystallographic structure refinement using single-crystal neutron diffraction data.  It was 
over ten years after its introduction before the Rietveld method was applied to X-ray data.  
Once accepted by crystallographers, the number of publications citing this method 
drastically increased.33  Under the Rietveld method, a powder pattern is thought of as a 
collection of individual profiles the have a peak height, position, breadth, and an 
integrated intensity proportional to the square of the structure factor.  Being a structure 
refinement technique, a starting structural model is refined to fit the experimentally 
determined intensity values.  Calculated intensity values are determined from the 
structure factor (derived from a structural model) that sums neighboring Bragg reflection 
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contributions plus a background estimate.  Adjustable parameters in the calculation of the 
structural model are iteratively altered as to obtain a least-squares minimization between 
the calculated and experimental intensity values.  No specific effort is made by the 
Rietveld method to allocate an observed intensity to a particular Bragg peak or resolve 
overlapped peaks, thereby mandating accurate initial model estimation.34  A central part 
of Rietveld’s contribution stated information in overlapping peaks (unless coincident) is 
not entirely lost when the peak profile function is known. 
 It was realized some time after the Rietveld method was proposed that the scale 
factors derived from the analysis of multiphase diffraction data are proportional to crystal 
phase composition when the product of the mass and volumes of the unit cell of each 
phase are known.35  This full-pattern analysis proceeds with structural parameters, 
experimental parameters, and scale values (weight fractions) that are simultaneously 
refined against the experimental pattern.  The Rietveld method has been successfully 
applied to both inorganic and organic samples, where additional information concerning 
preferred orientation may be gained from the analysis.36  This imposes a requirement of 
crystallographic structure solutions for all phases present and thus precludes its use for 
quantifying multiple amorphous phases, which is not to say that a collective amorphous 
content is unavailable through mass balance.   
 In all of the qPXRD methods mentioned thus far, the overarching limitation, with 
respect to pharmaceutical applications, is the inability to quantify multiple amorphous 
phases.  Although each ostensibly permits the ability to back-calculate the collective 
amorphous element of a mixture, they all fail to address the individual contributions 
comprising the disordered component.  This is particularly important, as an increasing 
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number of formulations contain amorphous excipients as well as disordered API, where 
differentiation is paramount for claiming sensitivity.  In an effort to assert sensitivity to 
all components present in a mixture, other full pattern techniques that consider Bragg 
diffraction and diffuse scattering have been developed. 
 The term “full pattern” with respect to qPXRD applications has traditionally 
referred to two different types of analyses, one that solely solved the issue of overlapping 
peaks and the other addressing the additional issue of multiple amorphous components.  
The first approach is generally referred to as profile fitting, as clusters of overlapping 
peaks are decomposed into components (i.e. individual peaks).  Unlike Rietveld’s method, 
structural data is not needed; rather, knowledge of peak shape (i.e. profile) and, less 
importantly, position are used to decompose convoluted peaks.  Once clusters are 
separated, integrated intensity values are assigned to each component.21  These intensity 
values can then be used in a calibration-based method, such as the diffraction-absorption 
technique, or standard-based methods that do not require construction of a calibration, as 
previously described. 
 The second approach may be tailored to handle the quantification of multiple 
amorphous phases in a mixture.  The entire powder pattern of a multiphase mixture is 
assumed to be the sum of the scaled patterns of the individual phases present.  Linear 
combinations of each pure component pattern are used to create a simulated pattern that 
can be compared with the experimental pattern.  The scaling constants serve as estimates 
of the mass fraction of each phase in the mixture.  To date, it appears as though this 
method has only been applied to pharmaceuticals in an effort to quantify the amount of 
amorphous lactose in a multiphase mixture.37  The technique, however, could be 
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theoretically extended to multiple amorphous phases, provided the diffuse scatter patterns 
of each individual disordered component were unique. 
 For the aforementioned method, the advantage in handling convoluted peaks and 
quantification of amorphous phase(s) without the creation of a calibration is contingent 
upon a few factors.  Diffraction patterns must be obtained for each individual component 
comprising the mixture; impurities in the composite pattern or individual component 
patterns would introduce error into the analysis.  Each pattern in the analysis should be 
collected using exactly the same parameters and conditions.  Additionally, peak shape 
and intensity must be consistent for a given phase to give reliable predictions.  Much of 
the success of implementing the latter full-pattern technique was attributable to invoking 
a pattern normalization method based on Vainshtein’s law.37  This states that total 
integrated diffraction intensity in reciprocal space is independent of phase, as total 
electron density does not change with solid form, given constant mass.  An important 
interpretive assumption linked to this law imposes either: (1) the whole sample must be 
irradiated throughout the entire angular range of the diffraction experiment; or (2) the 
same mass of sample is irradiated throughout the entire angular range of the diffraction 
experiment.  If violated, the total electron density interrogated between samples would 
vary.  Issues with preferred orientation, particle size broadening, strain, and 
microabsorption, unless uniformly observed between samples, will all introduce error 
into the analysis. 
 From the preceding qPXRD discussion, it may seem apparent that an increased 
sensitivity to materials that diffract X-rays at a lower intensity (e.g. amorphous, 
disordered, nanocrystalline materials) is afforded through multivariate techniques.  
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Recent qPXRD literature has introduced multivariate chemometric linear algorithms as 
useful tools in pharmaceutical applications and demonstrated robust modeling 
capabilities using classical least squares regression, principal components regression, and 
partial least squares regression.  The implementation of full-pattern analysis in 
combination with creating a calibration, avoids many of the preceding issues.  This is the 
subject of Chapter 2. 
1.3.1.2 Pair Distribution Function 
 The majority of pharmaceutical applications employing PXRD focus on analysis 
of Bragg diffraction peaks only.  These diffraction data contain highly useful information 
pertaining to the global view of the structure (i.e. long range interatomic correlations).  
To be rigorous, one must recognize that structure occurs at a local level (i.e. short- and 
intermediate- range interatomic correlations), as well.  When considering ideal crystalline 
systems, this distinction is rather irrelevant, as the global structure is indicative of the 
local structure.  Lattice periodicity is a crucial element to the successful implementation 
of Bragg’s law.  If a material is not perfectly periodic, however, Bragg’s law does not 
fully characterize the solid structure and researchers are forced to describe it in different 
ways.  Therefore, when deviations from average crystallographic order are present, 
consideration of local structure packing becomes pertinent. 
 Given Bragg diffraction peaks contain information pertaining to global structure 
only, additional data is required to investigate local structure.  Total scattering methods 
make use of the entire diffraction pattern and are sensitive to local level structure.  The 
name “total scattering” comes from intensity values encompassing Bragg peaks (average 
structure), elastic diffuse scattering (static local structure) and inelastic scattering 
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(atom/molecular dynamics).38  Total scattering analyses make use of the collection of the 
aforementioned sources without resolving or differentiating the individual contributions 
and are, therefore, sensitive to short- and intermediate-range interatomic correlations.   
 When an atom, j, is irradiated by an incident wave, the total scattering amplitude 
of the wave due to the sample is given by: 
∑1=
j
iQR
j
jef
f
Q)(ψ  (1.4) 
where ψ(Q) is the sample scattering amplitude, f is the atomic scattering factor, ‹› 
indicates the average, Rj is the position of the jth atom, and Q is the diffraction vector or 
momentum transfer.38  The momentum transfer is essentially equivalent to the change in 
momentum between the incident wavevector and the scattered wavevector.  If it is 
assumed that only elastic scattering is considered, the wavelength of each respective 
vector would remain constant, and thus the magnitude of the momentum transfer is given 
by: 
λ
θπ sin4
=Q  (1.5) 
where λ is the wavelength of radiation used, θ = 2θ/2, and 2θ is the maximum scattering 
angle interrogated in the experiment.  In deriving the sample scattering amplitude 
(Equation 1.4), the kinematic approximation was made, thereby only considering single 
scattering events.    
 Since the sample scattering amplitude can not be directly measured, it becomes 
highly advantageous that the square of its magnitude is directly related to the intensity of 
the diffracted beam.  Although PXRD intensity data are collected in “reciprocal space” as 
a function of Q, a direct representation of the real structure (i.e. real space domain) may 
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be obtained by Fourier transform of scattered intensity.  The pair distribution function 
(PDF) transform is a total scattering method that exploits the Fourier relationship 
between reciprocal space and real space.  The basis of this method resides in the structure 
function, S(Q), which is the normalized scattering intensity measured from a sample (i.e. 
normalized PXRD pattern).  The magnitude of the structure function with respect to the 
wavevector will be highly dependent on the direction interrogated in Q-space.  A 
simplification occurs when scattering becomes macroscopically isotropic, as only the 
magnitude of the scatter (and not direction) is important.  Isotropic scattering is easily 
envisioned for liquids, gases, and glassy materials; however, it is also reasonably 
assumed for fine crystalline samples, where each individual crystallite is not isotropic, 
but the ensemble of scattering is.38  The PDF, G(r), is therefore obtained as follows: 
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where r is the distance between two atoms, ρ(r) is the microscopic pair density, ρo is the 
average number density, f and ‹› are defined above, and δ is a delta function.  The PDF 
gives the probability of finding two atoms separated by a distance, r and is thus 
attributable to some atom-atom relationship, or interatomic correlation.39   
 From Equation 1.6, the integration of the function is taken from Q = 0 to Q = ∞ 
for an infinitely precise computation of the PDF.  The PDF of a perfectly crystalline 
material would display constant-amplitude oscillations in G(r) to infinity.  In reality, 
however, Q can only be measured over a finite range (i.e. Qmax).  The result is the 
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amplitude of the signal gradually falls off in G(r), not due to the limitation of structural 
coherence, but rather a limitation in spatial coherence of the measurement.  The finite Q-
resolution of a PXRD experiment can be the source of termination ripples (λ ~ 2π/Qmax)40 
in the PDF, unless treated appropriately. 
 In a PXRD experiment, substantial corrections need to be made to intensity data 
prior to Fourier transformation.  Generally speaking, a number of estimates and 
approximations are made when calculating the normalized structure function, thereby 
inducing some distortion(s) to the intensity data.  Fortuitously, inadequacies in the data 
normalization result in long-wavelength distortions to the structure function that manifest 
as nonphysical features (ripples) at very low r values in the PDF.41  These inadequacies 
are often dealt with through an arbitrary mathematical correction, including varying the 
sample density during scaling, varying the beam width, or scaling the structure function 
itself. 
 Although the sample density is fairly easy to determine with reasonable accuracy, 
it can be varied to produce a structure function consistent with its asymptotic 
requirements.  Varying sample density applies a predominantly multiplicative correction 
to the structure function, as is strongly affects both intensity normalization and absorption 
correction.  Although the beam size is known from the collimation of the instrument, the 
beam may not be homogeneous.41  The effective beam width will be different from the 
physical dimensions due to varying intensity across the beam profile.  Varying the beam 
size is primarily a multiplicative correction to the resulting structure function, as well.  
Both corrections can have additive components when multiple scattering manipulations 
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are applied.  Finally, directly scaling the structure function itself using multiplicative, 
additive, or a combination of the two, may be used to optimize the Fourier transform. 
 The selection of the value(s) to vary is arbitrary if some sort of quality criteria is 
implemented to assess the validity of optimization.  The PDF is highly sensitive to the 
asymptotic behavior of the structure function in the high Q region, which could 
ostensibly serve as a quality metric.  The density, beam width, or scaling factors would be 
varied to produce a structure function that asymptotes one.  Alternatively, the greatest 
manifestation of improper structure function correction is the introduction of ripples in 
the low r region of the PDF, and therefore, a quality criterion derived from this anomaly 
is more suitable.  The ΔGlow metric is given by: 
∫
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where rlow is a region in r before the appearance of the first physically possible peak, and 
ρfit is the average number density.  From the Equation 1.9, the ΔGlow criterion is a 
measurement of the magnitude of ripples in the region between r = 0 and r = rlow.  
Parameters are varied, as described above, to effectively minimize the ΔGlow metric.  A 
study by Peterson et al.41 concluded the ΔGlow criterion was more robust than other 
options, and the choice of the parameter to vary during optimization (i.e. sample density, 
beam width), for all practical purposes, is inconsequential, as all seemingly yielded the 
same result. 
 Justification for using high energy synchrotron radiation for X-ray diffraction-
based PDF studies is warranted in the mere definition of the magnitude of the momentum 
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transfer.  The increase in spatial coherence of the measurement and decrease in 
nonsensical artifacts from the Fourier transform are as good a reason as any to use 
synchrotron radiation for all PDF studies.  It is impractical, however, for the average 
researcher to perform all studies using this highly sought, expensive technology.  Bruhne 
et al.42 showed that PDF transforms obtained from both synchrotron and laboratory 
source data on three icosohedral alloys were qualitatively comparable and both suitable 
for least squares local structure refinement.  This is ultimately attributable to the robust 
nature of the PDF transform with respect to errors in the structure function, as previously 
discussed. 
 The PDF has been extensively applied to inorganic-based materials assessment 
since its introduction into the literature.  One of the largest applications involves material 
structure refinement, where successful structure elucidation for atomic amorphous 
materials43,44 and intrinsically disordered materials44-46 has been reported.  In addition, 
size-dependent structure and strain of semiconductor nanoparticles45 and assessment of 
thermal motions46,47 in atomic structures are becoming more routine.  Although the 
number of pharmaceutically-related PDF applications is substantially less, the increased 
exposure from recent publications is significantly advancing the interest among scientists 
in the field. 
 Pharmaceutical processing involving high-energy input is commonplace in the 
manufacture of solid oral dosage forms.  Shear-intensive particle milling, powder 
consolidation, and thermal challenging (i.e. fluid bed drying) all have the potential to 
affect structural order in pharmaceutical powders.  Of the PDF applications published in 
the pharmaceutical literature, the overwhelming majority have transformed standard 
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laboratory X-ray data.  Sheth et al.48,49 used PDF transforms to explain local structure 
differences in amorphous phases created from milling different polymorphic forms of 
piroxicam.  Interestingly, residual long range order in cryogenically milled samples 
explained recrystallization habits of different polymorphic forms of the starting material.  
A study by Bates et al.50 assessed the potential of the PDF transform to describe the 
nature of an amorphous substance.  From their analysis, materials were classified as 
disordered nanocrystalline or amorphous.  Disordered nanocrystalline materials exhibited 
peak broadening as a function of increasing introduction of disorder.  The final X-ray 
amorphous halo had specific correlations to highly intense Bragg peaks displayed by the 
crystalline material.  Additionally, a comparison between PDF transforms revealed 
interatomic probability peak correlations between the disordered nanocrystalline material 
and crystalline material.  In contrast, PXRD patterns of amorphous materials did not 
display peak broadening as a function of continuous disordering.  Further, the PDF of 
amorphous materials relative to crystalline material displayed significant differences.  
Again, from distinguishing different types of disordered materials, information 
concerning recrystallization behavior was gained. 
 Dehydration-initiated crystalline-to-amorphous conversions must be considered 
during high-temperature pharmaceutical processing, such as that observed for raffinose 
pentahydrate.  Authors proposed a quasi-mechanism for this transition using PDF 
transforms obtained as a function of drying time.51  The study revealed that a defect-
mediated process led to the collapse of the crystalline structure, where retention of the 
crystalline order was accompanied by significant defect generation during the loss of the 
first two water molecules.  Additional heating beyond this point resulted in a total 
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collapse of the intermediate- and long-rang order of material structure.  The ability of the 
PDF transform to yield information concerning defect-generated disordering due to 
shear-intensive and high energy input processing, as illustrated in the previously 
discussed examples, foreshadows its potential use in investigating structural changes 
resulting from powder compaction, which is ultimately the subject of Chapter 3. 
 In addition to the lack of Bragg diffraction peaks exhibited by amorphous 
molecular solid dispersions, PXRD patterns have been shown to provide additional 
information pertaining to local structure in these systems.  The sensitivity of the PDF 
transform to interatomic correlations makes it an obvious choice for studying 
pharmaceutical systems displaying order on only a short length scale.  One of the most 
recent applications of the PDF transform to pharmaceutical systems is in the 
characterization of co-solidified products to aid in identifying miscibility between a drug 
and polymer (Section 1.3.2).  Newman et al.52 illustrated the principles behind the use of 
PDF transforms to distinguish co-solidified products possessing unique short-range order 
relative to the amorphous components that comprise the mixture.  The method involved 
obtaining PXRD patterns of the amorphous phases comprising the co-solidified product, 
as well as, one for the co-solidified product itself.  All PXRD patterns were subsequently 
transformed by the PDF algorithm and linear combinations of the amorphous component 
PDFs were compared to the PDF of the co-solidified product.  If the calculated PDF 
exacted a “good fit” to the PDF of the composite, the co-solidified product was 
categorized as phase-separated, due to the absence of a unique packing pattern.  If a good 
fit could not be obtained, the co-solidified product was categorized as completely 
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miscible, due to formation of unique short-range order (i.e. nearest neighbor and next-
nearest neighbor correlations) not explained by the individual amorphous phases. 
 The power of this method is quickly realized by the scientist charged with the task 
of determining miscibility in drug:polymer products, an all too often intangible 
distinction.  Upon first glance, an initial weakness is the necessity of obtaining 
amorphous phase samples for each of the pure components.  As the purpose of forming a 
solid dispersion is to physically stabilize the amorphous form of a drug, the ability to 
isolate and physically maintain a sample to provide sufficient analysis time is not trivial.  
A second limitation was the ambiguity with which an assessment of “difference” was 
made between linearly combined PDF transforms and the transform of the co-solidified 
product.  To make the analysis more robust, a method has been proposed to propagate 
error estimates for the calculated difference and is the subject of Chapter 4. 
1.3.2 Solid Dispersions 
 Rigorous differentiation between the different composite systems, such as 
eutectics (Appendix A) and solid dispersions, is somewhat ambiguously presented across 
the breadth of the pharmaceutical literature.  This leads to a systematic misclassification 
of these products, thereby founding fundamentally irrelevant conclusions from studies 
encompassing the subject area.  A more accurate approach to defining and contrasting the 
individual composites can be realized through a strict materials-based structural 
assessment.  Analogous to the way in which crystal symmetry defines a crystal system 
(and not vice versa) the microstructure of a binary solid composite defines its type.  From 
these definitions, analytical techniques required for accurate product classification are 
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identified, a better fundamental understanding of aqueous solubility enhancement can be 
provided, and issues inherent to the underutilization of the technology is established. 
1.3.2.1 Structure 
 The three types of symmetry defining long-range crystallographic order are 
translational, orientational, and conformational.  Crystalline solids have all three, where 
mesophase materials possess one or two.53  In amorphous materials, all three symmetry 
operators are characteristically absent; therefore the orientation and position of molecules 
relative to one another is random, as similarly observed in liquids, but short-range order 
over a few molecular dimensions is present.54,55  The thermodynamic relationship 
between crystalline and amorphous phases is best rationalized schematically in the 
enthalpy-temperature phase diagram (Figure 1.2).  Starting with a crystalline material, 
small changes in temperature correspond to minor changes in enthalpy response, where 
the slope defines the heat capacity of the solid at constant pressure.  Upon further 
increase in temperature to Tf, a discontinuity in the diagram is encountered and a sharp 
increase in enthalpy is observed.  This is the first-order fusion event representing the 
crystalline-to-liquid transition.  If the melt is rapidly cooled, enthalpy may bypass the 
melting/freezing point producing a supercooled liquid.  Upon further cooling the glass 
transition event is encountered, where a change in heat capacity is observed due to a 
higher-order transition from a supercooled liquid to a glass.  Any additional cooling is 
thought to have very little influence on the microstructure of the material.56  The 
Kauzmann temperature (TK in Figure 1.2) represents the temperature at which the 
entropy of a supercooled liquid would fall below that of the stable crystalline material.  
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The change in heat capacity that occurs at the glass transition prevents the hypothetical 
decrease in entropy to permit this phenomenon.57   
 
Figure 1.2. Enthalpy:temperature phase diagram. 
 From Figure 1.2, the glass is a higher free energy phase compared to its 
crystalline counterpart, and further deviates from equilibrium.  The system is said to be 
kinetically “trapped” in the solid state, as it exhibits increased molecular mobility relative 
to the crystalline phase, but lower than that of the liquid state.  The higher free energy 
provides for enhanced apparent aqueous solubility, as NBIs maintaining the solid-like 
viscosity are weaker than those responsible for crystalline counterpart.58  A corollary of 
this solubility enhancement is the thermodynamic driving force to revert back to the 
lower energy, crystalline phase.  To maintain the amorphous phase and sustain the 
solubility enhancements, solid dispersions are formed between an amorphous drug 
substance and a polymeric carrier material; although, the exact mechanism of physical 
stabilization is largely unknown. 
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 A binary amorphous molecular solid dispersion is a material consisting of two 
components co-solidified such that the short-range order of the product is distinct from 
that intrinsic to the amorphous phases comprising the mixture.  Since solid dispersions 
are macroscopically amorphous systems, it is worthwhile to note that this implies that 
they are also non-equilibrium phases.  Many of the models founded on equilibrium 
thermodynamic principles may be highly inappropriate for solid dispersions.  As a 
consequence, specific mechanistic explanations describing structural correlations 
between solid dispersion co-solidification and observed physicochemical and mechanical 
properties of these systems are lacking.  This void is also an effect of the random 
orientations of the drug and carrier molecules, as well as the heterogeneity of the 
interactions between the two components, which ultimately differ between single- and 
two-phase systems.  Both specific (i.e., hydrogen bonding) and nonspecific (i.e., van der 
Waals forces) intermolecular interactions, however, have been characterized in solid 
dispersed systems, and are well represented in the pharmaceutical literature.59-62  The 
extent of the participation of these interactions in solid dispersion stabilization (or lack 
thereof) continues to be a matter of discussion.   
 The lack of periodic NBI schemes in amorphous materials results in a higher 
internal energy, which can provide enhanced physicochemical properties, such as 
increased apparent aqueous solubility and/or enhanced dissolution.  The random 
structural framework of solid dispersed systems and the presence of various combinations 
of specific/non-specific bonding schemes, make direct correlations between structure and 
enhanced solubility less straightforward than other composite bodies (e.g. eutectics).  The 
increase in dissolution rate of solid dispersions, however, has been attributed to three 
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factors: (1) reduction in drug particle size (i.e., in molecular dispersions, the “particle 
size” of the amorphous inclusion is on the order of the dimensions of the API molecule), 
(2) decreased drug:water interfacial energy, and (3) establishment of weaker NBIs per 
unit volume material relative to the NBIs per unit volume of the drug’s crystalline 
phase.19,63  Given the number of possible structural variants, the degree to which each of 
these contributes to the optimized physicochemical properties may be dramatically 
different.  It may seem apparent from the preceding discussion that more rigorous 
structural characterization will be required to model physicochemical benefits afforded 
through the directed design of solid dispersions.  Furthermore, these benefits will vary 
with respect to individual systems; a universal model of solid dispersion structure-
function correlation seems impractical. 
 A review by Craig64 introduced a model that explained the release behavior of 
drug molecules from a solid dispersion as being either carrier-mediated or drug-mediated.  
A representation of these two schemes is illustrated in Figure 1.3, where drug release 
from a two-phase solid dispersion is shown.  Initially, a polymer-rich diffusion layer is 
formed at the interface between the solid dispersion and the dissolution medium.  The 
viscosity of this interfacial layer is assumed to be greater than that of the liquid phase.  In 
carrier-mediated dissolution, the amorphous drug inclusions (assuming a biphasic solid 
dispersion) diffuse from the dispersion matrix into the polymer-rich phase, where they 
begin to dissolve.  Drug is further released from this polymer-rich layer into the 
dissolution medium as either solvated molecules, or as amorphous particles having 
undergone size-reduction, at a rate dictated by the carrier. 
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 Figure 1.3. Schematic showing various release modes of amorphous drug inclusions 
during dissolution of a solid dispersion (after Craig,64 with modifications); (a) carrier-
mediated dissolution: the carrier forms a polymer-rich phase aiding in initial drug 
complex dissolution; (b) drug-mediated dissolution: high solubility of the carrier in the 
dissolution medium prohibits formation of a polymer-rich phase; dissolution of the drug 
occurs following diffusion of the amorphous complex from the dispersion to the 
dissolution medium; (c) Complex aggregation following drug-mediated dissolution: 
amorphous inclusions agglomerate upon diffusion into the dissolution medium, resulting 
in their higher propensity for devitrification. 
 
 In drug-mediated dissolution, the solubility of the polymer in the medium is 
considered to be much greater relative to the dissolution time-frame, ultimately resulting 
in a polymer-rich layer that is smaller relative to the polymer-rich phase observed in 
carrier-mediated dissolution.  As the drug inclusions diffuse through the polymer-rich 
phase, the rate is sufficient to prevent their dissolution in the polymer layer.  The 
amorphous drug is, therefore, released intact into the surrounding aqueous medium, and 
its dissolution rate is proportional to the aqueous solubility of the amorphous condensed 
phase.  In both instances, solubility enhancement relative to crystalline materials is 
provided owing to either the total breakdown of drug inclusions prior to release in the 
medium (carrier-mediated), or to the release of amorphous complexes left to dissolve on 
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their own (drug mediated).  Craig proposes the application of this model to aid in 
identifying the correct strategy to improve dissolution via solid dispersion formulation.  
More importantly, the model may assist in understanding the basis for formulation 
instability, as related to dissolution, and provide a scientific approach to dealing with 
such issues. 
 A route of physical instability occurring during dissolution that is directly related 
to the drug-mediated model for solid dispersions is depicted in Figure 1.3c.  When the 
amorphous inclusions diffuse through the polymer-rich diffusion layer too rapidly, and 
their dissolution rate in the aqueous medium is relatively slow, a time-frame sufficient to 
promote recrystallization may be encountered.  Nucleation and growth can be thought of 
as occurring by, (1) each individual amorphous complex begins the recrystallization 
process independent of other amorphous complexes, or (2) agglomeration of amorphous 
complexes creates high-energy interfacial boundaries, thereby driving the interfacial term 
of nucleation models to favorable values.  The latter of these two conditions is expected 
to be more prevalent, as reduction in specific surface area upon formation of 
agglomerates would slow the dissolution rate even more, permitting a longer time-frame 
for recrystallization.  This particular mechanism of physical instability illustrates the 
importance of excipient selection in solid dispersion formulation; notably, the relative 
aqueous solubility of the carrier component may induce physical instability during the 
dissolution process.  Further, as will be discussed in greater detail, the relationship of 
manufacturing methods to resulting solid dispersion structure becomes an important 
variable when considering release behavior. 
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 The review by Craig was an important step in correlating the release behavior of 
solid dispersions to formulation, stability issues, solid dispersion design, etc.  However, 
the proposed model fails to address structurally-related bases for the proposed differences 
in release (e.g., effects of intermolecular interactions between drug and carrier on drug 
release mechanism) and focuses specifically on biphasic systems, thereby neglecting 
molecularly dispersed solids.  Karavas et al.,65 more recently reported that the molecular 
interactions between felodipine:polyethylene glycol (PEG) & 
felodipine:polyvinylpyrrolidone (PVP) dictate the resulting physical state of felodipine 
(crystalline versus amorphous), as well as the size of inclusions in the dispersed matrix.  
The additional characterization of the solid dispersion enabled the authors to ascertain the 
release mechanism as related to the specific structure of the dispersion and to identify 
critical manufacturing attributes which altered the structure and release mechanism.   
 The preceding discussion demonstrates the size-dependence of the carrier matrix-
dispersed inclusions on the release mechanism, and the additional implications 
concerning physical stability of the material during dissolution. Unfortunately, the 
structural heterogeneity of the solid dispersion variants often deters rigorous intrinsic 
correlation to physicochemical properties, creating an area having tremendous research 
potential. 
1.3.2.2 Manufacture 
 The traditional methods for manufacturing solid dispersions can generally be 
broken down into two general categories: (1) fusion-based methods and (2) solvent-based 
methods.  Sikiguchi and Obi66 were the first to demonstrate the use of a hot-melt 
procedure in the production of pharmaceutically-relevant solid dispersions.  Subsequently, 
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Tachibani and Nakumara67 dissolved both a drug and carrier in a common solvent, which 
was then evaporated under vacuum to produce a solid dispersion.  In the production of 
binary solid composites, each method has its own advantages and disadvantages 
stemming from production costs, ease of manufacture, scalability, and other critical areas.  
In the last decade, new techniques have emerged which address one or more of these 
deterrents.  Some of the barriers that complicate the application of each individual binary 
composite to pharmaceuticals manifest through investigation of the manufacturing 
regimes. 
 Since solid dispersions are structurally aperiodic, methods not traditionally used 
in other solid composite production may be employed in their creation.  Spray drying,68,69 
lyophilization,63 fluid-bed coating,70 and hot-melt extrusion71,72 have all been used in 
pharmaceutically-related manufacturing of solid dispersions, as these processes are 
known to result in amorphous products.  Current literature shows a trend in development 
of new schemes for solid dispersion formation that are fundamentally similar to 
traditional techniques; however, the newer methods have been shown to possess various 
benefits relative to their conventional counterparts, thereby deserving attention.  It may 
be worthwhile to note that although these methods are common in the sense that an 
amorphous co-solidified product is formed, it has been shown that common 
manufacturing methods may, in fact, have an effect on the supersaturation of drug in 
polymer.73  
 In a recent study, Papadimitriou et al.,74 used microwave irradiation in place of 
conventional heating to melt the drug and carrier mixtures and then compared the 
resulting dispersion with that prepared by the conventional fusion technique.  In both 
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instances, the resulting dispersions were two-phase systems possessing an element of 
periodicity; therefore, neither product would be defined as a solid dispersion according to 
the criteria proposed in this paper.  The authors claimed a reduction in production time by 
using microwave radiation with a slight enhancement in the dissolution profile.  However, 
the biphasic dispersion produced using this method was shown to result in a smaller 
particle size, which may better explain the improvement in dissolution kinetics.  
Although the authors attributed the decrease in particle size to the use of microwave 
irradiation, this actually appears to be a consequence of the more rigorous mixing regime 
employed.  The practicality of scale-up for this particular method may also limit its 
potential for adoption at the industrial level.  In addition to the limitations imposed by 
capital investment, since pharmaceutical applications of microwave technology are 
relatively new to the industry, considerable attention to issues involving distribution 
homogeneity, implications of microwave energy on chemical stability, and other method-
related topics is required. 
 Xu et al.,75 developed a pulse combustion dryer system designed from the basic 
principles of spray drying.  A combustion cycle is repeated at a specific frequency to 
produce consecutive high-temperature shock waves used to rapidly dry solutions of drug 
material and carrier.  Advantages of the system include an increased rate of heat transfer, 
decreased drying time, and lower costs compared with conventional spray drying.  
Studies show an enhanced apparent dissolution rate for ibuprofen solid dispersions 
prepared using the pulse combustion dryer versus conventional spray drying.  The 
authors failed to present structural characterizations for both products; therefore, the 
aforementioned dissolution advantage may be due to the decreased particle size of the 
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pulse combustion dryer final product relative to the conventional spray dryer product.  
Once again, the cost of developing a pulse combustion dryer system for large scale 
production may outweigh the benefits afforded by this technology.   
 Supercritical fluid processing was shown to be a valid alternative to the solvent-
evaporation method resulting in lower residual organic solvent, co-precipitates possessing 
smaller particle sizes, and better flowability.  In the work by Sethia and Squillante,76 the 
authors showed that solid dispersions prepared by supercritical fluid processing (SCP) 
had an enhanced intrinsic dissolution rate relative to dispersions made via conventional 
solvent evaporation (SE) augmented with amphiphilic carriers, thereby eliminating the 
stability issues associated with lipid carriers.  Powder X-ray diffraction analysis of 
products prepared by both SCP and SE augmented with an amphiphilic carrier revealed 
highly disordered materials; however, a closer look at the PXRD pattern of the SE 
product reveals some Bragg diffraction peaks attributable to the amphiphilic carrier.  The 
solubility advantage of this material is most likely due to considerable amorphous content; 
however, the presence of phase-separated crystalline solid suggests incomplete 
preparation of an amorphous dispersion via the SE method.  As with the other novel 
methods suggested above, although this technology holds some advantages, industrial 
scale-up may present a major cost-related barrier to its adoption.   
 Many of the authors presenting the manufacturing alternatives above advocate the 
cost-effectiveness of their respective processes in terms of efficiency (primarily 
decreased processing time) yet do not present a cost analysis to support their claims.  As 
a supplement to structural and physicochemical comparisons, contrasts in small-scale 
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research costs as well as large-scale manufacture should be considered when suggesting 
the viability of a new manufacturing technology.   
 Typically, studies involving the structural characterization and assessment of the 
physicochemical properties of solid dispersions only consider solids produced by a single 
manufacturing scheme.  In contrast, Dong et al.,77 published results that compared the 
solid state properties of dispersions prepared both by hot-melt extrusion and solvent co-
precipitation.  In this study, a proprietary compound was evaluated for its potential 
development as a solid dispersion formulation.  Dispersions were prepared using 
hypromellose acetate succinate (HPMC-AS) as the carrier molecule, via hot-melt 
extrusion and solvent co-precipitation.  Both methods were observed to yield a single-
phase (molecularly dispersed) amorphous dispersion.  Differential scanning calorimetry 
(DSC) analysis of each product showed them to have a single glass transition event, 
occurring at comparable temperatures.  The co-precipitation product, however, was 
determined to be more porous than the hot-melt extrusion product, thereby resulting in a 
larger specific surface area.  The co-precipitation product had a faster dissolution profile, 
but a slower intrinsic dissolution rate relative to the hot-melt extrusion product.  Though 
the authors did not suggest a reason for this observation and noted that it was unexpected, 
a possible explanation may be drawn from classical Noyes-Whitney dissolution theory: 
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where M is the mass of the drug dissolved in time t, D is the diffusion coefficient of the 
drug in the dissolution medium, S is the surface area of the exposed drug, h is the 
thickness of the diffusion layer, Cs is the solubility of the drug, and C is the concentration 
of the drug in the bulk solvent at time t.2  Traditional dissolution profiles were generated 
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by suspending the product in an aqueous vehicle and transferring it to a United States 
Pharmacopeia (USP) type II apparatus (paddles).  In these experiments, the co-
precipitation product reached its plateau dissolution value possibly attributable to the 
increased value of S relative to the hot-melt extrusion product.  Intrinsic dissolution 
studies were conducted by compressing each product at 2000 lbs. force to form a pellet 
having a constant exposed surface area.  Given that one of the principle steps in 
consolidation is a reduction in void volume, or porosity, it is not unexpected that the 
surface area enhancement gained by employing the solvent co-precipitation method was 
lost.  Normalization of the final compacted pellets to their solid fraction may explain the 
enhanced intrinsic dissolution observed for the hot-melt extrusion product.   
 The authors also showed an enhanced physical stability of the hot-melt extrusion 
product over the dispersion produced from the co-precipitation process, which once again, 
may be related to a specific surface area argument.  The co-precipitation product, having 
a larger specific surface area, possesses more accessible sites for water molecules relative 
to the hot-melt extrusion product.  The presence of water on the surface of amorphous 
materials can create supersaturated microenvironments which serve as nucleation sites.  
Additionally, water may act as a plasticizer,78 thereby theoretically increasing the 
molecular mobility.      
 Though this study illustrates that the various physicochemical properties of solid 
dispersions may be dependent upon the manufacturing method, it fails to address specific 
structural differences which may contribute to these properties.  For example, a powder 
X-ray diffraction pattern was shown for both products to illustrate an absence of Bragg 
diffraction peaks inherent of a crystalline material, which may be a result of the material 
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being truly X-ray amorphous or an artifact of inappropriate sensitivity to adequately 
detect diffraction.  Advanced methods in diffraction pattern processing (e.g. pair 
distribution function transformation) may have been applied to delineate local structure 
differences between the two products, where a correlation to these differences may be 
established.  Creation of models to explain and predict these types of phenomena will be 
imperative to understanding and applying these systems for commercial manufacturing 
and may ultimately result in the increased use of solid dispersions in pharmaceuticals. 
1.3.2.3 Stability 
 The amorphous state possesses a higher free energy relative to its crystalline 
counterpart, which should result in enhanced thermodynamic properties (i.e. solubility) 
and molecular motion.  A consequence of this increased molecular motion is the tendency 
to revert back to a stable crystalline phase (devitrification).56  Thermodynamically, 
amorphous substances will inevitably devitrify; however, the time frame of this process is 
at the heart of research directed at stabilizing these materials.   In addition to physical 
drivers for recrystallization, environmental factors, such as water, must be considered for 
dispersion systems, where the hygroscopicity of the polymeric carrier may be a 
significant factor.79  Oftentimes strategies to deal with physical stability issues in 
pharmaceutical products do not require elimination of the source for the mechanism of 
instability; rather, the kinetics of the transformation are manipulated to prolong a 
product’s shelf life. 
  Molecular mobility is frequently described as a key factor in the physical stability 
of amorphous phases.80  The glass transition, commonly represented as a single value (Tg), 
actually occurs over a temperature range delineating high and low molecular mobility 
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within the material.  Evidence of increased resistance to recrystallization in solid 
dispersions has been attributed to antiplasticization when polymeric carrier components 
having a higher Tg relative to that of the drug are used.81  However, other reports show 
examples where differences in Tg values between carrier components and API were not 
correlated to the physical stability of the dispersions studied.59,82  Both specific and 
nonspecific intermolecular bonds have been shown to occur in stable solid disperse 
systems.  This includes direct bonding interactions between carrier and drug molecules 
and/or the disruption of drug:drug interactions (e.g. dimer formation)48 by the carrier.48,83  
In conflicting reports, however, these interactions are shown unnecessary in the 
prevention of recrystallization.81  Consequently, the preceding points illustrate the 
difficulties with identifying and the limited understanding of the physicochemical 
properties of the carrier necessary for inhibiting drug devitrification. 
 The Gordon-Taylor equation,84 based on the mechanistic approach of free volume 
and related densities, has been successfully applied to predict Tg of molecular dispersions 
and is given by: 
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where w1 and w2 are the weight fractions of each component, Tg1 and Tg2 are the 
respective glass transition temperatures, and K = (Tg1ρ1)/(Tg2ρ2), where ρ is the density of 
the component.  A variation of Equation 1.11, where K = ΔCp1/ΔCp2 and derived from 
more thermodynamic assumptions, was later identified by Couchman and Karasz.85  
Although the Gordon-Taylor equation has been shown to be highly useful when both 
components are large polymeric materials, it has been shown to poorly predict SMO-
polymer systems.  Additionally, since many of the empirical parameters of each equation 
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are determined using thermodynamic techniques (e.g. DSC), it is somewhat more 
appropriate to use the Couchman-Karasz version of the equation.86
 Recall that formation of solid molecular dispersions assumes complete 
drug:polymer miscibility in the liquid phase, which, as previously interpreted, means that 
adhesive interactions must be comparable to cohesive interactions (in the liquid phase).  
In the case of antiplasticization, some intermolecular interactions between the polymer 
and drug would be anticipated to decrease the molecular mobility of the amorphous 
system.  This definition suggests a correlation between the two proposed mechanisms of 
stabilization, where this combination has been reported in studies as the underlying 
mechanism of stabilization.83   
 In order to maintain the advantage of drug substance solubility enhancement 
provided by its preparation in the amorphous state, methods to preserve its physical 
stability over a pharmaceutically-relevant time scale must be employed.  Water-soluble 
polymers such as PEG, PVP, and cellulose derivatives (e.g. hydroxypropylmethyl 
cellulose) are commonly incorporated as carriers in pharmaceutical solid dispersions.  
Much of the current research investigates the specific stabilization mechanisms afforded 
by polymers in pharmaceutical solid dispersions.  For amorphous molecular solid 
dispersions, it is recognized that devitrification is preceded by amorphous drug:polymer 
phase separation, in the case of nucleation and growth.87    In a study by Konno and 
Taylor59 the ability of three polymers to inhibit the recrystallization of felodipine was 
investigated.  PVP, HPMC, and HPMC-AS were combined with felodipine to create 
molecularly dispersed systems.  To study both antiplasticization effects and drug-polymer 
molecular interactions, the polymers were selected to span a range of Tg values and had 
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different potentials for hydrogen bonding.  PVP showed both increased hydrogen-
bonding interactions with felodipine as well as a greater antiplasticization effect relative 
to the other polymers.  All three polymers, however, were found to prolong the time to 
nucleation of amorphous API to a similar extent, given an equivalent weight fraction.  
The mechanism proposed by the authors ascribed the increase in physical stability to 
result from the provision of a kinetic barrier to nucleation by the polymeric carriers, with 
the magnitude of the effect being related to the polymer concentration (w/w). 
 The important distinction between drug:polymer miscibility and physical stability 
needs to be drawn.  The thermodynamic term “miscibility,” in a strict sense, is taken out 
of context when applied to drug:polymer systems.  Rather than associating miscibility to 
the equilibrium solubility between a drug and polymer, it more accurately describes the 
ability of a drug and polymer to form a supersaturated metastable phase.  Although 
miscibility between a drug and polymer is indicative of the compatibility between a drug 
and polymeric material, it does not, however, give any insight into the timeframe (extent) 
of physical stability.  
 Predicting drug:polymer miscibility at various concentration ranges, as well as 
differentiation from partial miscibility,88 has become the focus of recent studies.  The use 
of interaction parameters (e.g. derived from group contribution theory) and Flory-
Huggins theory to predict drug:polymer miscibility has recently appeared in the literature.  
One study89 concluded that the majority of SMO compounds will be supersaturated with 
respect to solubility in a polymer, providing a thermodynamic driving force for 
recrystallization.  Additionally, the physical stabilization was predominantly attributable 
to a kinetic barrier; however, molecular level miscibility was still shown to be an 
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important factor as molecularly dispersed systems have altered molecular level 
environments.  In an unrelated report, an attempt to predict dispersion potential from 
physical properties (melting point, molecular weight, etc.) and functional groups of 20 
compounds was described.  Although none of the physical properties probed were 
predictive of miscibility, compounds with hydrogen bonding potential were shown to be 
favorable candidates.90   
 From the background supplied herein on the subject of PXRD structural and 
quantitative analyses, an appreciation for the necessity of accurately characterizing 
amorphous systems and the local structure deviations in a crystalline material is gained.  
The ability to successfully model predictability for overall aperiodic systems, such as 
amorphous molecular solid dispersions, will be discussed in great detail and ultimately 
hinged on the credibility of differentiating co-solidified products at the local structure 
level.   
 A general consensus among the pharmaceutical community concerning 
appropriate characterization methods for studying solid dispersions is sufficiently lacking.  
Characterization inconsistencies between research groups have yielded conflicting reports, 
thereby complicating the advancement in understanding of solid dispersion systems.  
Vibrational spectroscopy has been successfully used to identify specific/non-specific 
interactions developed between a drug and polymer in co-solidified systems.59-62  
Unfortunately, the level of mixing between materials is not available from spectral 
changes.  Further, cohesive interactions are either so subtle or absent altogether that 
changes to molecular vibrations may not be detected.81  Traditional PXRD analyses only 
confirm a lack of detectable crystallinity in a co-solidified product and fail to provide 
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information concerning the extent of mixing between the components, as well.  Although 
DSC has served as the conventional method for identifying an overall phase-separated 
system, forthcoming sections will aim to illustrate instances where it is not sensitive to 
phase separation and the use of multiple characterization techniques is imperative.  To 
this end, the successful completion of the theoretical portion of this dissertation (i.e. solid 
dispersion potential) was afforded by the analytical optimization comprising Chapters 2, 
3, and 4. 
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Chapter 2: Chemometric Applications in Quantitative Powder 
X-ray Diffraction (PXRD) of Intact Multi-Component 
Consolidated Samples  
 
2.1 Introduction 
 Powder X-ray diffraction (PXRD) of intact, consolidated samples is an important 
technique for pharmaceutical materials and drug product characterization.  Quantitative 
PXRD methods are the most universal of the structure-sensitive methods for phase 
analysis of multi-phase systems.20,23  The foundation of quantitative PXRD techniques for 
analyzing mixtures was originally developed by Alexander and Klug,26 and some 
examples applied to pharmaceutical mixture analyses are reported in the literature.52-57
 Traditional quantitative PXRD methods can be subcategorized into those which 
incorporate a standard and those which are standardless.  Standardless techniques, such as 
whole-pattern fitting and Rietveld refinement, are particularly useful because they permit 
quantification without the use of specific calibration standards.  These methods have the 
ability to assess and account for physical phenomena (such as preferred orientation); 
however, selecting an appropriate function, is not trivial.36  Standardless quantification 
has also been limited to uses with crystalline materials.  Further, they require a known 
crystal structure, which is often obtained from the literature/online databases.   
 Numerous quantitative PXRD methods exist to incorporate a standard material 
into mixtures for analysis,21 the use of which permits correction for matrix absorption.  
The most commonly employed of these is the internal standard technique.  Incorporation 
of a standard within a sample, however, prevents analysis of intact, marketable drug 
products, for which the inclusion of an analytical dopant would be prohibited.  Moreover, 
finding a standard that is stable, has approximately the same absorption characteristics as 
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the sample, does not exhibit preferred orientation, and possesses isolated peaks which do 
not overlap with sample peaks are all potential barriers to using this method.21
 Diffraction-absorption calibrations are created through empirical linear regression 
modeling of component concentration against single diffraction peak intensity, a few 
diffraction peak intensities, or the integrated area under diffraction peak(s).  These 
techniques assume constant mass attenuation across the sample, and therefore, are 
susceptible to errors resulting from diffraction intensity attenuation.  Anisotropic 
intensity reduction due to microabsorption and extinction often result in non-linearities 
observed in quantitative PXRD calibrations.26,36  The largest contributor to intensity 
attenuation, however, is preferred orientation, which can be particularly problematic in 
consolidated samples.36  Problems with preferred orientation in powdered samples are 
traditionally resolved by optimizing the particle size used for PXRD analysis, which may 
add significantly to method development and execution,30 as well as the potential for 
induction of experimental artifact owing to conversions elicited by triturative particle 
sizing.20   
 By using only Bragg diffraction intensities, the traditional methods are limited to 
quantification of crystalline materials.  Many solid oral dosage forms are developed using 
excipient materials having no long range order.  The physicochemical benefits afforded 
by incorporating amorphous active pharmaceutical ingredients in formulations of solid 
oral dosage forms has resulted in increased interest in the use of these systems;56 however, 
for PXRD to be sufficiently sensitive to quantify disordered materials, a method that 
models both diffuse scatter and Bragg diffraction is required.  
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 Many of the aforementioned issues are addressed through the use of multivariate 
calibrations.91  In quantitative chemometrics, a multivariate relationship is sought 
between input data (e.g., diffraction patterns) and output data (e.g., composition, various 
physical phenomena).  Applications of chemometric-based analyses in PXRD are starting 
to surface in the literature.  Examples of applications of partial least squares regression 
(PLS),92 principal components analysis (PCA),93,94 and advanced techniques such as 
artificial neural networks (ANN)95,96 to PXRD data have all been reported.  The possible 
benefits of incorporating entire diffraction patterns into empirical models include 
enhanced signal-to-noise, analyte sensitivity and selectivity.97  The objective of this work 
was to investigate applications of different multivariate calibrations used to quantify both 
crystalline and amorphous components in consolidated samples.  Intact compact analysis 
using PXRD was used to determine which algorithm was most suitable for intact 
quantification of multi-phase consolidated pharmaceutical systems. 
 Quaternary mixtures composed of two crystalline materials and two disordered 
materials were compressed at multiple compaction pressures and subjected to intact 
PXRD analysis using two different instrumental optics setups.  Quantitative calibrations 
were created using the traditional (univariate) diffraction-absorption technique, and three 
multivariate algorithms commonly employed in spectroscopy.  Calibration linearity, 
precision, and prediction error were calculated for assessing model suitability. 
2.2 Materials and Methods 
 Four-component mixtures comprised of anhydrous theophylline (Lot No. 92577, 
Knoll AG, Ludwigshafen, Germany), Lactose 316 Fast Flo NF Monohydrate (Lot No. 
8502113061, Hansen Labs, New Berlin, WI), microcrystalline cellulose (Avicel PH 200, 
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Lot No. M427C, FMC BioPolymer, Mechanicsburgh, PA), and soluble starch GR (Lot 
No. 39362, EMD Chemicals, Inc., Gibbstown, NJ) were prepared.  The design matrix 
was fully balanced for compact concentration, having values ranging from 0 – 60% w/w.  
Approximately 800 mg of each mixture was compressed at 67.0 MPa, 117.3 MPa, 167.6 
MPa, 217.8 MPa, and 268.1 MPa using a single station Carver Press (Carver, Inc, Model 
3887.1SDOA00, Wabash, IN) equipped with a 13 mm flat-faced punch.     
2.2.1 Powder X-ray Diffraction Analysis of the Four Component Compacts 
 PXRD data were collected using an X’Pert Pro MPD system (PANalytical B.V., 
Alemlo, the Netherlands) equipped with a copper anode (λ = 1.5406 Å), programmable 
divergence slit, and X’CeleratorTM detector.  The operational voltage and amperage were 
set to 45.0 kV and 40.0 mA, respectively, and diffraction patterns were acquired using an 
angular step size of 0.02° 2θ over a range of 2 – 60° 2θ.  Data were collected with the 
instrument set in both Bragg-Brentano reflectance geometry (equipped with a spinning 
sample stage) and transmission geometry (equipped with a vertical spinner sample stage 
with the sample sandwiched between Kapton® film), optically fitted with an auxiliary 
elliptical mirror used to expose the sample to quasi-parallel beam radiation. 
 All chemometric routines were performed in the Matlab programming 
environment (v7.1, MathWorks, Natick, MA) using the PLS_Toolbox (v3.0, Eigenvector 
Research, Manson, WA), together with several analysis routines developed in-house. 
2.2.2 Data Preprocessing  
 Prior to the application of chemometric algorithms, sample diffraction patterns 
were corrected for anisotropic peak (axis) shift using an iterative program that tested for 
correlations between a reference pattern and the sample pattern as a function of 
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incremental calculated shifts.  Corrected shifts that resulted in the highest correlation 
were ultimately selected.  Additionally, the diffraction pattern of an empty sample holder 
(geometry dependent) was used to correct for scatter from that sample holder by pattern 
subtraction.  Sample absorption correction was also performed according to published 
equations specific to the geometric setup of the instrument,38 and finally, a modified 
version of the Rachinger method98 was used to mathematically correct for Kα2 radiation.    
2.2.3 Inverse Least Squares (ILS) Regression 
 Inverse least squares (ILS) regression assumes that component concentration is a 
function of diffraction intensity.  The standard ILS univariate model for a single 
component is calculated by: 
exby +=  (2.1) 
where y is the reference concentration value, b is the regression coefficient, x is the 
diffraction value at a specific peak position (i.e. a single peak intensity, a calculated peak 
area, ratio of intensities, etc.), and e is the error, which is assumed to be attributed to the 
concentration values.  One of the features of ILS regression is that quantitative analysis 
can be performed even when the concentration of only a single component is known in 
the calibration mixture.  In multiple linear regression (MLR), several independent 
variables are used, and the regression vector is calculated as follows (in matrix notation): 
XX'
YX'
=B  (2.2) 
where Y is a matrix of concentration values, X is a matrix of intensity values, B is an 
matrix of regression coefficients.  MLR is limited, in that the number of variables 
selected can not exceed or equal the number of samples in the calibration set.  For 
example, a calibration set having nvars = nsamples only possesses enough statistically-
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independent information to estimate the mean; a larger sample set provides additional 
degrees of freedom to estimate other statistical parameters.  Although statistical methods 
are available to assist with variable selection (i.e. stepwise regression), calibrations 
created with suboptimal selections can introduce modeling errors such as noise inflation 
from collinearity and over-fitting.99   
2.2.4 Classical Least Squares (CLS) Regression 
 Classical least squares (CLS) regression is often used in spectroscopic 
quantitative modeling owing to its agreement with Beer’s law.  Under some conditions, 
PXRD intensity will be a linear function of the number of diffracting planes present, 
which qualifies the application of CLS regression in PXRD data modeling.  CLS assumes 
a linear combination of pure component sensitivities, where each component is weighted 
by concentration.  Unique to this technique is the feature that the regression vectors can 
be used as estimates of the pure component diffraction patterns.  CLS regression models 
can be generated using PXRD data provided all reference constituent concentrations are 
known (Equation 2.3): 
cEKYX +=   (2.3) 
where X is a matrix of diffraction intensities, K is a matrix containing the regression 
vectors (pure component estimates), Y is a matrix of concentration values for all 
constituents, and Ec is the error matrix.  Model error is attributed to diffracted intensities 
(i.e., microabsorption, extinction, preferred orientation, etc.).  The calculation of the 
regression vector (estimated pure components) is as follows: 
X•Y=K +  (2.4) 
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where the superscript “+” indicates the Moore-Penrose pseudoinverse.  The effectiveness 
of CLS regression in multivariate modeling is limited when the concentrations of all 
constituents contributing to signal (in the case of PXRD, diffract or cause diffuse scatter) 
are not known, or when non-linearities are present.99   
2.2.5 Principal Components Regression (PCR) 
 Principal components regression (PCR) is the ILS regression of “scores” 
calculated from principal components analysis (PCA) against a dependent variable(s).  
The objective of PCA is to maximize the variation contained in a data matrix with as few 
underlying “factors” as possible.100  The PCA model has the form of: 
ETP'X +=  (2.5) 
where X is a data matrix of k sample-independent variables (diffraction intensities), for n 
samples, T is a matrix of component “scores” in vector form for each component, P is a 
matrix of component “loadings,” and E is a matrix containing the residuals (the prime 
indicates the transpose of the matrix).  Principal component scores and loadings are 
calculated using singular value decomposition.101  The algorithm proceeds through a least 
squares fit of a straight line through the data in a k-dimensional hyperspace.102  New 
components are fitted to the data until an adequate amount of the variance has been 
explained.  In PCR, the dependent variable(s) (i.e., reference concentration values) are 
linearly regressed against the scores.  The regression coefficients are calculated as 
follows: 
P•
TT'
YT'
=B  (2.6) 
where Y is a matrix of concentration values.  A full-length regression vector is obtained 
by projecting the regression coefficients onto the loading vector(s).  Calibrations may be 
 54
created with fewer samples than variables.  Reviews of PCA and PCR can be found 
elsewhere.99,102
2.2.6 Partial Least Squares (PLS) Regression 
 The PLS and PCR algorithms, being factor-based analysis methods, have similar 
goals.  The objective of PLS is to maximize the amount of co-variation explained 
between dependent variables and independent variables using the fewest number of 
factors.  Contrary to PCA where only the independent variables are used to calculate the 
basis set, PLS incorporates both dependent and independent variables in the basis set 
calculation.  It may be envisioned that this method is particularly powerful when the 
dependent variable set contains low noise.  Generally speaking, PLS explains the total 
variance in fewer factors relative to PCR.  In this study, the SIMPLS algorithm was used 
to directly calculate factors as linear combinations of the original variables, while 
constrained to orthogonality and normalization restrictions.103  The PLS algorithm used 
herein,104 and representative reviews can be found elsewhere.99,102  
2.3 Results and Discussion 
 The fully balanced concentration design matrix used for this study is shown in 
Table 2.1 and contains five concentration points (0,20,25,40,60% w/w) for each of the 
four constituents.  The concentration points were added to the design matrix in a one-by-
one fashion, followed by a calculation of the matrix covariance; each point was adjusted 
to minimize this covariance.  It should be noted that separate experimentation concerning 
instrument sensitivity, selectivity, and signal-to-noise has been previously reported in 
Moore et al.,.97  At each concentration point, mixtures were compacted using 5 different 
pressures (67.0 MPa, 117.3 MPa, 167.6 MPa, 217.8 MPa, and 268.1 MPa), resulting in a 
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calibration sample size of 145 compacts.  Recognizing that consolidation may induce 
changes to diffraction intensity105,106 and diffuse scatter, samples compacted at different 
pressures were included in the calibration set to incorporate pattern variability into the 
model approximation.   An additional sample at each concentration point, compacted 
using a randomly-assigned pressure, was used to test the calibrations. 
Table 2.1.  Sample composition design matrix. 
 
Tablet 
# 
Theophylline 
wt/wt 
Lactose 
wt/wt 
MCC 
wt/wt 
Starch 
wt/wt 
1 0.600 0.200 0.200 0.000 
2 0.400 0.400 0.200 0.000 
3 0.200 0.600 0.200 0.000 
4 0.400 0.200 0.400 0.000 
5 0.200 0.400 0.400 0.000 
6 0.200 0.200 0.600 0.000 
7 0.600 0.200 0.000 0.200 
8 0.400 0.400 0.000 0.200 
9 0.200 0.600 0.000 0.200 
10 0.600 0.000 0.200 0.200 
11 0.400 0.200 0.200 0.200 
12 0.200 0.400 0.200 0.200 
13 0.000 0.600 0.200 0.200 
14 0.400 0.000 0.401 0.200 
15 0.200 0.200 0.400 0.200 
16 0.000 0.400 0.400 0.200 
17 0.200 0.000 0.600 0.200 
18 0.000 0.200 0.600 0.200 
19 0.400 0.200 0.000 0.400 
20 0.200 0.400 0.000 0.400 
21 0.400 0.000 0.200 0.400 
22 0.200 0.200 0.200 0.399 
23 0.000 0.400 0.200 0.400 
24 0.200 0.000 0.400 0.400 
25 0.000 0.200 0.400 0.400 
26 0.200 0.200 0.000 0.600 
27 0.200 0.000 0.200 0.600 
28 0.000 0.200 0.200 0.600 
29 0.250 0.250 0.250 0.250 
 
 Univariate calibrations were created by regressing a single intensity value for 
each individual component (i.e., the largest Bragg peak for crystalline materials and the 
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largest overall intensity for the disordered materials) against constituent concentration 
(nominal value from the design).  The PCR and PLS regression vectors for each 
constituent were estimated individually from a component-specific orthogonal basis set.  
Selection of the ideal number of principal components/latent variables (shown in Table 
2.2) was performed through minimization of both the root mean square error of 
calibration (RMSEC) and the root mean square error of cross validation (RMSECV).
 Transmission Reflectance 
Method Component LV R2
SEP 
(%) 
Precision 
(%) R2 SEP (%) 
Precision 
(%) 
Theophylline 0.961 3.79 0.00024 0.898 5.09 0.09491 
Lactose 0.927 5.70 0.00081 0.911 4.95 0.03195 
MCC 0.809 9.70 0.00324 0.940 5.81 0.04044 Univariate 
Starch 
N/A 
0.292 15.30 0.00935 0.006 18.18 0.07608 
Theophylline 0.972 2.90 0.00027 0.942 3.57 0.16771 
Lactose 0.963 3.48 0.00076 0.939 3.63 0.12726 
MCC 0.955 3.69 0.00237 0.958 5.47 0.07263 CLS 
Starch 
N/A 
0.946 5.24 0.00413 0.866 4.91 0.01797 
Theophylline 1 0.972 2.92 0.00027 0.926 4.81 0.07780 
Lactose 3 0.968 3.16 0.00062 0.919 4.82 0.02580 
MCC 4 0.751 9.77 0.00346 0.875 7.49 0.03176 PCR 
Starch 5 0.941 4.98 0.00133 0.868 5.00 0.10102 
Theophylline 1 0.972 2.91 0.00028 0.933 4.49 0.08007 
Lactose 3 0.978 2.48 0.00110 0.943 3.71 0.02915 
MCC 3 0.955 3.84 0.00210 0.937 6.23 0.03226 PLS 
Starch 3 0.950 4.88 0.00256 0.804 7.15 0.07829 
Table 2.2. Selected statistical values for the different quantitative PXRD calibrations relative to the collection geometry. 
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 Traditionally, it is not common to use a univariate PXRD calibration to predict the 
concentration of a disordered component in a mixture; however, it was performed in this 
study as a means to illustrate the practicality of different multivariate methods.  In 
general, data collected in transmission geometry provided better linearity, precision and 
lower concentration prediction error relative to reflectance geometry for both the 
crystalline and disordered components.  In transmission geometry, the entire sample 
volume is irradiated, whereas only a fraction of the sample is interrogated in reflectance 
analysis.  Therefore, data collected in transmission mode is less susceptible to errors 
derived from analyzing inhomogeneous “regions” within a sample matrix. 
 The data in Table 2.2 indicate that the standard error of prediction (SEP) for 
theophylline in most instances is greater when using data collected in reflectance 
geometry relative to that in transmission.  This indicates a correlation between instrument 
geometry and prediction error; more than likely a result of the diffraction pattern 
anomalies related to specific analytical optics setup modes.  Barring microabsorption, 
extinction, and other anomalies, regression vectors should mimic pure component 
diffraction patterns.  In Figure 2.1, the pure component pattern and the calculated 
regression vectors for all three multivariate theophylline prediction models are shown for 
data collected in reflectance geometry.  There is good agreement between all regression 
vectors and the pure component pattern, as would be expected.  For PCR and PLS, 
negative correlations are observed at ~18º 2θ, which specifically corresponds with the 
location of Bragg peaks resulting from lactose monohydrate diffraction.  Therefore, the 
PCR and PLS models are sensitive to the changes in both theophylline and lactose 
concentration at this angle.  In Figure 2.2, the theophylline regression vectors calculated 
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from data collected using transmission geometry are identical to the pure component scan.  
Further, the negative correlations observed at ~18º 2θ in the reflectance geometry 
regression vectors are nearly absent from transmission data.  The calculated regression 
vectors from the transmission geometry are, therefore, more highly correlated to only 
changes in theophylline concentration, thereby resulting in enhanced theophylline 
sensitivity and decreased prediction errors. 
 
Figure 2.1. Calculated regression vectors for each multivariate calibration used in the 
prediction of anhydrous theophylline from data collected in reflectance geometry. 
  
 60
 Figure 2.2. Calculated regression vectors for each multivariate calibration used in the 
prediction of anhydrous theophylline from data collected in transmission geometry. 
 
 When considering disordered materials, the diffuse scatter that produces the 
characteristic “amorphous halo” may not be linearly related to constituent concentration.  
Non-linear relationships may manifest as negative correlations in regression vectors as a 
result of modeling the decrease in concentration of other components.  In Figure 2.3, the 
calculated regression vectors for the three multivariate starch prediction models and the 
corresponding pure component scan are shown for data collected in reflectance geometry.  
The CLS regression vector bears the highest correlation with the pure component 
diffraction pattern, thereby affording enhanced linearity and decreased prediction error 
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relative to PCR and PLS (from Table 2.2).  Although they possess the same positive 
correlations as the starch pure component scan, the regression vectors from both PCR and 
PLS once again exhibit negative correlations attributable to changes in the concentrations 
of other mixture components at angles corresponding to their respective peaks of 
principal diffraction: theophylline (~12º 2θ), lactose (~18º 2θ) and MCC (~22º 2θ).  This 
same trend is also observed for the transmission data, as shown in Figure 2.4, where both 
the PLS and PCR regression vectors exhibit the same negative correlations seen in 
reflectance.  Additionally, the CLS regression vector of transmission data representing 
diffraction by the starch component possesses negative correlations at ~12º 2θ and ~18º 
2θ.  These regression vector similarities resulted in near-equal linearity and prediction 
error for the PCR, PLS, and CLS starch calibrations created from data collected in 
transmission.  The negative correlations observed in the disordered component regression 
vectors, therefore, could quite possibly be a result of the non-linear relationship between 
constituent concentration and diffuse scatter intensity. 
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Figure 2.3. Calculated regression vectors for each multivariate calibration used in the 
prediction of starch from data collected in reflectance geometry. 
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No 
corrections
Axis 
shift
Kα2 
subtraction
Absorption 
correction
Background 
subtraction All
Crystalline 0.723 0.898 0.759 0.729 0.723 0.904 Univariate Disordered 0.493 0.489 0.484 0.486 0.493 0.473 
Crystalline 0.906 0.936 0.906 0.908 0.906 0.938 R
2
PLS Disordered 0.864 0.890 0.866 0.849 0.864 0.871 
Crystalline 7.61 5.59 6.75 7.34 7.61 5.02 Univariate Disordered 11.41 11.19 11.54 11.76 11.41 11.99 
Crystalline 4.39 4.45 4.40 4.11 4.39 4.10 
SEP 
(%) PLS Disordered 5.97 6.40 5.98 6.42 5.97 6.69 
Table 2.3.  The effects of various powder pattern corrections on linearity and the standard error of prediction of the univariate and 
PLS calibrations for prediction of both crystalline and disordered components using data collected by reflectance geometry. 
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Figure 2.4. Calculated regression vectors for each multivariate calibration used in the 
prediction of starch from data collected in transmission geometry. 
 
 In Table 2.3, linearity and SEP are reported as a function of applied pattern 
corrections using data collected in reflectance geometry.  Statistics are reported as an 
average of the two crystalline components and an average of the two disordered 
components.  The importance of correcting for axis shift prior to creating a univariate 
calibration in the prediction of crystalline components is supported by the observed 
increased linearity and decreased prediction error.  When modeling a single intensity, or 
the area of a single peak, anisotropic peak distortions may build errors into the calibration 
and result in inaccurate predictions.  Interestingly, in multivariate calibrations (such as 
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PLS) the linearity and predictability are not significantly affected by corrections to the 
powder patterns relative to univariate modeling.  By modeling multiple intensities having 
correlation with constituent concentration, the anisotropy of error-related variance is 
compensated for through increased correlation at unaffected variables.  Further, through 
maximization of the explained covariance between diffraction intensity and constituent 
concentration, variability due to anisotropic peak aberrations is modeled in the regression 
vectors. 
 
No 
corrections
Axis 
shift
Kα2 
subtraction
Absorption 
correction
Background 
subtraction All
Crystalline 0.940 0.947 0.937 0.939 0.941 0.944 Univariate Disordered 0.260 0.590 0.260 0.186 0.260 0.551 
Crystalline 0.968 0.972 0.968 0.971 0.968 0.975 R
2
PLS Disordered 0.770 0.948 0.772 0.771 0.770 0.952 
Crystalline 4.24 4.10 4.42 4.47 4.15 4.75 Univariate Disordered 16.30 10.72 16.30 16.49 16.30 12.50 
Crystalline 3.07 2.89 3.07 2.96 3.07 2.70 
SEP 
(%) PLS Disordered 8.07 4.17 8.10 8.17 8.07 4.36 
Table 2.4.  The effects of various powder pattern corrections on linearity and the standard error of prediction of the univariate and 
PLS calibrations for prediction of both crystalline and disordered components using data collected by transmission geometry. 
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 Table 2.4 shows the effects of PXRD pattern corrections on linearity and 
prediction error using data collected in transmission geometry.  Comparison with Table 
2.3 (reflectance geometry collection) indicates that performance statistics are superior for 
transmission data, particularly for disordered (weakly diffracting) materials.  This is not 
unexpected, given that transmission experiments interrogate the entire compact sample 
volume.  Although the low mass attenuation coefficients of pharmaceutical materials 
permit some sample penetration (on the order of mm), reflectance experiments 
interrogate a much smaller volume compared to transmission experiments.  For the 
crystalline components, both models are invariant to all of the applied corrections.  
However, the SEP for the disordered components using PLS shows significant 
dependence on axis shift correction.  Figure 2.5 illustrates the effects of applied pattern 
corrections on the calculated PLS regression vectors.   The calculated regression vectors 
of raw diffraction patterns, patterns corrected for absorption only, patterns corrected for 
Kα2 only, or background subtraction only are highly correlated to one another.  Further, 
these regression vectors exhibit differences from the regression vector calculated from 
patterns corrected for axis shift.  The dashed boxes highlight the main differences 
observed between the aforementioned group of regression vectors and those for which 
axis shift was corrected.  These differences represent uncertainties correlated to peak 
aberrations and result in modeling concentration changes of other components.  
Ultimately, the prediction error was larger due to the error in modeling the concentration 
changes in multiple components. 
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 Figure 2.5. The effects of various corrections on the PLS calibration regression vectors 
as applied to data collected in transmission geometry. 
 
 For many spectroscopic methods, building quantitative models that include 
variability associated with compression force is imperative.  However, the variability in 
diffraction intensity observed to have resulted from consolidation was minimal because 
the materials used in this study have low mass-attenuation coefficients and require few 
applied absorption corrections. Admittedly, creating a calibration and test sample matrix 
the size of the set presented in this work (n = 174) may be impractical in a multi-product 
industrial development group.  Given the results of the present data, however, efficient 
calibrations could have been created using fewer samples.  This was tested by 
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compressing a single sample from each concentration point (Table 2.1) at 268.1 MPa in 
order to re-create the calibrations (29 samples total), while the remaining samples (n = 
145) were used to test the models generated from this reduced data set.  The graph in 
Figure 2.6 shows prediction error as a function of component, as modeled by each 
calibration method for differently sized calibration sets relative to the experimental optics 
utilized.  Linearity statistics (not shown) were not affected by the reduction of the dataset 
used for calibration.  The data in Figure 2.6 illustrate that prediction error associated with 
transmission geometry is relatively unaffected by the size of the calibration set employed.  
Reflectance geometry, however, indicates that a slight increase in prediction error occurs 
when using the smaller calibration set, possibly due to the decreased signal-to-noise. 
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Figure 2.6.  The effects of the number of samples in the calibration set on the standard error of prediction for both collection 
geometries. 
 The starch and theophylline calculated CLS regression vectors for reflectance and 
transmission geometry are shown in Figure 2.7 and Figure 2.8, respectively.  When 
comparing the starch regression vectors as calculated from data collected in reflectance 
geometry, the smaller calibration set vector exhibits increased noise (rougher) and larger 
peak/trough correlations ultimately attributable to increased uncertainty.  Though the 
starch regression vector (as calculated from data collected in transmission geometry) for 
the smaller calibration set is “rougher” relative to the vector from the larger set, the 
overall shape is the same for both.  The regression vectors calculated from the smaller 
calibration set using data collected in transmission mode demonstrated increased 
correlation to the regression vectors calculated from the larger calibration set relative to 
the reflectance data.  Therefore, this enhanced correlation results in nearly identical error 
statistics independent of calibration sample size (shown in Figure 2.6). 
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 Figure 2.7.  The effects of the number of samples in the calibration set on the starch and 
theophylline CLS regression vectors for data collected from reflectance geometry. 
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 Figure 2.8.  The effects of the number of samples in the calibration set on the starch and 
theophylline CLS regression vectors for data collected from transmission geometry. 
 
 Based on the results presented herein, calibrations via PLS, created from the data 
collected in transmission geometry can be recommended as optimal for quantitative 
PXRD of similar systems.  The calibrations created using this algorithm exhibited 
optimal linearity values of 0.972, 0.978, 0.955, and 0.950 for theophylline, lactose, MCC, 
and starch, respectively.  The calibrations created in the present work stem from a 
quaternary design using the design matrix concentration values.  Given that each nominal 
design value is likely to differ slightly from the actual concentration, each component 
reference concentration value has some random error.  Overall, a cumulative 2-3% error 
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in content uniformity of all the constituents may be anticipated; linearity values 
approaching 0.98 in this design are, therefore, statistically acceptable.    Additionally, 
minimum prediction error and enhanced precision for both crystalline and disordered 
components in complex, intact compacts was achieved.  Furthermore, PLS models were 
observed to be less susceptible to errors associated with diffraction pattern anomalies and 
effects related to the size of the calibration set. 
2.4 Conclusions 
 The ability to analyze intact compacts makes PXRD an important analytical tool 
for non-destructive pharmaceutical characterization.  The structure-sensitivity afforded 
by PXRD enables quantitative applications having the ability to discriminate between 
different chemical components, polymorphs, and other phase mixtures. It has been shown 
in this work that the traditional univariate calibrations are affected by peak distortion, 
variable selection, and applied powder pattern corrections.  Multivariate calibrations, 
however, provided enhanced linearity, decreased prediction errors, and exhibited less 
susceptibility to errors attributable to peak distortions relative to single-point calibrations.  
Further, calibration errors related to pattern anomalies were minimized through empirical 
modeling of the entire diffraction pattern (i.e. both Bragg diffraction and diffuse scatter 
intensities).  As an increased amount of mixed amorphous/crystalline systems are 
formulated into dosage forms, the need for discriminative and sensitive quantitative 
analytical tools for intact analysis will become more prevalent. 
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Chapter 3: A Structural Investigation into the Compaction 
Behavior of Pharmaceutical Composites Using Powder X-ray 
Diffraction and Total Scattering Analysis  
 
3.1 Introduction 
 The US Food and Drug Administration’s Critical Path Initiative to New Medical 
Products maintains the need for industry to continue investigation and development of 
analytical methods capable of fundamentally characterizing pharmaceutical systems. The 
availability of more effective analysis techniques will facilitate product and process 
understanding, and reduce drug product failures.107  Challenges encountered during drug 
product development are often the result of unpredicted changes to the physicochemical 
and mechanical properties of materials used in manufacturing.  Characterization during 
small-scale research should predict performance modifications that may occur at 
commercial scale. This goal is contingent upon accurate detection and quantification of 
specific changes in material structure that can be linked with product performance.  Some 
such changes (i.e. dissolution rate, friability, etc.) can be traced to very subtle structure 
modifications, where the largest limitation in detection and quantification is inadequate 
analytical sensitivity, particularly in the context of complex mixtures of materials.  At 
present, research in this area is heavily focused on active pharmaceutical ingredients 
(API), with substantially fewer reports concerning responses of excipients or composites 
to processing.  As the pharmaceutical industry moves forward, it is imperative that the 
synergistic functions of both API and excipients be considered as the basis for claiming 
product understanding at the level of specifically engineered delivery platforms.   
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 Powder X-ray Diffraction (PXRD) is universally applied for detecting phase 
changes and assessing material structure and order.  Industrial applications of PXRD rest 
in the ability to analyze materials from all stages of powder processing, without prior 
destructive sample preparation.  Traditional uses of this technique have focused on 
analysis of prominent, high-intensity Bragg diffraction peaks that are characteristic of a 
given crystalline phase.  In addition to long-range order, the powder diffraction pattern 
contains information pertaining to intermediate and short-range order.  Specifically, 
diffuse scatter, which occurs between and superimposed on Bragg diffraction peaks, 
offers additional information pertaining to the short- and intermediate-range structure of 
materials, when treated appropriately.   
 In the present work, the compaction behavior of anhydrous theophylline was 
investigated.  Binary composite compacts were also prepared and analyzed, using either a 
common tablet filler (α-lactose monohydrate), or a common tablet compression aid 
(microcrystalline cellulose; MCC) in combination with anhydrous theophylline.  PXRD, 
in combination with total scattering computational methods, was used to assess the 
effects of powder compaction without reversion of compacts to powders.  Furthermore, 
the use of PCA as an alternative to the traditional weighted agreement factor in 
comparing PDF transformed diffraction data was explored. 
3.2 Materials and Methods 
 Binary mixtures comprised of anhydrous theophylline (Lot No. 92577, Knoll AG, 
Ludwigshafen, Germany) and either crystalline α-lactose monohydrate, referred to as 
lactose for the remaining discussion, (Lot No. 125090020, Acros Organics, Geel, 
Belgium) or microcrystalline cellulose, referred to as MCC for the remaining discussion, 
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(Avicel PH 200, Lot No. M427C, FMC BioPolymer, Mechanicsburgh, PA) were blended 
and compacted using an automatic single-station Carver Press (Carver, Inc, Model 
3887.1SDOA00, Wabash, IN) equipped with a 13 mm flat-faced punch.  The 
approximate median particle size of theophylline was 90 μm.  A circumscribed central 
composite experimental design102 was used for sample preparation, in which both 
excipient concentration (0 – 75% w/w) and compaction pressure (67 – 503 MPa) were 
varied.  Consolidation at each pressure resulted in composite solid fractions ranging from 
0.85 – 0.98.  The central point was repeated five times to build precision into the design. 
3.2.1 Powder X-Ray Diffraction (PXRD) 
 PXRD data were collected using an X’Pert Pro MPD system (PANalytical B.V., 
Almelo, the Netherlands) equipped with a copper anode (λ = 1.5406 Å), an auxiliary 
elliptical mirror, and X’CeleratorTM detector.  The operational voltage and amperage 
were set to 45.0 kV and 40.0 mA, respectively, and diffraction patterns were acquired 
using an irradiation time of 101.42 seconds per step and an angular step size of 0.017° 2θ 
over a range of 2 – 100° 2θ.  Data were collected with the instrument set in transmission 
geometry, using intact compact samples, sandwiched between two layers of X-ray 
transparent kapton film and placed on a spinning vertical sample stage (16 rpm). 
3.2.2 Pattern Separation 
 PXRD analysis of binary compacts produced diffraction patterns containing 
information from both components.  To study the effects of powder compaction on a 
specific constituent, a method for accurately separating diffraction events attributable to 
each individual component was required.  The pattern subtraction technique,108 
commonly reported for this purpose, often leaves residual artifact in separated patterns 
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attributable to diffraction by component(s) that are not of interest, or negative peak 
intensities as a result of overcompensation.  An alternative approach for isolating single 
constituent diffraction patterns from multi-component data has been recently reported in 
the literature.97
 Generalized Least Squares (GLS) pre-processing has been reported in the near-
infrared spectroscopy literature as a multiplicative orthogonalization technique used to 
make spectra “blind” to interferants, while retaining sensitivity to the main analyte.109  
Signal pre-processing using this covariance-weighted technique reduces the 
dimensionality of final models by including prior knowledge.  The scaling matrix, T, is 
calculated as follows: 
ILLL +'=∑
2
L d  (3.1) 
)∑(= 1/2LinvT  (3.2) 
where d is a scalar covariance-scaling constant, L is an m × n noise matrix, L' is the 
transpose of L, and I is an n × n identity matrix.  In the case of PXRD, the matrix L 
would be comprised of diffraction information from material(s) that are not of interest to 
a given evaluation.  The final scaling of the multi-component diffraction patterns, X, is 
given by: 
XTXFIN =   (3.3) 
where T multiplicatively suppresses diffraction in X displaying covariance with the noise 
matrix.  A problem is encountered with this particular method when components that are 
not of interest (noise) diffract at the same angle (2θ) as the component of interest.  This 
issue results in the suppression of diffraction events from the component being isolated.  
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The method was, therefore, modified to account for covariance between the “noise” 
component(s) and the component of interest by creating a second scaling matrix: 
IRRdR +'=∑
2
R   (3.4) 
where R is an m × n matrix of the reference material (i.e. a pure component diffraction 
pattern of the constituent of interest) and the remaining variables are defined above.  The 
scaling matrix, ΣR, was used to suppress angular variables in the noise matrix, which are 
covariate with the component of interest as follows: 
)∑(•∑=∑FIN RL inv   (3.5) 
  (3.6) )∑(= 1/2FINinvT
where T is substituted back into Equation 3.3.  By compensating for angular variables 
(2θ) of the noise matrix that are covariate with those of the constituent of interest, a more 
accurate separation is obtained.  All data manipulations in this study were performed 
using programs written in-house in the Matlab programming environment (v7.1, 
MathWorks, Natick, MA). 
3.2.3 Pair Distribution Function (PDF) 
 The PDF is a total scattering method that exploits the Fourier relationship 
between X-ray diffraction intensity and the real-space arrangement of atoms, given 
appropriate data treatment.  This method has received extensive attention in the inorganic 
literature;39,43,44,110 however, few pharmaceutical applications have been reported.48,51,52  
In the present work, the PDF was calculated for (a) compacts formed from pure 
components, and (b) mathematically isolated diffraction attributable to a single 
component, detected from PXRD patterns of binary compacts.  This provided a sensitive 
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method to assess the structure-specific compaction behavior of theophylline, individually 
as well as in a consolidated mixture.  The PDF, G(r), is defined as: 
[ ]oρrρrrG -)(π4=)(   (3.7) 
where ρ(r) and ρo are the local and average atomic number densities, respectively, and r 
is the inter-atomic separation distance.111  The PDF calculates the probability of finding 
atom pairs separated by a distance r, and is obtained by transformation of the reciprocal 
space structure function, S(Q), according to: 
[ ] dQQrS(Q)QrG )sin(1-
π
2
=)( ∫
max
0
Q
  (3.8) 
where S(Q) is obtained from a diffraction experiment, and Q is the magnitude of the 
scattering vector.41  The term Qmax is the resolution of the diffraction experiment, which 
is dependent on the wavelength of radiation used and the maximum diffraction angle (°2θ) 
of data collection.  Corrections were made to the intensity data to obtain a structure 
function normalized to the total-scattering cross-sectional area, consistent with the 
assumptions of Egami and Billinge.38   
 For a crystalline material, a theoretical PDF may be calculated from a solved 
crystal structure.  The mathematical corrections applied to a theoretical PDF, including 
compensations for limited Q-resolution and broadening of probability peaks as a result of 
thermal motion are detailed elsewhere.38,47  Theoretical modeling of the PDF, G(r)c, for a 
crystalline material is achieved by: 
orρrr
f
ff
r
rG πδ 4-)-(
1
=)( nm,
n
2
nm
m
c ∑∑   (3.9) 
where fm and fn are the atomic form factors for the individual atoms, ‹f› is the mean 
atomic form factor for the structure, and rm,n is the separation distance between atoms m 
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and n (from the crystal structure), where the delta function is assessed out to a user-
defined radial distance rmax.  
 Reviews of the PDF, both experimental and theoretical, are found elsewhere.38,111  
All intensity corrections and PDF calculations were performed using software developed 
in-house in the Matlab programming environment based on published equations.  
Theoretical PDF patterns for anhydrous theophylline were calculated using the solved 
Cambridge Structural Database (CSD) crystal structure, (refcode: BAPLOT01). 
3.2.4 Principal Components Analysis (PCA) 
 PCA is a multivariate, bilinear decomposition technique used to identify the 
orthogonal basis set, which explains the maximum amount of variance in a data matrix, X; 
where X is n observations of an m-dimensional vector.  PCA decomposes data into 
loadings and scores, where loadings represent the weight of each variable for a given 
principal component (PC), and scores represent the weight of the PC for each sample.  
Vectors comprising a data matrix, X, possessing comparable score values for a given PC 
are similar; dissimilar score values indicate differences between vector features.  Reviews 
of principal components analysis may be found elsewhere in the literature.99,112  PCA 
models were calculated in the Matlab programming environment using the PLS_Toolbox 
(v3.0, Eigenvector Research, Manson, WA). 
 Traditional comparison of PDF transforms have involved calculation of a 
weighted agreement factor, Rwp, between the properly scaled sample PDF and a reference, 
albeit a theoretically calculated or empirically derived pattern.38  In this study, PCA was 
used to assess variations among PDF patterns as an alternative to the weighted agreement 
factor commonly employed for this purpose.  This method may be preferable to the Rwp 
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calculation when there are a large number of PDFs to compare, as in this study. PCA is 
also applicable when a reference pattern is not available or comparison to a reference 
pattern is inappropriate for a given analysis.   
3.3 Results 
3.3.1 Pure Theophylline Compaction 
 In Figure 3.1, the PXRD patterns (average of 3 samples) for theophylline 
compacted at 67 MPa and 503 MPa are shown as blue and red solid lines, respectively.  
The original patterns were normalized and were corrected for absorption, Laue 
monotonic scattering, Compton scattering, etc.38 to remove physical artifacts (i.e., sample 
thickness and solid fraction).  The red and blue dashed lines in Figure 3.1 respectively 
represent one standard deviation (n=3) for diffraction from theophylline compacts 
prepared at 67 MPa and 503 MPa.  The Bragg peak positions of samples compacted at 
higher pressures occur at the same diffraction angle (°2θ) relative to the sample 
compacted at 67 MPa, indicating low probability of uniform residual strain.  Moreover, 
additional PXRD peaks, which would be indicative of a polymorphic conversion, are not 
observed.  One noticeable difference between the patterns, however, is increasing diffuse 
scatter over the 23-30 º2θ range for samples compacted at higher pressures.     
 Figure 3.2 (solid lines) shows the average PDF pattern (n=3) for each of the 
corresponding samples in Figure 3.1.  The dashed lines represent one standard deviation 
as calculated from the three replicates.  At lower radial distances in the PDF (r < 30 Å), 
peak positions and intensities are highly correlated, irrespective of compaction pressure.  
In contrast, the Figure 3.2 inset, which focuses on r > 40 Å, shows a dampening of the 
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probability peaks, as well as peak shifts, which become significant with increased 
compaction pressure.   
 
Figure 3.1. Mean PXRD patterns (average of n=3) for anhydrous theophylline 
compacted at 67 MPa (blue, solid line) and 503 MPa (red, solid line).  The red and blue 
dashed lines correspond to 1 standard deviation from the mean of samples compacted at 
67 MPa and 503 MPa, respectively. 
 
 In an attempt to arrive at a possible materials-based explanation for the alterations 
observed in the PDF of anhydrous theophylline upon compaction at high pressures, 
simulations based on reverse Monte Carlo39,113 refinement were performed.  Briefly, as 
unit cell translation and expansion was calculated from the crystal structure solution, 
spatial permutations were applied to randomly selected atomic coordinates.  These 
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permutations included linear deviations from periodicity, as well as alterations to axial 
orientation (e.g., the molecule may be rotated 120° with respect to the c-axis). The fully 
translated model, calculated to a defined rmax, therefore contained a certain percentage of 
atomic coordinates that varied from their original positions defined by the average 
structure.  PDF patterns for computationally altered structures were subsequently 
calculated, and the data were mathematically compared with experimentally derived PDF 
patterns using an agreement factor. 
 
Figure 3.2. Mean PDF patterns (average of n=3) of theophylline compacted at 67 MPa 
(blue, solid line) and 503 MPa (red, solid line). The red and blue dashed lines correspond 
to 1 standard deviation from the mean of samples compacted at 67 MPa and 503 MPa, 
respectively.  
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 When simulating atomic displacements from average structure, it is important to 
define the proper constraints to yield physically-meaningful simulations.  One of the 
constraints incorporated in the models calculated for this study was the rigid body 
assumption; i.e, the molecule was held rigid such that permutations to atomic coordinates 
could not result in changes to intra-molecular bond distances, angles, or conformations.  
An additional constraint prevented atomic overlap of coordinates resulting from 
simulated displacements.  The final constraint allowed only atomic coordinates residing 
at r values comprising long-range order (r > 40 Å) to be randomly selected for 
permutation, as this region defines the marked differences between the PDFs presented in 
Figure 3.2. 
 
  
87 
Figure 3.3.  (a) Experimental PDF pattern for theophylline compacted at 67 MPa (black), calculated PDF pattern from the crystal 
structure (blue circles), and the difference plot (green, below); (b) Experimental PDF pattern for theophylline compacted at 503 MPa 
(red), a simulated PDF pattern from reverse Monte Carlo refinement (blue circles), and the difference plot (green, below).
 The experimentally derived PDF pattern for theophylline compacted at 67 MPa 
(blue line) and the PDF pattern calculated from the crystallographic structure of 
theophylline (black circles) are shown in Figure 3.3a.  Generally speaking, the difference 
plot indicates pattern similarity, especially at longer r values.  This result is expected as 
the compaction pressure is insufficient to induce large deviations from the average 
crystallographic structure.   
 Recall from Figure 3.2 that the PDF of the high pressure sample shows 
dampening and shifts in peak position relative to the lower pressure sample at r > 40 Å.  
An acceptable fit between the PDF of the sample compacted at high pressure and the 
theoretical PDF will require alterations to the original calculated PDF to accommodate 
the probability peak aberrations.  Figure 3.3b shows the experimentally derived PDF for 
theophylline compacted at 503 MPa (red line), a refined PDF from the Monte Carlo 
simulation (black circles), and the difference between the two PDFs (green line, shown 
below Figure 3.3b).  The simulated PDF shows the same probability peak shifts and 
dampening as the experimental PDF of the sample compacted at a high pressure.  The 
goodness of fit between the calculated PDF and the experimental PDF can be seen in the 
difference plot (green) shown below Figure 3.3b.  The simulated PDF was modeled by 
pseudo-randomly selecting molecules in the defined spherical volume (radius = 60 Å) 
and inducing a deviation from the average crystallographic structure.  The number of 
molecular permutations was converted to a percentage of total molecules probed in the 
simulation.  Therefore, the simulated PDF in Figure 3.3b (black circles) differs from the 
calculated PDF in Figure 3.3a (black circles) as a result of 0.928% of the molecules 
deviating from the defined average structure.   
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3.3.2 PDF of Mathematically Isolated Theophylline 
 Figure 3.4a shows the PXRD pattern of a sample (blue, circles) comprised of 
25% w/w theophylline and 75% w/w MCC, compacted at 118 MPa.  Diffraction data 
attributable only to theophylline (red) are superimposed over the diffraction pattern of the 
aforementioned sample.  Most of the diffuse scatter observable in the diffraction pattern 
of the original binary sample (blue, circles) is absent when theophylline diffraction was 
isolated (red data).  In Figure 3.4b, the PDF transform of the mathematically isolated 
theophylline (red) is shown superimposed with the calculated theoretical PDF pattern for 
theophylline (black, circles).   
 89
 Figure 3.4.  (a) PXRD pattern (zoomed) of a compact containing 75% MCC and 25% 
theophylline (sample3) compressed at 67 MPa (blue, circles) and the isolated diffraction 
attributable to theophylline (red); (b) The calculated pair distrubtion function of 
anhydrous theophylline (crystal structure ref: BAPLOT01) (black, circles), the pair 
distribution function of isolated theophylline from sample 3 (red), and the difference 
between the calculated and experimental (green). 
 
 Figure 3.5a shows the diffraction pattern of a sample (blue, circles) containing 
25% w/w theophylline and 75% w/w lactose, compacted at 118 MPa.  Mathematically 
isolated theophylline diffraction (red) is superimposed over the total diffraction data from 
this sample.  Many of the Bragg diffraction peaks observed in the original sample pattern 
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(blue, circles), which are strictly attributable to lactose, are absent from the isolated 
theophylline diffraction pattern.  In Figure 3.5b, the PDF transform of the isolated 
theophylline (red) is shown with the calculated PDF pattern for theophylline (black, 
circles). 
3.3.3 PCA of PDF Transformed Data 
  As introduced, PCA is a bilinear decomposition method, where principle 
components (PCs) are calculated in a manner to explain the maximum amount of 
variance such that PCn and PCn+1 are orthogonal.  Similar PDF patterns will have similar 
scores for a given PC, while dissimilar PDF patterns will have drastically different score 
values for the same PC.  Examples employing PCA score cluster analysis to ordinary 
PXRD patterns are found in the pharmaceutical literature;45,114 however, the authors are 
unaware of the existence of previous applications of PCA cluster analysis to PDF data. 
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 Figure 3.5.  (a) PXRD pattern of a compact containing 75% lactose and 25% 
theophylline (sample 19) compressed at 67 MPa (blue, circles) and the isolated 
diffraction attributable to theophylline (red); (b) The calculated PDF pattern for 
anhydrous theophylline (crystal structure ref: BAPLOT01) (black, circles), the PDF 
pattern for isolated theophylline from sample 19 (red), and the difference between the 
calculated and experimental (green). 
 
 Three different PCA models were calculated, where each varied in the 
number/type of samples included.  The first analysis incorporated PDF patterns for pure 
theophylline and theophylline mathematically isolated from binary mixtures with MCC.  
The resulting scores plot is shown in Figure 3.6.  First, in the dimension of the first PC, 
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where 36.28% of the overall variance is explained, the score values for pure theophylline 
samples compacted at low pressures are drastically different than those for samples 
compacted at high pressures.  The variance explained by the first PC, therefore, is 
weighed differently in PDF patterns for samples compacted at low pressures relative to 
samples compacted at high pressures.  Secondly, PDF patterns for theophylline data 
mathematically isolated from binary samples containing MCC compacted at low 
pressures had similar score values for the first PC relative to those calculated for pure 
theophylline compacted at low pressures.  This indicates that PDF patterns of samples 
compacted at low pressures were similar in the dimension of the first PC, regardless of 
MCC concentration.  Additionally, all samples containing MCC compacted at higher 
pressures had score values similar to pure theophylline compacted at high pressures in the 
dimension of the first PC.  Overall, it was observed that scores of PDF data from samples 
compacted at low pressures formed one general cluster, while those from samples 
compacted at higher pressures formed another cluster. 
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 Figure 3.6.  PCA scores plot corresponding to the first and second principal components 
for analysis of PDF patterns from pure theophylline samples (black, closed symbols) and 
PDF patterns from theophylline mathematically isolated from binary compacts containing 
MCC (blue, open symbols).  Black, dashed line circles surround the replicate samples. 
 
 94
 Figure 3.7.  PCA scores plot corresponding to the first and second principal components 
for analysis of PDF patterns for pure theophylline samples (black, closed symbols) and 
PDF patterns for theophylline mathematically isolated from binary compacts containing 
lactose (red, open symbols). Black, dashed line circles surround the replicate samples. 
 
 The second PCA performed incorporated PDF data obtained from theophylline 
mathematically isolated from binary mixtures containing lactose, as well as pure 
theophylline compacts.  The PCA scores plot for these data is shown in Figure 3.7, 
where the dimension of the first PC explained 46.88% of the overall variance.  Score 
values for PDF patterns from pure theophylline samples compacted at low pressures were 
considerably different relative to PDF patterns from pure theophylline compacted at high 
pressures.  Samples compacted at low pressures tended to cluster together, regardless of 
lactose content; as did samples compacted at high pressures.  A particularly interesting 
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sample was the compact containing 75% w/w lactose compacted at 268 MPa, which 
clustered with the samples compacted at low pressures.  These data indicate that the PDF 
pattern resulting from the isolated theophylline diffraction data of this sample is more 
similar to PDF data for samples compacted at low pressures than samples compacted at 
high pressures. 
 
Figure 3.8.  PCA scores plot corresponding to the first and second principal components 
for analysis of all samples, including: PDF patterns for pure theophylline samples (black, 
closed symbols), PDF patterns for theophylline mathematically isolated from samples 
containing MCC (blue, bold open symbols), and PDF patterns for theophylline 
mathematically isolated from samples containing lactose (red, un-emboldened open 
symbols).  
 
 The final PCA performed incorporated data from PDF patterns obtained from all 
samples in the circumscribed central composite experimental design, resulting in the 
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scores plot shown in Figure 3.8.  In Figures 3.6 and 3.7, scores of samples compacted at 
low pressures formed one cluster while samples compacted at high pressures formed a 
separate cluster in the dimension of the first PC.  In Figure 3.8, delineation between 
score values is not as obvious, and merit further explanation.  Beginning with the pure 
theophylline compacts (filled symbols), the score values in the dimension of the first PC, 
where 33.89% of the overall variance is explained, are drastically different for samples 
compacted at low pressures versus those compacted at high pressures.  The scores in the 
dimension of the first PC of PDF data from samples containing MCC (blue, unfilled 
symbols) again tended to cluster with pure theophylline samples compacted at similar 
pressures, irrespective of MCC concentration.  Contrary to the previous analyses of PDF 
data for samples containing lactose, a clear-cut boundary delineating clusters of similarly 
compacted samples in the dimension of the first PC is not observed.  Interestingly, almost 
all samples containing lactose (red, unfilled symbols) resulted in PDF patterns having 
score values (in the first PC) that were most similar to all other samples compacted at low 
pressures.  The score values for all lactose samples compacted at the intermediate 
pressure (268 MPa) clustered around samples compacted at low pressures.  Further, a 
lactose-containing sample compacted at 419 MPa clustered in the same area.   
3.4 Discussion 
3.4.1 Pure Theophylline Compaction 
 The PXRD patterns of pure theophylline compacted at different pressures exhibit 
an increase in diffuse scatter over the 23-30 º2θ range.  With a median particle size of 90 
μm, it is anticipated that the effects on pattern features and further mathematical 
manipulations will be minimal, as peak broadening and increased diffuse scatter tend to 
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occur for particle sizes in the nanometer scale.  Replicate samples (n=3) of pure 
theophylline compacted at 67 and 503 MPa were analyzed to estimate contributions of 
sample variability to the PXRD patterns.  At both compaction pressures, the standard 
deviation intervals (Figure 3.1, dashed lines) indicate that the increase in diffuse scatter 
is not attributable to random sample variations, as the magnitude of the standard error is 
not sufficient to explain the scattering deviations between the PXRD patterns of the 
samples compacted at two different pressures (Figure 3.1, solid lines).   
 The previously discussed pattern distortion can be associated with many different 
physical and structural anomalies;45,111 however, a discussion of each is beyond the scope 
of this manuscript.  Rather, it is proposed that the introduction of disorder into a 
crystalline material may result in the alterations observed in the average diffraction 
patterns (solid lines) in Figure 3.1.  The PDF method is relatively sensitive to instances 
where materials exhibit long-range order; however, significant structural distortions may 
also be present that would not be representative of the average crystallographic structure.  
These “crystallographically challenged materials” result in dampened PDF features as a 
function of increasing radial distances relative to their pure crystalline counterparts.39  It 
may, therefore, be suggested that the features observed as a function of increasing 
compaction pressure in Figure 3.2 are the result of increasing deviations from the 
average crystallographic structure of anhydrous theophylline.  Replicate samples at each 
compaction pressure were carried through the PDF transformation to assess the effect of 
sample variability on the resulting PDF patterns.  As shown by the standard deviation 
intervals (Figure 3.2, dashed lines), the probability peak dampening and shifting can not 
be adequately explained by sample-to-sample variability, as the magnitude is not 
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sufficient to justify the pattern distortions.  This is further supported by data in Figure 3.3.  
Key features in the experimental PDF and the pattern generated by simulating distortions 
to 0.928% of the molecules from their defined average position (Figure 3.3b), agree well 
with one another. This agreement further supports the observation that compaction-
related structural distortions resulted in the types of probability peak changes observed in 
Figure 3.2. 
 It is worthwhile to note that the PDF is a one-dimensional representation of a 
three- dimensional structure; therefore, multiple simulated models may result in the same 
one-dimensional PDF representation.  Though the simulations in this study were properly 
constrained to prevent physically meaningless solutions, other random structure 
permutations may give an acceptable or better answer than the one yielded in Figure 
3.3b.  The proposed model is presented only to show that the PDF differences associated 
with compaction are consistent with compaction-induced disorder. 
3.4.2 PDF of Mathematically Isolated Theophylline 
 The significant disorder of MCC presents a potential problem with respect to 
separation of diffuse scatter specifically attributable to MCC from the diffuse scatter from 
theophylline introduced as a result of compaction.  The green difference plot in Figure 
3.4b shows that theophylline diffraction data mathematically isolated from the 
theophylline:MCC mixtures agrees well with the theoretical PDF of theophylline.  Given 
the low compaction pressure used to prepare the samples for Figure 3.4b, significant 
changes to the anhydrous theophylline structure were not anticipated, and accurate 
mathematical isolation of theophylline diffraction was, therefore, expected.   
 99
 Different issues with isolation of scattering from theophylline:lactose compacts 
occurs owing to the crystallinity of the excipient.  Specifically, isolation of theophylline 
diffraction from regions in the PXRD pattern where both components have  peak overlap 
may result in multiple anomalies with the isolated pattern, including inaccurate peak 
intensity values, peak shape distortions, and/or the disappearance of theophylline peaks 
altogether.  The green difference plot in Figure 3.5b shoes that PDF-transformed 
theophylline diffraction data mathematically isolated from the theophylline:lactose 
mixtures agrees well with the theoretical PDF of theophylline.  Again, considering the 
low pressure used to prepare compacts for Figure 3.5b, significant structural changes to 
anhydrous theophylline were not anticipated.   
3.4.3 PCA of PDF Transformed Data 
 The circumscribed central composite design of experiments used in the present 
work directly built sample variability into each model through replication of the center 
point (n=5), which corresponded  to a compaction pressure of 268 MPa and an excipient 
concentration of 48% w/w.  The variance in the PDF attributable to sample variation is 
therefore susceptible to explanation by PCA.  In the dimension of the first PC, however, 
the replicate samples are observed to cluster together (dashed circles in Figures 3.6, 3.7), 
thereby precluding sample variability from acting as the sole contributor to the data 
segregation observed in each plot.   
 The data-segregation correlated to compaction pressure observed in Figure 3.6 
occurred regardless of the concentration of MCC present.  As described above, long-
range atomic correlation dampening (r ≥ 40 Å) was concluded to be most likely 
attributable to structural differences arising from compaction.  Ultimately, these data 
 100
strongly support that the variance explained by the first PC is correlated to the probability 
peak dampening observed in PDF data (Figure 3.2).   
 The same data segregation observed in the first analysis (Figure 3.6) was also 
observed in the second PCA model (Figure 3.7), which suggests that clustering 
corresponds with the same probability peak dampening explained above.  Recall that the 
point representing the binary sample containing 75% w/w lactose compacted at 268 MPa 
clustered with the samples compacted at low pressures.  Interpretation of this behavior 
suggests that the presence of this much lactose may provide some degree of “protection” 
against the theophylline structural changes interpretable from the PDF; however, this 
warrants further investigation.   
 Almost all samples containing lactose (Figure 3.8, red, unfilled symbols) had 
PDF patterns with score values (in the dimension of the first PC) that were most similar 
to all other samples compacted at low pressures.  The score values for all lactose samples 
compacted at 268 MPa clustered around samples compacted at low pressures, as did a 
lactose-containing sample compacted at 419 MPa.  The clustering of this particular 
sample with others compacted at low pressures may not seem intuitive given that the 
remaining two lactose samples (containing less % w/w lactose) compacted at a high 
pressure did not.  When sample composition is taken into consideration, however, a trend 
in the dimension of the first PC is observable.  At a compaction pressure of 419 MPa, as 
the amount of lactose is decreased (Figure 3.8, red triangles), the sample score values 
became increasingly similar to the rest of the samples compacted at high pressure.  
Overall, every sample containing lactose (with the exception of the two compacted at 419 
MPa having low % w/w concentrations), resulted in PDF patterns similar to all samples 
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compacted at low pressures.  These PDF data, therefore, did not exhibit the probability 
peak dampening displayed by PDF-transformed data of (a) pure theophylline samples 
compacted at high pressures, and (b) PDF-transformed data of mathematically isolated 
theophylline from samples containing MCC compacted at high pressures.  Hence, the 
samples containing > 50% w/w lactose did not demonstrate any detectable structural 
modifications as a function of compaction pressure in the range investigated. 
3.5 Conclusion 
 In this study, the effects of powder consolidation on solid structure were 
examined.  Simulated data suggest that the compaction-related changes observed in real-
space analyses (PDF) of theophylline are primarily attributable to molecular deviations 
from average crystalline order.  The analysis of pharmaceutically relevant, intact 
consolidated systems was performed using PXRD, which afforded structure-sensitive 
capabilities without the introduction of artifacts arising from traditional sample 
preparation (e.g. subsequent grinding to revert to powder samples).  The application of 
the PDF transform to an individual constituent, in the presence of an excipient, was 
successfully accomplished as a result of a novel, accurate mathematical pattern separation 
technique.  Ultimately, this permitted practical real-space structural analysis of a single 
component in the presence of another material, thereby enabling the investigation of 
compound consolidation effects (i.e. the affect a material has on the compaction behavior 
of another).  The use of PCA as an alternative to the weighted agreement factor for 
comparing multiple PDF patterns was successfully demonstrated.  Relative to binary 
compacts formed with microcrystalline cellulose, structural changes to theophylline in 
the presence of α-lactose monohydrate were not observed (except in the two samples 
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compacted with the least amount of lactose).  This suggests the inclusion of lactose 
provides protection to theophylline from structural changes that would otherwise occur at 
high pressures.  Further exploration of this particular conclusion, however, deserves 
additional attention and will be the focus of future experiments. 
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Chapter 4:  Structural Interpretation in Composite Systems 
Using Powder X-ray Diffraction: Applications of Error 
Propagation to the Pair Distribution Function 
 
4.1 Introduction 
 Advanced analytical techniques used to characterize pharmaceutically-relevant 
materials properties are becoming increasingly sensitive to changes in short-range order 
of material structure.  At the forefront of these advancements is a total scattering powder 
X-ray diffraction (PXRD) method adapted from the inorganic materials science literature, 
commonly referred to as the atomic pair distribution function (PDF).  The PDF transform 
exploits the Fourier relationship between powder diffraction intensity and the real space 
arrangement of atomic species.  It has been used extensively to study crystalline, 
nanocrystalline, and amorphous inorganic materials, and its application in the 
pharmaceutical literature has increased substantially in the last decade. 
 Recent applications of the PDF in the pharmaceutical literature include the 
investigation of dehydration mechanisms in excipients,51 phase differentiation,48,115 
assessing structural changes during pharmaceutical manufacturing,116,117 and 
characterization of solid dispersions.52,118,119  An unfortunate occurrence in recent 
analyses incorporating PDF transforms involves drawing subjective conclusions with 
little to no statistical support.  Additionally, errors made to pre-Fourier transformed 
intensities manifest as pattern anomalies oftentimes mistaken for structural phenomena, 
thereby further detracting from the merit of the study.  Deriving an error estimate for a 
PDF pattern would largely increase the value of PDF-related conclusions. 
 Experimental errors in the PXRD experiment may arise from quantum counting 
inefficiencies, experimental imprecision, sample inhomogeneities, etc. and should be 
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propagated and accounted for when interpreting PDFs.  In addition to uncertainties in the 
PXRD experiment, the lack of infinite momentum transfer resolution, as well as 
inaccurate data corrections applied to intensity data affect the degree of uncertainty in the 
resulting PDF.  The inherent artifacts incurred as a result of Fourier transforming lower 
energy X-ray source data to real-space representation are well known and when treated 
appropriately41 are less significant contributors to errors in the PDF.  An appropriate 
estimate of error at the outset of the experiment and subsequent propagation through the 
entire mathematical transformation would significantly aid in drawing meaningful 
conclusions from PDF studies. 
 The use of error propagation methods in assessing the fit between a theoretical 
PDF calculated from a known crystal structure and experimental PDF has been developed 
and applied in the materials sciences literature.120,121  As it is becoming routine to 
compare two experimentally derived PDFs (i.e. two individual components versus 
composite materials), a question arises as to appropriate treatment of each individual 
error source in combined comparisons.  In this study, the propagation of initial PXRD 
error estimates through the PDF transform is presented.  Monte Carlo simulations were 
performed to assess the validity of applying traditional error propagation algorithms to 
accurately estimate uncertainty in the resulting PDF.  The propagated error estimates for 
individual experimentally-derived PDFs were mathematically combined to define 
uncertainty intervals around difference plots.  Statistical hypothesis inferences were 
drawn from these intervals to aid in identifying differences between experimental PDF 
patterns attributable to structure as opposed to those resulting from random error.  The 
aforementioned principles were applied to co-solidified products in an attempt to assess 
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drug:excipient miscibility, an area where differentiation between structural information 
and error in the PDF is of the utmost importance. 
4.2 Materials and Methods 
 Ketoconazole was purchased from Spectrum Chemicals (New Brunswick, NJ), 
polyvinyl pyrrolidone:vinyl acetate (PVPva) was purchased from BASF (Ludwigshafen, 
Germany), terfenadine was purchased from Sigma-Aldrich (St. Louis, MO) and  
felodipine was purchased from Tecoland (Edison, NJ).  Molecular structures for the 
compounds used in this study are shown in Figure 4.1. 
 
Figure 4.1. Molecular structures for felodipine, ketoconazole, terfenadine, and PVPva. 
4.2.1 Solid Dispersion Preparation  
 Co-solidified products were prepared using the melt-quench method.66  Briefly, 
the powdered components were physically mixed in a scintillation vial and added to a 
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crucible heated in a silicone oil bath at a temperature sufficient to melt the mixture.  The 
molten mixture was held isothermally for 30 minutes.  The molten mixture was quenched 
using an ice water bath.  Individual amorphous phases were produced by holding the 
sample above the melting temperature for 10 minutes followed by quenching in an ice 
bath.  All samples were removed from the bottom of the crucible intact for analysis. 
4.2.2 Powder X-ray Diffraction (PXRD) 
 The PXRD data were collected in transmission geometry using an X’Pert Pro 
MPD system (PANalytical B.V., Almelo, the Netherlands) equipped with a copper anode 
(λ = 1.5406 Å), an auxiliary elliptical mirror, and X’CeleratorTM detector.  The 
operational voltage and amperage were set to 45.0 kV and 40.0 mA, respectively.  
Diffraction patterns were acquired on intact samples, sandwiched between two layers of 
Kapton® film and subsequently placed on a spinning vertical sample stage (16 rpm).  
Experimental parameters include an irradiation time of 51.04 seconds per step and an 
angular step size of 0.02° 2θ over a 2-100° 2θ range.   
4.2.3 Differential Scanning Calorimetry (DSC) 
 Glass transition temperatures (Tg) were measured using a Q100 DSC (TA 
Instruments, New Castle, DE) under constant nitrogen purge (~50mL/min).  A three-
point enthalpy and temperature calibration was performed at 20 °C/min using o-terphenyl, 
indium, and tin standards.  In an attempt to avoid artifacts arising from grinding samples, 
approximately 5 mg intact “sample chips” were hermetically sealed in aluminum pans.  
To normalize thermal history, samples were first heated at 20 °C/min to 105 °C, held 
isothermally for 2 minutes, and subsequently cooled to -20 °C at 20 °C/min.  Samples 
were then cycled through Tg at 20 °C/min for temperature determination.  Ideal glass 
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transition temperatures for drug:polymer amorphous molecular solid dispersions were 
calculated using the Couchman-Karasz equation85 and are listed in Table 4.1. 
Table 4.1. Summary of DSC and PDF analyses.   
 DSC Analysis PDF Analysis  
 
Ideal Tg 
(°C) Tg (°C) R value 
Drug 
Conc. 
(w/w) 
Polymer 
Conc. 
(w/w) Conclusion 
felodipine:PVPva 62.1 66.9 (0.015) 0.2126 0.81 0.19 miscible 
terfenadine:PVPva 77.48 60.7 (0.21) 0.0864 0.73 0.27 phase-separate 
 
4.2.4 Pair Distribution Function (PDF) 
 The PDF is a total scattering method that exploits the Fourier relationship 
between X-ray diffraction intensity and the real-space arrangement of atoms, given 
appropriate data treatment.38,111  This method has received extensive attention in the 
inorganic literature with an increasing number of pharmaceutical applications reported 
recently.  The PDF, G(r), is defined as: 
[ ]orrrG ρ)(ρπ=)( -4  (4.1)  
where ρ(r) and ρo are the local and average atomic number densities, respectively, and r 
is the inter-atomic separation distance.  The PDF calculates the probability of finding 
atom pairs separated by a distance r, and is obtained by Fourier transform of the 
reciprocal space structure function, S(Q), according to: 
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where S(Q) is the structure factor obtained from a diffraction experiment and Q is the 
magnitude of the scattering vector.  The term Qmax is the momentum transfer resolution of 
the diffraction experiment, which is dependent on the wavelength of radiation used and 
the maximum diffraction angle (°2θ) of data collection.  Corrections consistent with those 
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outlined by Egami and Billinge38 were made to the measured diffraction data leading to 
the calculation of the structure function.  All intensity corrections (e.g. background due to 
Kapton® film scattering, absorption, etc.) and PDF calculations were performed using 
software developed in-house in the Matlab programming environment (v7.1, MathWorks, 
Natick, MA) based on published equations.  The PDF transforms were optimized using 
the Glow quality criteria introduced by Peterson, et al.41   
4.2.5 Error Propagation 
 The method of error propagation through the PDF transform has been derived and 
applied in previous work.38,121  If it is assumed that the measurement of each individual 
observation is statistically independent of all others (i.e. the count intensity at a given 
diffraction angle is independent of all others), the covariance between observations is 
eliminated.  It is worthwhile to note that the aforementioned assumption is appropriate in 
PXRD experiments provided the mathematical manipulations to the raw diffraction 
pattern do not introduce statistical correlation among individual data points (i.e. 
windowed smoothing, interpolation).  When a quantity T is the sum of two independent 
observations, X1 and X2, each having their own error estimate, σ(X1) and σ(X2), the 
estimated error σ(T) is: 
2
2
2
1 ))((+))((=)( XXT σσσ  (4.3) 
The quantity T calculated from the product of a constant value, c, and X has an estimated 
error given by, 
)(•=)( XcT σσ   (4.4) 
When a quantity T is the product of two independent observations, X1 and X2, each 
having their own error estimate, σ(X1) and σ(X2), the estimated error σ(T) is: 
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 Error propagation was performed by setting up two data vectors.  The first data 
vector contained the raw PXRD intensity values for a given powder pattern.  The second 
vector contained the initial error estimates for each intensity value.  The vectors were 
propagated side-by-side through to the calculation of the structure function using the 
principles outlined in Equations 4.3, 4.4, and 4.5 for the mathematical manipulations to 
the error vector. 
 The final step of the PDF method involves the sine Fourier transform of the 
structure function, S(Q), into real-space representation.  Given accurate propagation of 
error up through calculation of the structure factor and no introduction of statistical 
correlation among the independent scattering events, a good estimate of the standard 
uncertainty in the PDF, σ(G(r)), is given by: 
∑ 222 ))(())sin((
4
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i
iijiij QSQrQQrG σΔπ
σ  (4.6) 
where σ(S(Q)) is the error estimate of the structure function. 
4.2.6 Monte Carlo Simulation 
 The term Monte Carlo refers to a broad class of methods that employ generation 
of random numbers as a starting point for solving a complicated numerical problem. 
Monte Carlo methods are often used to simulate physical and mathematical systems. 
They are especially useful for modeling phenomena having significant uncertainty. The 
simulation typically begins with defining a distribution of possible inputs. An input 
generated from the distribution is used to perform deterministic computations to obtain an 
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individual result. Finally, the results from individual computations are compiled and 
interpreted.122  
 The raw PXRD counts go through a number of mathematical manipulations when 
transformed using the PDF algorithm; oftentimes optimized according to specific quality 
criteria.41  In order to confirm the appropriate propagation of an initial raw count error 
estimate, Monte Carlo simulations were employed.  The simulations began with a defined 
distribution of intensity values at each °2θ.  The distribution at each specific scattering 
angle (°2θ) was formed by using the raw intensity (i.e. counts) as the distribution mean 
and the error estimate as the spread.  Simulated PXRD patterns were formed by randomly 
selecting an intensity value from the previously defined distributions at each °2θ angle. 
Each simulated PXRD pattern was subsequently transformed into real-space 
representation using the PDF. After ten-thousand iterations, a matrix of PDF patterns 
spanning the variance of the simulated PXRD patterns was formed.  The minimum and 
maximum G(r) at each r-value in the PDF was compared to the error vector calculated 
using the previously defined equations. 
4.3 Results 
 The count of scattered intensity within a given time interval obtained from the 
PXRD experiment is subject to an unavoidable, random uncertainty due to statistical 
variation in quantum counting.123  This stochastic variation best follows a Poisson 
probability density function a discrete distribution that possesses unique statistical 
properties.  Assuming that n counts occur in a specific time interval, the distribution 
possesses a mean and variance equal to n, when n is a positive integer.38  The standard 
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deviation for n counts at the scattering angle x° 2θ is, therefore, equal to the square-root 
of n and will serve as the initial error estimate.   
 Figure 4.2a shows the diffraction pattern for amorphous ketoconazole (black, 
solid line) and ±3 standard deviations (blue, solid line).  The subsequent PDF transform 
of the PXRD pattern is shown in Figure 4.2b (zoomed, black, solid line).  To confirm the 
appropriate propagation of error through the transform, Monte Carlo simulations were 
performed as previously described.  The calculated error (blue, dashed lines) and 
simulated error (red, dashed lines) is shown as intervals in Figure 4.2b and as absolute 
error values in Figure 4.2c. 
 
Figure 4.2.  (a) The diffraction pattern for amorphous ketoconazole (black, thick line) 
and ±3σ (blue, thin line); (b) the PDF transform of (a) (black, thick line), calculated ±3σ 
(blue, dashed line), and simulated ±3σ (red, dashed line); (c) absolute representation of 
calculated 3σ (blue) and simulated 3σ (red). 
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 It is common practice to compare an experimentally obtained PDF to one 
calculated from a structural model.  Previous studies have illustrated the advantages of 
error propagation to this particular application.  Recently, an increasing interest to 
compare multiple experimental PDFs has emerged.  Difference plots with error intervals 
calculated from experimental PDFs may assist in delineating random errors from true, 
structural variations.  Figure 4.3a shows the PDF transform of a 50 wt% physical 
mixture of amorphous felodipine and PVPva (black, solid line) with an overlay of a linear 
combination of PDFs from amorphous felodipine and PVPva (blue, line with circles).  
Figure 4.3b shows the difference plot (black, solid line) obtained from the two traces in 
Figure 4.3a.  Additionally, the estimated combined error contribution (±3σ) calculated 
from the propagation through each transform is also shown as an interval around the 
difference (red, dashed lines).  That is to say, an interval calculated from the combination 
of the two amorphous component PDFs comprising the blue trace and the physical 
mixture PDF represented by the black trace. 
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 Figure 4.3. (a) The PDF of a 50 wt% physical mixture of amorphous felodipine and 
PVPva (black) and the refined linear combination of the amorphous component PDFs 
(blue, circles); (b) the difference between the PDFs (black) and ±3σ (red, dashed line). 
 
 To illustrate the potential to differentiate random error from true structural 
differences, the error propagation principles were applied to the method outlined by 
Newman et al.52 that was proposed to identify miscibility between a drug and excipient.  
Briefly, the PDF of a co-solidified product is compared to the linear combination of the 
PDFs obtained from the amorphous components comprising the mixture.  The scaling 
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constants serve as concentration estimates for each amorphous phase in the co-solidified 
mixture.  If the linear combination of the PDF for each amorphous component describes 
the PDF of the co-solidified sample, it is reasonable to conclude that the system is at least 
partially phase-separated as the short-range order (i.e. the static local structure) of the co-
solidified product can be described by the intrinsic distances found in the amorphous API 
and polymer.  Substantial differences between the PDF calculated from linear 
combination of the individual amorphous component PDFs and the PDF of the co-
solidified sample are indicative of short-range order not presented in the individual 
components, (i.e. that of a unique packing pattern).  Figure 4.4a shows the PDF 
transform (black, solid line) for a 75 wt% felodipine and PVPva co-solidified product.  
The superimposed trace (blue, circles and line) is the best refined linear combination of 
the amorphous component PDFs.  Figure 4.4b shows the difference between the two 
PDFs (black, solid line) with the calculated ±3σ error estimates. 
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 Figure 4.4.  (a) The PDF of a 75 wt% co-solidified product of felodipine and PVPva 
(black) and the refined linear combination of the amorphous component PDFs (blue, 
circles); (b) the difference between the PDFs (black) and ±3σ (red, dashed line), where 
the green dots are indicative of the error interval not containing zero. 
 
 As a point of comparison, Figure 4.5a contains the PDF (black, solid line) for a 
75 wt% terfenadine and PVPva co-solidified product.  Superimposed is the best refined 
linear combination of the amorphous component PDFs.  Figure 4.5b shows the 
difference between the two PDF traces (black, solid line) with the calculated ±3σ error 
estimates.  The Tg for the co-solidified products in Figure 4.4 and Figure 4.5 are shown 
in Figure 4.6 and Figure 4.7, respectively.  In both products, a single Tg event is 
 116
observed (middle traces in Figure 4.6 and 4.7) intermediate to the Tg observed for the 
pure components (top and bottom traces in Figure 4.6 and 4.7).  Table 4.1 summarizes 
the DSC and PDF results. 
 
Figure 4.5. (a) The PDF of a 75 wt% co-solidified product of terfenadine and PVPva 
(black) and the refined linear combination of the amorphous component PDFs (blue, 
circles); (b) the difference between the PDFs (black) and ±3σ (red, dashed line). 
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Figure 4.6. The DSC thermograms for felodipine:PVPva systems (as labeled). 
 
 118
 
Figure 4.7.  The DSC thermograms for terfenadine:PVPva systems (as labeled). 
 
4.4 Discussion 
 The PXRD experiment is traditionally regarded as robust.  Fluctuations in 
scattering intensity attributable to experimental geometry (Lorentz factor) and radiation 
polarization are assumed to be insignificant contributors to the overall variance due to 
their precision.23,123  The uncertainty due to statistical variation in quantum counting, 
therefore, serves as an appropriate initial error estimate (Figure 4.2a).  Although this 
estimate does not contain all possible sources of error, it does enable the ability to rule 
out changes that are too small to be taken seriously.   
 By randomly selecting scattering intensities spanning the defined error interval for 
each scattering angle (°2θ) over ten-thousand iterations, the Monte Carlo simulation 
creates a matrix of diffraction patterns that possess the overall variance contained within 
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the initial uncertainty estimate.  The simulated patterns were individually transformed 
using the PDF algorithm.  Since the simulated PXRD patterns span the total variance of 
the estimated uncertainty in reciprocal space, the resulting PDF patterns span that same 
variance in real-space.  The propagated PDF uncertainty interval (Figure 4.2b, blue, 
dashed lines) is in good agreement with the simulated PDF uncertainty interval (Figure 
4.2b, red, dashed lines).  For a point of reference, the absolute PDF errors derived from 
propagation and simulation are given in Figure 4.2c.  The agreement between simulated 
and propagated errors confirms the appropriate propagation of the initial error estimate 
through the PDF transform. 
 Comparisons and modeling between multiple experimentally obtained PDFs is 
becoming increasingly common.  Similar to comparing an experimental PDF to a 
calculated PDF from a structural model, the premise in these analyses is to identify 
correlations between PDFs while maintaining the ability to differentiate pattern 
dissimilarities attributable to structural differences from those attributable to random 
error.  To do this, it is proposed that error intervals are estimated for the difference plot 
calculated between experimental PDFs of interest.  In Figure 4.3a, the PDF transform of 
a PXRD pattern obtained from a 50 wt% physical mixture of amorphous felodipine and 
PVPva is represented by the black, solid line.  The blue line with circles in Figure 4.3a 
represents the refined linear combination of amorphous component PDFs.  The difference 
between the calculated and physical mixture PDF is given in Figure 4.3b (black, solid 
line).  The uncertainty interval around the difference plot was obtained from the 
combined propagated error of the two PDF patterns.  The PDF transform of a PXRD 
pattern of an amorphous felodipine:PVPva physical mixture would be expected to be the 
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same as a linear combination of a PDF transform of a PXRD pattern of pure amorphous 
felodipine and a PDF transformed of a PXRD pattern of pure PVPva.  This expectation is 
founded on the principle that a physical mixture of two amorphous materials would not 
alter the short-range order intrinsic to the two materials comprising the blend.   
 A null hypothesis may be formed stating that the difference between the two 
PDFs is equal to zero (ho: μa – μb = 0).  The alternative to the null hypothesis states the 
difference between the two PDFs is not equal to zero (hA: μa – μb ≠ 0).  If, at any value of 
r, the ±3σ interval around the difference plot contains zero, then the null hypothesis is 
accepted.  If, however, the ±3σ interval at a value r does not contain zero, then the 
difference between the two PDFs can not be explained simply by random error and the 
null hypothesis is rejected.  The ±3σ interval shown in Figure 4.3b contains zero for 
every value of r, and therefore, reflects that all differences between the two PDFs is 
attributable to random error.  Defining a threshold below ±3σ would lead to conclusions 
of structural differences between the two PDFs, as the entire range of r would not contain 
zero.  As a result of this finding, ±3σ difference plot intervals that do not include zero are 
assumed to be indicative of statistically significant structural dissimilarities between 
experimental PDFs for the remainder of this manuscript. 
 It is worthwhile to point out that the aforementioned conclusion concerning the 
±3σ threshold is not universal; rather, it is dependent on the PXRD experimental 
parameters.  Longer irradiation times or different experimental geometries may result in 
better counting statistics, hypothetically producing relative initial error estimates orders 
of magnitude less than the ones illustrated herein.  The principles surrounding error 
propagation and the conclusions drawn from statistical hypotheses testing outlined 
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previously, however, are valid and warrant application when drawing inferences from 
differences between multiple analytical results. 
 The DSC data for 75 wt% felodipine and PVPva co-solidified product, as well as 
75 wt% terfenadine and PVPva co-solidified product are shown in Figure 4.6 and 4.7, 
respectively.  From Table 4.1, the calculated ideal Tg for a 75 wt% felodipine:PVPva 
amorphous molecular solid dispersion is 62 °C.  The experimentally determined Tg for 
the co-solidified product, cycled through the event three times, was 67 ± 0.02 °C and in 
good agreement with the ideal value.  The ideal Tg for a 75 wt% terfenadine:PVPva 
(Table 4.1) is 77 °C. The experimentally determined Tg for the co-solidified product was 
60 ± 0.2 °C.  In both instances, a single Tg intermediate to the individual amorphous 
phase Tg that remains constant upon cycling was observed for the co-solidified products 
(Figures 4.5 and 4.6).  From purely thermal analyses, both co-solidified products may be 
classified as amorphous molecular solid dispersions due to the presence of only a single 
Tg intermediate to the pure amorphous phase Tg events.   
 In Figure 4.4a, the PDF of the PXRD pattern for the felodipine:PVPva co-
solidified product (black, solid line) is shown with the refined linear combination of the 
amorphous component PDFs.  The scaling constant-derived concentrations of 81 % and 
19 % drug and polymer, respectively (Table 4.1) deviate substantially from the 
theoretical values of 75 % drug and 25 % polymer.  The sum-of-squares agreement factor 
(R) shows an error estimate of 21 % between the calculated PDF and the co-solidified 
product PDF.  From the difference plot in Figure 4.4b, variations between the two 
patterns are observed within the range of 6 – 9Å that are not explained by random error 
as indicated by portions of the error interval not encompassing zero (green dots).  As 
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previously suggested, this result would be indicative of a true amorphous molecular solid 
dispersion, as the product would have short-range order (i.e. nearest neighbor and next 
nearest neighbor interatomic distances) not explained by either pure component PDF. 
 The PDF for the terfenadine:PVPva co-solidified product (black, solid line) is 
shown with the calculated PDF in Figure 4.5a.  The scaling constant-derived 
concentrations of 73 % and 27 % drug and polymer, respectively (Table 4.1) are close to 
the theoretical values of 75 % drug and 25 % polymer.  The sum-of-squares agreement 
factor (R) shows an error estimate of only 8 % between the calculated PDF and the co-
solidified product PDF (Table 4.1).  Upon inspection of the difference plot uncertainty 
interval in Figure 4.5b, it was found that zero is contained within the ±3σ interval over 
the entire range of r.  The short-range order displayed in the PDF of the co-solidified 
product is well explained by that found in the individual amorphous components and 
thereby negates formation of a unique packing pattern.  The terfenadine:PVPva 
dispersion product, therefore, is phase-separated. 
 A plausible explanation as to why a second Tg was not observed for the 
terfenadine co-solidified product was extrapolated from Newman, et al.52  Close 
inspection of Figure 4.7 shows the Tg of the dispersion product to be nearly equal to the 
Tg of amorphous terfenadine.  Since terfenadine represents the major phase of the 
dispersion (75%), PVPva only constitutes 1.25 mg of a 5 mg sample.  As the 
concentration of the PVPva amorphous domain decreases with respect to that of the 
amorphous terfenadine, the heat capacity change at the PVPva glass transition becomes 
so subtle relative to that of amorphous drug that it is not detectable using standard DSC.  
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4.5 Conclusion 
 The successful propagation of an initial error estimate through the PDF transform 
enabled statistically-based conclusions to be drawn from multiple pattern comparisons.  It 
was found that difference plots calculated from linear combinations of amorphous phase 
PDFs and co-solidified product PDFs could be used to differentiate between phase-
separated systems and amorphous molecular solid dispersions.  The calculation of error 
intervals on the difference plot assisted this classification scheme by providing statistical 
thresholds to define structural dissimilarities as opposed to subjective interpretation.  
Though this study does not define a universal threshold for differentiation of random 
errors and structural dissimilarities, the principles developed herein may be adapted and 
applied accordingly. 
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Chapter 5: Informatics Calibration of a Molecular Descriptors 
Database to Predict Solid Dispersion Potential of Small 
Molecule Organic Solids 
 
5.1 Introduction 
 The aqueous solubility of a small molecule organic (SMO) solid is one of the 
principle physicochemical properties considered when evaluating the developability of a 
new chemical entity (NCE) for pharmaceutical use.  Although a number chemical- and 
physical-based approaches are available for enhancing the apparent aqueous solubility of 
active pharmaceutical ingredients (API), it is still estimated that more than 40% of highly 
potent compounds fail to reach clinical trials due to the inability to overcome poor 
aqueous solubility.15  It is proposed that this statistic is somewhat inflated, not necessarily 
due to the inefficacy of available methods, but rather the raw material requirements 
associated with empirically assessing the potential of each.  Formulation scientists are 
ultimately forced to investigate only a fraction of the existing technology, where 
unsuccessful outcomes may deem a therapeutically efficacious API undevelopable.  The 
development of predictive models to optimize these methods in an attempt to preserve 
early stage raw material supplies is thus imperative. 
 Stabilization of an API as an amorphous solid phase through the formation of 
binary amorphous molecular solid dispersions has received increasing attention yielding 
up to a four-fold enhancement of apparent aqueous solubility relative to the crystalline 
form.58  Binary amorphous molecular solid dispersions are created through the rapid co-
solidfication of an API and a pharmaceutically acceptable excipient, such as a polymer, at 
loadings sufficient to achieve a physically stable amorphous API.  Due to the kinetic 
nature of the formation, spray drying,69 super-critical fluid processing,76 lyophilization,63 
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and hot-melt extrusion72 have all been successfully implemented in the preparation of 
amorphous molecular solid dispersions.  Successful formation has been attributed to the 
presence of specific and/or nonspecific adhesive interactions,62,83 as well as 
antiplasticization effects intended to reduce molecular mobility.81   
 Predictive models for API:polymer miscibility have been introduced and are 
largely derived from solution thermodynamics.  Lattice based solution models, such as 
Flory-Huggins theory, can be used to assess miscibility in API:polymer blends.  In 
addition to developing methods for estimating the Flory-Huggins interaction parameter, 
Marsac et al.89 developed a model that predicted the solubility of an API in a polymer 
based on a combination of interaction variables and Flory-Huggins theory.  Janseens et 
al.73 applied the similar theory to model solid dispersion preparation method effects on 
the solubility of API in polymer.  Friesen et al.68 showed physical properties of APIs, 
such as hydrophobicity (i.e. log P), thermodynamic parameters (e.g. melting temperature) 
and kinetic parameters (e.g. glass transition temperature) to provide insight concerning 
formulation strategies for solid dispersion systems.  In addition to ionic interactions, 
when applicable, Yoo et al.124 also observed a correlation between hydrophobicity values 
of APIs and miscibility with a given polymer.  Despite the recent advances, explicit 
universal criteria for API:polymer miscibility are still lacking. 
 Quantitative structure property relationships (QSPR) were derived from the 
fundamental concept that a compound’s behavior is a result of its chemical structure.  In 
QSPR models, molecular descriptors, single integer indices that encode specific structural 
information for a given compound, are typically regressed against some physical, 
chemical, or mechanical property.  Applications of molecular descriptors in QSPR 
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modeling include predicting pharmacokinetic performance,125 describing physical 
properties of alkanes,126 and prediction of soil sorption coefficients of pesticides.127  
Coupled with characterization techniques to classify the co-solidified composites 
containing a given API, molecular descriptors have the potential to provide insight to 
API:polymer miscibility using a materials informatics approach. 
 In this study, 12 model compounds were prepared by a melt-quench procedure 
using polyvinylpyrrolidone:vinyl acetate (PVPva) copolymer as a stabilizing agent with 
useful thermoplastic properties and the potential (i.e. miscibility) for generating an 
amorphous molecular solid dispersion.  Each co-solidified sample was characterized by 
thermal analysis, powder X-ray diffraction (PXRD). and a pair distribution function (PDF) 
method recently introduced into the literature.52  Rather than attempting to quantify the 
extent of miscibility between API and polymer to afford a continuous dependent variable, 
each sample was classified as a successful formation (i.e. completely miscible) or an 
unsuccessful formation (i.e. partially miscible or immiscible) based upon conclusions 
drawn from the analyses.  Molecular descriptors were calculated for each of the 12 model 
compounds comprising the library and tested for correlation to dispersion potential using 
logistic regression.  A univariate model was created that predicted solid dispersion 
potential from a single molecular descriptor and challenged using three compounds not 
included in the calibration. 
 At the outset, it should be noted that the model developed herein is not proposed 
to be universally applicable across all SMO compounds nor is it predictive of the time 
course of physical instability (i.e. devitrification).  Rather, a significant portion of the 
discussion will attempt to highlight the limitations associated with the model and define 
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the pertinent variance space for its applicability.  The central objective of this work was 
to illustrate the potential of in silico calculations to create models that may one day 
provide the means for intelligent selection of stabilizing agents in the design of 
amorphous molecular solid dispersions.  This possibility is ultimately afforded by the 
ability to classify co-solidified samples to compliment the interpretation that is possible 
from solid-state characterization methods alone. 
5.2 Materials and Methods 
 Cloperastine, terfenadine, propranolol, chlorpropamide, nifedipine, melatonin, 
and quinidine were all purchased from Sigma-Aldrich (St. Louis, MO).  Ketoconazole 
and itraconazole were purchased from Spectrum (Gardena, CA).  Indomethacin, 
cimetidine, and tolbutamide were purchased from MP Biomedicals (Solon, OH).  
Felodipine was purchased from Tecoland Corporation (Edison, NJ), sulfanilamide was 
purchased from Acros Organics (Geel, Belgium), bicalutamide was purchased from Altan 
(Orange, CT), and Kollidon VA64 (PVPva) was a gift from BASF (Ludwigshafen, 
Germany).  All model and test compounds are shown in Table 5.1. 
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Table 5.1. Molecular structures and Cambridge Structural Database Codes for 
compounds used in this study. 
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5.2.1 Solid Dispersion and Amorphous Phase Preparation 
 Solid dispersion samples were manufactured using a melt-quench method.66  
Briefly, each API and PVPva was weighed and dispensed into a scintillation vial at 75 
wt% API loading.  The powders were physically mixed for a period of 5 minutes by 
manual agitation.  To avoid sub-sampling, the entire mixed sample was added to a 
crucible heated in a silicone oil bath.  The oil bath was maintained at a temperature equal 
to the fusion temperature of the API (Tf,API) + 10°C.  In the instance where Tf,API was less 
than 150 °C (e.g. the temperature at which PVPva liquefies), the mixture was held 
isothermally at 160 °C.  The isothermal hold time was between 10-20 minutes to provide 
sufficient time for mixing.  The hold time was determined using thermogravimetric 
analysis and was defined as the time (at a given preparation temperature) where ≥2% 
weight loss occurred.  The molten mixture was subsequently quenched in an ice water 
bath.  Amorphous samples of each component were produced by holding the crystalline 
API above its melting temperature for approximately 10 minutes followed by quenching 
in an ice bath.  The melt-quench samples were removed from the crucible intact and 
examined.  All preparations were repeated twice (n=3). 
5.2.2 Differential Scanning Calorimetry (DSC) 
 Glass transition temperatures (Tg) for amorphous preparations of each model 
compound, PVPva, and the co-solidified samples were measured using a Model Q100 
DSC (TA Instruments, New Castle, DE) under constant nitrogen purge (~50 mL/min).  A 
three-point enthalpy and temperature calibration was performed at 20 °C/min using o-
terphenyl, indium, and tin standards.  In an attempt to reduce artifacts arising from 
sample preparation procedures (i.e. grinding), approximately 5 mg intact “sample chips” 
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were hermetically sealed in aluminum pans.  To normalize thermal history, samples were 
first heated at 20 °C/min to 105 °C, held isothermally for 2 minutes, and subsequently 
cooled to -20 °C at 20 °C/min.  Samples were then cycled from -20 °C to 120 °C at 20 
°C/min for Tg determination. 
 The expected Tg assuming an intimate mixture was calculated using the 
Couchman Karasz85 equation given by: 
pAPI
gpgAPI
g Kww
TKwTw
T pAPI
+
+
=  (5.1) 
where wAPI and wp and the weight fractions of API and polymer, respectively, TgAPI and 
Tgp are the glass transition temperatures of amorphous API and polymer, respectively, 
and K = ΔCpAPI/ΔCpp, where ΔCpAPI and ΔCpp are the heat capacity step change through 
the glass transition region of the API and polymer, respectively.  Experimental Tg values 
were determined from the measured DSC heat flow signal as the onset of the step change 
in heat capacity. 
5.2.3 Powder X-ray Diffraction (PXRD) 
 The PXRD data were collected in transmission geometry using an X’Pert Pro 
MPD system (PANalytical B.V., Almelo, the Netherlands) equipped with a copper anode 
(λ = 1.5406 Å), an auxiliary elliptical mirror, and X’CeleratorTM detector.  The 
operational voltage and amperage were set to 45.0 kV and 40.0 mA, respectively.  
Diffraction patterns were acquired on intact samples, sandwiched between two layers of 
Kapton® film and subsequently placed on a spinning vertical sample stage (16 rpm).  
Experimental parameters include an irradiation time of 51.04 seconds per step and an 
angular step size of 0.017° 2θ over a 2-100° 2θ range. 
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5.2.4 Pair Distribution Function 
 The PDF is a total scattering method that exploits the Fourier relationship 
between X-ray diffraction intensity and the real-space arrangement of atoms, given 
appropriate data treatment.38,111  The PDF gives the probability of finding atom pairs 
separated by a distance r, and is obtained by Fourier transform of the reciprocal space 
structure function, S(Q), according to: 
[ ]∫ -
max
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1
2
 (5.2) 
where S(Q) is the structure function obtained from a diffraction experiment and Q is the 
magnitude of the scattering vector.  The term Qmax is the momentum transfer resolution of 
the diffraction experiment, which is dependent on the wavelength of radiation used and 
the maximum diffraction angle (°2θ) of data collection.  Corrections consistent with those 
outlined by Egami and Billinge38 were made to the measured diffraction data leading to 
the calculation of the structure function.  All intensity corrections (e.g. background due to 
Kapton® film scattering, absorption, etc.) and PDF calculations were performed using 
software developed in-house in the Matlab programming environment (v7.1, MathWorks, 
Natick, MA) based on published equations.38,111  The PDF transforms were optimized 
using the Glow quality criteria introduced by Peterson, et al.41
 The PDF has been shown to be useful in characterizing co-solidified composite 
samples in differentiating phase-separated from completely miscible systems.52,118  
Briefly, the PDF transform for a co-solidified sample is compared to the linear 
combination of the PDF transforms obtained for each amorphous component comprising 
it.  Scaling coefficients are multiplied by the amorphous component PDFs and serve as 
estimates of each component concentration in the co-solidified product.  If the linear 
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combination of the PDF for each amorphous component describes the PDF of the co-
solidified sample, it is reasonable to conclude the system is at least partially phase-
separated, as short-range order (i.e. the static local structure) of the co-solidified product 
can be described by the intrinsic distances found in the amorphous API and polymer.  
Large deviations between the calculated PDF determined by linear combination of the 
PDFs for the individual amorphous components and the PDF of the co-solidified sample 
are indicative of short-range order not presented in the individual components, (i.e. that 
of a unique packing pattern).  A statistically-founded protocol based on principles of error 
propagation has recently been introduced to aid in drawing conclusions from the 
aforementioned method (Chapter 4).  A sum-of-squares difference, R, between the 
calculated PDF and PDF of co-solidified sample was also determined for comparative 
purposes.123  
5.2.5 Molecular Descriptors 
 The term molecular descriptor refers to a broad class of indices calculated under 
the principal objective of representing a 3-dimensional molecule as a simple number(s).  
Their successful use in QSPR studies, relating the structure of a compound to how it 
behaves, provides impetus to modeling amorphous molecular solid dispersion potential.  
By employing graph theory,128 a branch in discrete mathematics dealing with the way 
objects are connected and the consequences of connectivity, single integer indices may be 
calculated that encode structural information for a given molecule.  Molecular graphs are 
a 2-dimensional depiction of molecules, where atoms are represented by vertices and 
bonds by edges.   Two molecular graphs are isomorphic if there is a one-to-one 
correspondence between their vertex sets and edge sets.  For a given molecular graph, U, 
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a graph invariant is a quantity that has the same value for any graph that is isomorphic 
with U.128   
 From the molecular graph, important theoretical matrices may be calculated.  The 
vertex-adjacency matrix is a square symmetric matrix having off-diagonal values of one 
for adjacent vertices and zero for non-adjacent vertices.  Similarly, the edge-adjacency 
matrix is a square symmetric matrix having off-diagonal values of one for adjacent edges 
and zero for non-adjacent edges.  The distance matrix is a square symmetric matrix 
having off-diagonal values describing the shortest topological distance between two 
vertices.  Single integers may be obtained from the mathematical manipulation of these 
matrices, thereby generating a class of molecular descriptors called topological indices.  
These indices are graph invariants and do not possess atom identities, thereby lacking 
heteroatom differentiation and stereochemical features of the molecule.126
 To combat this issue, indices are calculated from weighted graph invariants, 
where atomic mass, atomic number, van der Waals volumes, and atomic polarization 
constants have all been implemented.  These descriptors are much more powerful and 
have seen an increasing exposure to structure-property relationships studies.  In this study, 
molecular descriptors were calculated using the EDRAGON online program.129-131  
Three-dimensional coordinates and atom connectivity was obtained from the Cambridge 
Structural Database (CSD),132,133 where the CSD code for each model and test compound 
are listed in Table 5.1. 
5.2.6 Logistic Regression 
 The intent of this study was to introduce a novel method for modeling the 
potential of a compound to successfully form an amorphous molecular solid dispersion 
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with PVPva using a common method of preparation.  Attempting to define and quantify 
the extent of miscibility between API compounds and PVPva would likely confound the 
results of the analysis, as errors in this determination would propagate into the regression 
modeling.  Therefore, the response in this analysis is a discrete, dichotomous variable 
taking a value of 1 for successful formation of an amorphous molecular solid dispersion 
(i.e. completely miscible) or a value of 0 for unsuccessful formation (i.e. partially 
miscible or immiscible) based upon conclusions drawn from the analyses.  The inclusion 
of a dichotomous dependent variable unfortunately violates many of the assumptions of 
general linear regression.134  Logistic regression was, therefore, used for modeling 
purposes in this study. 
 Logistic regression was performed using maximum likelihood (ML) estimation to 
calculate the regression coefficient for each molecular descriptor. Initial regression 
coefficients are estimated and the ML is calculated.  The regression coefficient is 
iteratively adjusted until the maximum value of the ML (Equation 5.3) is achieved.  To 
avoid multiplication of probabilities, the natural logarithm of the ML function is used and 
given by: 
∑ -1-1+= )]ln(*)[(]ln*[)ln( iiii PYPYML  (5.3) 
where Yi is the observed value (i.e. 0 or 1) and Pi is the estimated probability as obtained 
by: 
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where b0 + b1Xi is the general linear model.134-136  The effect of individual variables on 
model significance was tested by comparing the change in deviance (D), which is 
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Equation 5.3 multiplied by -2.  The likelihood ratio (LR) test statistic, corresponds to the 
arithmetic difference between the deviance values for two models (e.g., with and without 
a particular variable included), and follows a χ2 distribution. The significance of the 
calculated regression coefficient for each molecular descriptor was evaluated by 
comparing the reduction of deviance value of the full model against using only the model 
intercept. 
 The error of cross-validation was assessed using the leave-one-out (LOO) method.  
Briefly, one of the compounds comprising the calibration library was removed from the 
data set.  The remaining compounds were used to construct a calibration and a 
subsequent prediction on the compound removed from the library was performed.  This 
was iteratively repeated for all compounds, where the sum of the total error was reported. 
5.3 Results 
5.3.1 Co-solidified product characterization 
 Amorphous molecular solid dispersions are formed as a result of the miscibility 
between the components comprising the sample.  To enable model estimation, DSC and 
PDF analyses were used to characterize and classify the co-solidified samples according 
to the extent of miscibility.  To achieve this, both DSC and PDF analyses were employed.  
To support the implementation of multiple characterization methods, three examples will 
be examined.  The first example will illustrate a co-solidified sample categorized as an 
amorphous molecular solid dispersion, the second will detail identification of a phase-
separated system according to both DSC and PDF results, and the final will showcase a 
phase-separated system identified by PDF results.  A compilation of calculated 
parameters associated with each example are given in Table 5.2. 
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Table 5.2. DSC and PDF analyses results. 
 DSC Analysis PDF Analysis  
 
Ideal 
Tg 
(°C) 
Tg1 
(°C) 
Tg2 
(°C) 
R 
value 
Drug 
Conc. 
(w/w) 
Polymer 
Conc. 
(w/w) 
Conclusion 
felodipine:PVPva 63.4 64.9 -- 0.213 0.81 0.19 miscible 
quinidine:PVPva 76.8 59.7 81.9 0.069 0.73 0.27 phase-separated 
terfenadine:PVPva 77.2 60.6 -- 0.086 0.73 0.27 phase-separate 
 
 The DSC thermogram for amorphous felodipine, PVPva, and the 75 wt% co-
solidified sample is shown in Figure 5.1a.  A single Tg at 64.9 ºC was observed for the 
co-solidified sample.  The PDF analysis and respective difference plot for this system is 
shown in Figure 5.1b.  From Table 5.2, the calculated Tg for an ideal 75 wt% mixture is 
63.4 ºC, which is in good agreement with the experimentally determined 64.9 ºC shown 
in Figure 5.1a.  The difference plot for the PDF analysis (Figure 5.1b) exhibits regions 
in r where the confidence intervals do not contain zero.  An R of 0.2126 (Table 5.2) 
corresponds to 21% error between the two PDF patterns.  Refined API and polymer 
concentrations (scaling coefficients) of 0.81 and 0.19 (Table 5.2) deviate substantially 
from theoretical concentrations of 0.75 and 0.25, respectively.  Based on a single Tg and 
the large deviations between the calculated and measured PDF of the co-solidified sample, 
the system is an amorphous molecular solid dispersion. 
 138 
Figure 5.1. (a) DSC thermogram for amorphous felodipine (blue), PVPva (red), and 75 wt% co-solidified product (black); (b) PDF 
analysis (as labeled). 
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Figure 5.2. (a) DSC thermogram for amorphous quinidine (blue), PVPva (red), and 75 wt% co-solidified product (black); (b) PDF 
analysis (as labeled).
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 The DSC thermogram for amorphous quinidine, PVPva, and the 75 wt% co-
solidified sample is shown in Figure 5.2a.  Glass transition events at 59.7 ºC and 81.9 ºC 
were observed for the co-solidified sample.  Although the DSC results alone provide 
conclusive evidence of phase-separation, the PDF analysis was performed and is shown 
in Figure 5.2b.  The difference plot (Figure 5.2b) for the PDF analysis shows confidence 
intervals that contain zero through the entire r region.  In addition to this, a satisfactory R 
value of 0.0689 and refined API and polymer concentrations of 0.73 and 0.27 (Table 5.2), 
respectively, were also observed.  The system is phase-separated based on evidence of 
two Tg events and the agreement between the calculated and measured PDF for the co-
solidified sample.
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Figure 5.3. (a) DSC thermogram for amorphous terfenadine (blue), PVPva (red), and 75 wt% co-solidified product (black); (b) PDF 
analysis (as labeled).
 The DSC thermogram for amorphous terfenadine, PVPva, and the 75 wt% co-
solidified sample is shown in Figure 5.3a.  A single Tg event at 60.6 ºC was observed for 
the co-solidified sample, albeit relatively close to the Tg observed for the amorphous 
terfenadine.  The difference plot (Figure 5.3b) for the PDF analysis shows confidence 
intervals that ultimately contain zero through the entire r region.  In addition to this, a low 
R and refined concentration values (Table 5.2) that are close to the theoretical 
concentrations were also observed.  It is concluded that the system is phase-separated as a 
result of a single, Tg value near that of the amorphous API and the good agreement 
between the calculated and measured PDF for the co-solidified sample. 
 The final results of the co-solidified sample analyses are listed in Table 5.3.  Of 
the 12 compounds comprising the calibration library, DSC and PDF analyses revealed six 
successfully formed an amorphous molecular solid dispersion (i.e. miscible with PVPva) 
and six formed phase separated systems.  Propranolol, cloperastine, and sulfanilamide all 
exhibited Bragg diffraction peaks (PXRD analysis), a clear indication of phase separation, 
following preparation.  Nifedipine and terfenadine both displayed a single Tg but were 
shown to be phase-separated using the PDF analyses. 
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Table 5.3. Calibration library generation results. 
Compound Miscible? Comments
Felodipine YES -- 
Indomethacin YES -- 
Ketoconazole YES -- 
Itraconazole YES Could not obtain amorphous itraconazole; No PDF test 
Tolbutamide YES -- 
Chlorpropamide YES -- 
Nifedipine NO PDF confirmation only; crystallinity day 1 for repeats 
Quinidine NO Detectable phase separation from DSC and PDF 
Propranolol NO Detectable crystallinity (PXRD) on day 1 
Cloperastine NO Detectable crystallinity (PXRD) on day 1 
Terfenadine NO PDF confirmation only; crystallinity day 1 for repeats 
Sulfanilamide NO Detectable crystallinity (PXRD) on day 1 
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5.3.2 Calibration 
 Univariate logistic regression was performed by estimating regression coefficients 
for each of the calculated molecular descriptors.  Subsequently, a model containing the 
regression coefficient for a given molecular descriptor was compared with a model 
containing only the mean using the LR test statistic.  From this metric, the significance of 
the descriptor was determined.  Molecular descriptors with a significance ≥ 0.999 (i.e. α 
= 0.001) were retained for further analysis.  The results of the univariate screening are 
given in Table 5.4.  Along with the regression equation, deviance, LR, and error of cross-
validation are shown.  From each of these parameters, the atomic mass-weighted third-
order R autocorrelation index, R3m, appears to be the most significant.  Other significant 
molecular descriptors include the topological distance between oxygen and chlorine 
atoms (T(O…Cl)), the sum of the eigenvalues of an atomic number-weighted distance 
matrix (SEigZ), the sum of the eigenvalues of an atomic mass-weighted distance matrix 
(SEigm), first-order H autocorrelation weighted by atomic mass (H1m), the total H 
autocorrelation weighted by atomic mass (HTm), and the maximum of the fourth-order R 
autocorrelation weighted by atomic mass (R4m+).  The R3m index will be described in 
detail later; however, an explanation of other indices is beyond the scope of the paper and 
interested readers are directed elsewhere.137  
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Molecular 
Descriptor Regression Equation Deviance LR LOO CV
T(O..Cl) logit P(Y) = -1.927 + 0.208T(O…Cl) 6.513 10.86 0.3841 
SEigZ logit P(Y) = -12.33 + 7.37SEigZ 4.889 12.49 0.4208 
SEigm logit P(Y) = 12.57 + 7.50SEigm 4.813 12.56 0.4199 
H1m logit P(Y) = -17.78 + 12.31H1m 6.314 11.06 0.3964 
HTm logit P(Y) = -13.25 + 1.14HTm 5.992 11.39 0.3720 
R3m logit P(Y) = -88.54 + 135.18R3m 0.039 17.34 0.0565 
R4m+ logit P(Y) = -15.2 + 346.22R4m+ 3.253 14.12 0.2637 
Table 5.4. Model parameters for the seven best univariate models. 
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 Following univariate screening, both forward and backward elimination 
multivariate screening were performed at a significance level of 0.8 (i.e. α = 0.2).  The 
R3m index was the only remaining variable, and therefore, served as the final model.  
Predicted probabilities of amorphous molecular solid dispersion potential using the R3m 
model are shown graphically in Figure 5.4.  The results from testing the R3m model with 
three compounds not used in the calibration are shown schematically in Figure 5.5.  A 
description of the R3m index and explanation of its potential significance will be 
addressed in the discussion section.
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Figure 5.4. Predicted dispersion potential probabilities for each of the 12 model compounds.  Red indicates a correct prediction for 
unsuccessful formation and blue indicates a correct prediction for successful formation. 
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Figure 5.5. Predicted dispersion potential probabilities for each of the three test compounds.  Red indicates a correct prediction for 
unsuccessful formation and blue indicates a correct prediction for successful formation.
  
5.4 Discussion 
 As stated in the introduction, the central objective of this research was to illustrate 
the potential of using in silico molecular calculations to create predictive models for 
assessing miscibility between a compound and polymeric material, afforded by the ability 
to classify co-solidified samples using advanced solid-state characterization methods.  A 
further interpretation of this hypothesis states that some underlying molecular property is 
responsible for its ability to form a unique phase when intimately mixed with a carrier 
material.  It is assumed that API:polymer miscibility is represented by the formation of 
short range order possessing physical, structural, and other intrinsic properties distinct 
from either individual amorphous component.  It is further assumed that a completely 
miscible system will need to undergo phase separation as a pre-requisite to crystallization.   
 The extent of miscibility between a given compound and polymer is sensitive to 
many different variables.  The method of preparation, drug loading, and environmental 
factors may all affect the outcome of this determination.  The process of heating the 
materials to prepare co-solidified may introduce chemical impurities into the system.  As 
shown elsewhere,138 the presence of impurities can provide resistance to crystallization in 
co-solidified products by itself.  This is recognized as a potential confounding factor to 
the analysis presented herein, where TGA impurity assessment limits quantification to 
volatile degradants only.  It is assumed that the identification of miscible co-solidified 
products is a result of the compatibility between the API and polymer and not a 
consequence of thermal degradation.  Therefore, conclusions concerning miscibility in 
this study will be with reference to the melt-quench method used, the fixed concentration 
 149
 range interrogated, and assumptions derived from direct observation of characterization 
data. 
5.4.1 Co-solidified product characterization 
 The purpose of showing the three examples was to illustrate the requirement for 
using multiple solid-state characterization techniques in order to classify the co-solidified 
samples.  Although the two techniques are often complimentary, instances occur when 
results are contradictory.  In the first example, a single Tg (Figure 5.1a, black line) 
intermediate to each of the amorphous component Tg events was observed for the co-
solidified felodipine:PVPva sample.  Since the experimental Tg of 64.9 ºC is relatively 
close to the predicted 63.4 ºC (Table 5.2), this may support classification as an 
amorphous molecular solid dispersion on its own accord.   
 Instances arise where DSC may not be sensitive to the presence of multiple Tg 
events.  Possible explanations include convolution of two Tg events into a single Tg, the 
magnitude of the heat capacity change associated with an additional phase(s) is below the 
sensitivity of the instrument, the Tg event is superimposed over some other thermal 
transition, or the glass transition event unexpectedly occurs outside of the temperature 
range interrogated.  In addition, heating the sample during the measurement may 
consequently force miscibility in a phase separated system.  Each instance warrants the 
application of an alternative characterization technique, such as the PDF method using 
error propagation estimates, to examine the co-solidified sample.   
 For the felodipine:PVPva co-solidified sample, the high R value of 21.26%, 
concentrations inconsistent with theoretical values, and the presence of confidence 
intervals for r-values not containing zero (Figure 5.1b and Table 5.2)  all serve as 
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 indicators that the co-solidified product exhibits a packing pattern different than that 
produced by the local structure of each individual amorphous component.  From Figure 
5.1b, the difference plot indicates a significant difference between the calculated PDF 
and the co-solidified PDF around 8-9Å.   
 From Equation 5.2, the integration of the PDF is taken to Qmax, which ostensibly 
serves as the resolution of the calculation.   In this study, Cu Kα radiation was used as the 
source in the PXRD experiments, which produces a Qmax of approximately 7Å-1.  Fully 
resolved PDFs require a Qmax much greater than 7Å-1, often achieved using synchrotron 
radiation sources.  Due to the limited Q-resolution afforded by laboratory source X-ray 
data, each probability peak in the PDF represents a convolution of many different delta 
peaks.  With infinite Q-resolution, the formation of a new phase in the co-solidified 
sample would result in the appearance of unique delta peaks representing newly formed 
interatomic distances.  The limitations imposed by using Cu Kα radiation call for 
considering the distributions of delta peaks in the convoluted probability peaks.  
Distribution changes manifest as alterations to the shape of the probability peak, as 
observed for the felodipine:PVPva co-solidified sample (Figure 5.1b, black line) relative 
to the combine amorphous components (Figure 5.1b, blue circles).  It may be concluded 
that this sample has unique interatomic distances formed around 8-9Å not found in either 
amorphous component, and therefore, is an amorphous molecular solid dispersion.  This 
conclusion is consistent with those found elsewhere.79
 In the second example, the thermogram of the quinidine:PVPva co-solidified 
sample (Figure 5.2a, black line) displays a Tg event near that of the amorphous quinidine 
(Figure 5.2a, blue line) and a second intermediate to each amorphous component.  Given 
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 the detection of two Tg events, it is reasonable to conclude that the co-solidified sample 
has phase-separated.  In an effort to illustrate an instance where the PDF method supports 
the conclusions drawn from DSC, an analysis was performed on the quinidine:PVPva 
system.  From Figure 5.2b, agreement between the calculated PDF and the co-solidified 
sample was obtained as evidenced in the difference plot.  The inclusion of zero 
throughout the entire r range, low R value, and experimentally determined concentration 
values close to theoretical (Table 5.2) all support the conclusion of phase separation. 
 The final example is unique due to the disagreement in conclusions drawn from 
each characterization technique.  In Figure 5.3a, the thermogram for the 
terfenadine:PVPva co-solidified sample (black line) shows a single detectable Tg of 60.6 
ºC close to the Tg of 59.8 ºC for amorphous terfenadine (blue line).  Although this is 
likely indicative of the presence of amorphous terfenadine, unfortunately, a definitive 
conclusion is not readily available.  Deeming this analysis as inconclusive, an additional 
characterization technique is required.   
 In Figure 5.3b, the linearly combined amorphous component PDF patterns are 
superimposed over the co-solidified sample PDF.  From the difference plot, it is shown 
that the confidence intervals include zero throughout the entire range of r values.  
Additionally, the refined concentration values and low R value (Table 5.2) indicate a 
good fit between the two PDF patterns.  The aforementioned PDF data supports the 
conclusion that the terfenadine:PVPva co-solidified sample is phase-separated. 
 Table 5.3 summarizes miscibility determination between the 12 model 
compounds comprising the calibration library and PVPva, where a few noteworthy points 
deserve some discussion.  Propranolol, cloperastine, and sulfanilamide all exhibited 
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 Bragg diffraction peaks in PXRD patterns obtained following co-solidification, thereby 
indicating phase separation.  Nifedipine and terfenadine were identified as phase-
separated using the PDF method, where their respective co-solidified sample 
thermograms displayed single Tg events.  This conclusion was indirectly confirmed when 
the repeat co-solidification samples were analyzed.  In their subsequent preparations, 
PXRD patterns from both compounds displayed Bragg diffraction peaks immediately 
following sample preparation, thereby corroborating the previous conclusions.   
 Itraconazole was deemed to successfully form an amorphous molecular solid 
dispersion.  From Table 5.3, amorphous itraconazole was not obtained thereby 
preventing the PDF analysis; a definite shortcoming of the PDF method.  It may be 
expected that making conclusions solely on DSC data increases the probability of a 
misclassification.  In the previous discussion, terfenadine and nifedipine were classified 
as phase separated by PDF analysis. It was shown that subsequent preparations were 
prone to different levels of devitrification as evidenced in PXRD analyses.  The inability 
to procure amorphous itraconazole was attributable to the tendency for instantaneous 
crystallization upon quench cooling.  Given this characteristic, phase-separated 
itraconazole would be expected to instantaneously crystallize upon quenching.  Three 
different itraconazole:PVPva preparations consistently produced a single Tg event with 
PXRD patterns lacking any detectable Bragg diffraction.  The combination of all 
information supports a classification of complete miscibility between itraconazole and 
PVPva, which is further founded on conclusions drawn elsewhere.139
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 5.4.2 Calibration 
  From Table 5.4, the most promising molecular descriptor appears to be the R3m 
index.  Deviance is the natural logarithm of the likelihood value multiplied by negative 
two and serves as an estimate of error.  As the deviance is minimized (approaches zero), 
therefore, the predictions approximate experimental values and the model becomes more 
significant.  With a deviance of 0.039 for the R3m model, it is two orders of magnitude 
lower than that of the next best index.  The LR approximates a χ2 statistic, where a larger 
value is indicative of greater significance.  The R3m index has the greatest LR value for 
all molecular descriptors tested.  Finally, the error of cross-validation (LOO CV) is a 
metric for determining the robustness of the model.  By iteratively removing a compound 
from the library, creating a calibration, make a prediction on the compound removed, and 
calculating the error, the extent to which each sample influences the calibration is 
assessed.  The LOO CV for the R3m is an order of magnitude less than that of the next 
best value, thereby confirming the robustness of the R3m model.   
 It is important to consider the possibility of over-saturating a model constructed 
from only 12 samples.  With this in mind, multivariate logistic regression at a 
significance level of α = 0.2 was performed.  Both forward- and backward-elimination 
yielded the same conclusion; the R3m index was the single most significant descriptor.  
Shown in Figure 5.4 are the R3m predicted probabilities for each calibration sample with 
an estimated confidence interval in bar graph form.  Interestingly, 10 of the 12 
compounds were predicted perfectly, while quinidine and tolbutamide only slightly 
deviated.  The estimated confidence intervals (α = 0.05) for all 12 predictions indicated 
the predictions are reliable. 
 154
  The R3m index is part of a class of molecular descriptors known as GETAWAY 
(Geometry, Topology, and Atom-Weights AssemblY).140,141  The GETAWAY indices 
link 3-D geometry to atom relatedness, while retaining specific chemical information.  
The first part of calculating any GETAWAY descriptor is to calculate the molecular 
influence matrix, H, given by: 
M'•M)inv(M'M•=H  (5.5) 
where M is the molecular matrix comprised of A rows (number of atoms in molecule) 
and three columns (Cartesian atomic coordinates).  The molecular influence matrix is 
equivalent to a leverage matrix, ostensibly describing the Euclidean distance of atoms 
from the geometric center of the molecule.  The diagonal elements of H, hii, are called 
leverages and represent the “influence” of each atom in determining the whole shape of 
the molecule.  Interestingly, lower leverages are found for atoms in molecules of 
spherical shape, while higher leverages for atoms in more linear compounds.  Each off-
diagonal element of H represents the accessibility of the ith atom to interactions with the 
jth atom, where negative elements represent a low degree of accessibility.  From the 
molecular influence matrix, various R-GETAWAY descriptors can be calculated, 
including the w-weighted kth order autocorrelation index, Rk(w) , given by: 
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where h is the element of the molecular influence matrix, r is the geometric interatomic 
distance, w is the chemical weighting, k is the path length, d is the topological interatomic 
distance, and δ is equal to 1 when k = d and 0 when k ≠ d.  From this equation, the R3m 
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 descriptor may be interpreted as follows: “R”-GETAWAY “3rd”-order autocorrelation 
index weighted by the atomic mass, “m”.140  
 A direct physical interpretation of the correlation between the R3m index and 
amorphous molecular solid dispersion potential is not readily apparent.  From equation 
5.6, some key conceptual attributes of this index are evident.  Larger values are obtained 
for two peripheral atoms (i.e. further from the geometric center of the molecule) that are 
in close proximity to each other (rij).  Additionally, as the atomic masses of the two atoms 
increase, so does the index; ultimately attributable to a larger number of electronegative 
atoms (i.e. oxygen, sulfur, chlorine) in SMO compounds.  In this study, it was observed 
that as the index increases, the probability of successful solid dispersion formation 
increases, as well.  From the previous discussion of the R3m index, it is reasonable to 
state that a molecule having electronegative atoms along its periphery that are 
conformationally positioned such that their interatomic distances are minimized results in 
an increased probability of dispersion formation.   
 One of the most intriguing comparisons is that of felodipine and nifedipine.  
Commonly prescribed calcium channel blockers, their structural similarities are readily 
apparent in Table 5.1.  It has been previously reported that the nucleation rate in 
amorphous nifedipine, both as a pure phase and as a 3 wt% amorphous molecular solid 
dispersion with PVP, is substantially greater than that of felodipine in the equivalent 
state.142  In this study, felodipine was shown to be completely miscible with PVPva, 
whereas the co-solidified product of nifedipine and PVPva exhibited detectable phase 
separation.  The benzene flanking the dihydropyridine in nifedipine contains a nitro 
group, where the same benzene contains two chlorine atoms in felodipine (Table 5.1).  
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 This substituent change causes a marked increase in the R3m index from 0.579 for 
nifedipine to 0.813 for felodipine. 
 Since the R3m includes specific information concerning 3D molecular geometry 
provided by the molecular influence matrix, atom relatedness by molecular topology, and 
chemical information by using the atomic mass weighting scheme, it’s difficult to 
simplify the relationship between this sophisticated index and the mechanism of 
API:polymer miscibility.  The mere increase in the R3m index can be attributable to 
multiple molecular features (i.e. increasing amount of electronegative atoms, large 
number of atoms distant to the geometric center, or intramolecular interactions three 
topological units apart).  Any further extrapolation, at present, concerning this correlation 
would be unfounded and is the subject of ongoing research. 
 The R3m model was challenged with three compounds not used in the calibration.  
The results are shown in Figure 5 as a bar plot.  Both cimetidine and melatonin were 
accurately predicted to not form an amorphous molecular solid dispersion with PVPva.  
Bicalutamide, however, was accurately predicted and identified to be completely miscible 
with the polymer.  It was important, when selecting compounds to test the model, that 
molecular attributes did not exceed the variance space of the molecules used to construct 
the calibration.  For example, the fusion temperature for compounds included in the 
calibration fell in the range of 120-180°C.  Predictions for molecules with fusion 
temperatures substantially deviating from this range tended to be incorrect.   
 As with any materials informatics calibration, the power of the model increases 
with the variance spanned by the samples comprising it.  Since this calibration only 
contained 12 compounds, it may seem apparent that the variance space is relatively small.  
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 It is anticipated that as more compounds are added to this library, predictions will 
become more accurate over a wider range of molecular attributes.  Additionally, an 
expanded library may identify different/additional molecular descriptors that are 
correlated to dispersion potential.  This may shed further light onto the specific structural 
properties responsible for the correlation to dispersion potential.  
5.5 Conclusion 
 The ability to identify phase-separated co-solidified samples was afforded by 
implementing a combination of standard DSC and PDF transforms of PXRD patterns.  
Classification of co-solidified samples based on extent of miscibility enabled construction 
of a 12 compound library to model amorphous molecular solid dispersion potential.  
Logistic regression analysis of a molecular descriptor database identified a GETAWAY 
index highly correlated to solid dispersion potential.  When the model was tested with 
external compounds possessing materials-properties spanning an appropriate variance 
space, successful predictions were made.  The model developed herein is not universally 
applicable across all SMO compounds.  The methodology presented outlines a novel 
approach to solving the complex issues surrounding API:polymer miscibility, where 
pharmaceutical sectors having large compound libraries at their disposal are poised to 
benefit from these materials-based models.  Future work aims to increase interpretability 
of molecular indices to aid in understanding the complex phenomena associated with 
API:polymer miscibility requirements. 
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 Chapter 6: Summary 
 The plethora of recent pharmaceutical literature devoted to the topic of solid 
dispersion technology is a testament to its appeal for enhancing aqueous 
solubility/dissolution rate of poorly soluble NCEs.  Despite the large amount of work 
focused on the miscibility between a drug and polymer, there remains a lack of consensus 
concerning specific properties underlying this phenomenon.  As an alternative to case-by-
case studies of specific intermolecular interactions to arrive at an explanation for 
miscibility, it was hypothesized that some structural characteristic(s) of a compound may 
be indicative of dispersion potential, when the polymer, concentration, and 
manufacturing method are all held constant.  The approach to testing this hypothesis, 
calibrating a material informatics database of molecular descriptors, is novel to the best 
of the author’s knowledge. 
 One of the central themes to this dissertation work, mentioned in the introduction, 
states that “innovation in the areas of pharmaceutical pre-formulation and formulation 
development are often precluded by advancements in materials characterization.”  As 
illustrated in this work, the types of materials used as/in medicinal products and inherent 
issues surrounding their implementation in pharmaceutical dosage forms are becoming 
increasingly complex.  Although PXRD as an analytical method serves as the mainstay 
for assessing material structure, traditional data processing techniques neglect to benefit 
from the information in the entire diffraction pattern and, therefore, are unable to provide 
the scale of scrutiny required for analyzing highly disordered systems. 
 To accommodate sensitivity to “local” environments, full pattern PXRD 
techniques have emerged.  Total scattering analysis coupled with multivariate 
 159
 chemometric linear modeling was successfully shown to provide enhanced quantitative 
selectivity to multiple amorphous/disordered components in composite samples over 
traditional univariate diffraction-absorption processing.  Additionally, the selection of 
transmission geometry, combined with multivariate modeling, further enabled a reduction 
in calibration size with little effect on standard error of prediction. 
 The pertinence of using PDF transformed PXRD data to study short-range 
structure in complex materials was described in great detail.  The sensitivity of PDF 
transforms of laboratory PXRD data to local order of material structure deviations in 
composite pharmaceutical materials was successfully investigated.  It was shown that 
high-energy input processing, such as powder compaction, induced structural alterations 
to average crystallographic molecular location and orientation relative to the raw 
crystalline material as evidenced by changes in PDF transforms.  Additionally, these 
structural modifications were modeled using reverse Monte Carlo simulations and were 
shown to be consistent with deviations to long range order.  Further, composite 
diffraction data was accurately separated permitting PDF transform of component-
specific isolated diffraction.  The conclusions drawn from this work are significant 
because they show the minor PXRD pattern aberrations resulting from subtle structural 
changes manifest as substantial modifications to interatomic correlations.  Ultimately, 
this was important in supporting the use of our X-ray data to study solid dispersion 
systems, as low-frequency features in PXRD patterns of amorphous/disordered 
pharmaceutical materials that may not be interpretable as-is, become considerable in the 
PDF transform. 
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  The published method for using PDF transforms to detect phase-separated co-
solidified products was scientifically rigorous in its inception; however, it failed to 
provide a statistically-robust approach for drawing conclusions.  As the actual PDF 
transform itself was adapted from the inorganic materials science literature, principles of 
error propagation using initial error estimates from the PXRD experiment were, as well.  
The novelty of the approach is the application of these algorithms to comparing multiple 
experimental PDF patterns.  By developing a characteristic threshold to distinguish 
significant differences between experimental PDF transforms from insignificant, the 
conclusions drawn from analyses were consistent. 
 An alternative to circumvent one of the aforementioned limitations to the PDF 
method is possible.  As previously described, the requirement of producing an amorphous 
standard of the drug substance to use in the analysis can be a difficult task.  With the 
increasing power of structural simulations, akin to those used in some of the preceding 
work, and the knowledge of local structure in disorder systems, a simulated amorphous 
PDF transform for drug substances may be possible to model.  This would be 
advantageous as it would bypass the difficulty in producing an amorphous phase of the 
drug, as well as decrease the raw material supplies associated with the task. 
 The final segment of this work tied together all of the analytical development to 
support a study to predict solid dispersion potential from in silico modeling.  Given the 
ability to identify phase-separated co-solidified systems from true amorphous molecular 
solid dispersions, a compound library was generated for calibration.  The ability to 
calculate molecular descriptors from the 3-dimensional coordinates of the atoms 
comprising the compound affords a wealth of information with no raw material costs.  
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 The implementation of a material informatics calibration for correlating dispersion 
potential to structural attributes (via molecular descriptors), to the best of the author’s 
knowledge, is the first attempt at this approach.  A significant correlation between 
dispersion potential and the R3m GETAWAY index was observed.  A direct physical 
meaning of the correlation between R3m and dispersion potential, however, was not 
readily identifiable or interpretable. 
 The informatics calibration largely suffered from an inadequate sample size, as 
accuracies in screening a large number of multi-scale independent variables increase as 
the sample size increases.  The addition of compounds to the library that span further 
variance space may result in other selected significant molecular indices.  These 
additional molecular descriptors may further provide information into structural 
characteristics responsible for dispersion potential.  Analysis of molecular-level 
interactions, as by vibrational spectroscopy, may supplement some of the conclusions 
drawn from future work.  Coupling structural features with information pertaining to 
local interactions may yield a complete picture of these complex systems. 
 The ability to optimize NCE properties, dosage form selection, and formulation 
characteristics using little-to-no raw material supplies is highly imperative to decreasing 
escalating development costs.  The principles outlined throughout this dissertation may 
be adapted within the pharmaceutical setting, where the large libraries of drug compound 
information and advanced technological capabilities render them imminent.  With the 
push for complete product understanding by the Food and Drug Administration, 
pharmaceutical companies are set to benefit from adapting and applying these 
computational methodologies to their standard development programs. 
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 Appendix A: Eutectics 
 The distinction between solid dispersions and eutectics is important, as the 
structural, physicochemical, and other intrinsic properties are vastly different.   A large 
number of pharmaceutical references inappropriately use these terms interchangeably; 
therefore, the following sections develop the materials properties of eutectics and how 
they limit preparation methods, enhance physicochemical performance, and induce 
physical instability. 
A.1 Structure 
 A eutectic solid is a condensed phase formed when a specific composition (χe) of 
two miscible liquid phases is co-solidified at a specific temperature (Te), resulting in a 
crystalline microstructure that has a lower melting temperature relative to that of either 
pure constituent.  For eutectic solidification to occur, the components must be mutually 
miscible as liquids.  From a molecular perspective, this implies that the NBIs between 
unlike components must be similar to interactions between like components, in the liquid 
phase.   
 Binary eutectic crystallizations typically proceed as first-order phase transitions, 
which mechanistically advance through several stages (i.e. appearance of nuclei, nuclei 
growth without replication, Ostwald ripening, etc.).143 Eutectic solid products are, 
therefore, crystalline materials.  Further, eutectics possess a microstructure-level 
component of periodicity different than that of either pure crystalline phase.  Without the 
microstructural element, the system cannot be accurately classified as a eutectic.  This 
particular concept is often neglected in the pharmaceutical literature, where accounts of 
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 eutectic formation are reported without proper supporting thermal and structural 
characterization.144-147
 An important part of the aforementioned definition of a eutectic surrounds the 
newly-formed eutectic microstructure.  The effective entropy change and the volume 
fraction of the eutectic phase are inter-related during solidification, where the relationship 
between them may be used to characterize the microstructure (neglecting kinetics).148  
According to Hunt and Jackson,149 the entropy of fusion of the individual pure 
components controls the resulting eutectic microstructure.  When two materials possess 
equivalent entropy of fusion values, both phases grow simultaneously behind a planar 
solid/liquid interface resulting in a normal eutectic microstructure (Figure A.1).  In 
contrast, large differences in entropy of fusion result in faceted growth, producing an 
anomalous structure.  In normal structures, the phases appear as alternating lamellae or 
rods of one phase embedded in the other; anomalous structures, however, exhibit many 
variants.16
 
Figure A.1.  A schematic of lamellar growth for a binary eutectic behind a near-planar 
solid-liquid interface (from Porter and Easterling, 1981, with modifications). 
 
A.1.1 Structural Interpretation of Physicochemical Benefits 
 The enhanced aqueous solubility gained through eutectic formation is often 
attributed (in the pharmaceutical literature) to the lower temperature of fusion of the 
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 solidified material.150  A more fundamental reason for this lower fusion temperature, and 
the resulting increased aqueous solubility, exists.  In Figure A.1, a schematic 
representation of normal eutectic solidification is shown.  As the saturated α phase 
(composed of component A) and β phase (composed of component B) solidify, excess B 
and A diffuse laterally to the tips of the β phase and α phase, respectively, promoting 
further growth.  In this figure, λ represents the interlamellar spacing between the α-phase 
and the β-phase and is directly related to the rate of growth (i.e., rapid growth rate results 
in small λ).  The unique eutectic solid microstructure, which results in incoherent 
interphase boundaries (the line between the α-phase and β-phase in Figure A.1), provides 
a less thermodynamically stable interface relative to the normal coherent interactions that 
comprise the individual crystalline phases.  This boundary possesses a higher free energy 
because its structural makeup consists of NBIs between different molecules (i.e., a drug 
and its carrier, or two different drugs) where these interactions are typically not 
energetically equivalent to those between like molecules.  Further, the number of 
unfulfilled bonds at the interphase boundary is greater relative to either pure component 
phase, and the NBIs formed between unlike molecules are not as stable relative to those 
involved in maintaining the pure component crystal lattice resulting in an increase in 
internal energy.  These bonds are, therefore, energetically easier to overcome.   
A.2 Manufacture 
 Application of the fusion technique in the production of eutectics151-156 requires 
that a mixture of the two components be heated above the melting temperature of the 
highest melting component.  The two miscible liquids are mixed until homogenous, and 
controlled solidification is facilitated by cooling the liquid mixture through Te.  The 
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 resulting solid may be further processed (e.g. sizing, blending) depending upon the 
specific downstream application.  Although the fusion method is commonly applied, 
additional consideration to temperature must be given when using with pharmaceutically 
relevant materials.  The temperature at which the onset of thermal degradation occurs 
relative to the fusion temperature must be taken into account, as alternative methods of 
preparation exist for thermally labile drugs and carriers.  Further, the molten state of the 
component having the lower melting temperature may adversely affect the fusion kinetics 
of the other material.  In particular, non-specific and specific interactions between the 
molten state of one material and the solid state of the other material during the fusion 
process may lead to effective dissolution of the higher melting component in the lower 
melting material’s molten phase.157
 Solvent-mediated co-precipitation is most commonly used to manufacture 
pharmaceutical eutectic solids, serving as the choice for temperature-sensitive 
products.158-160  In this process two components are dissolved at the eutectic composition 
either in a single medium in which they are mutually soluble, or in separate media that 
are eventually mixed together in proportions representing the eutectic composition.  The 
solvent is then removed in either a controlled or uncontrolled fashion, and the co-
precipitated solid is subjected to further processing as above.    
 Although common, solvent-mediated co-precipitation has several practical 
disadvantages.  Given a candidate NCE having sufficient hydrophobicity to merit 
exploration of solubilization strategies such as eutectic formation, and a second 
hydrophilic component, it is may be difficult to find a common solvent capable of 
dissolving both solutes.  Many organic solvents are highly toxic to humans, imposing 
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 additional concern with residual solvent levels following precipitation and processing.  
Further, the amount of solvent required to perform such a process on a commercial scale 
poses a tremendous production cost.  Additionally, the method and rate of evaporation 
both have implications on the resulting solid microstructure, which may, therefore, alter 
product performance.  Finally, the amount of time required to evaporate the solvent to 
acceptable levels places a constraint on the efficiency of this application.  Given these 
impracticalities, the fusion method seems to hold an apparent advantage relative to the 
solvent technique.   
 Eutectic growth velocity holds considerable influence on the mechanical 
properties of the resulting binary solid material,161 which is of concern particularly if the 
eutectic is to be formulated as part of a solid oral dosage form.  During growth of a 
phase-pure single crystal, the principal faces governing morphology will grow at the 
slowest rate, and correspond with planes having the highest intraplanar density and 
greatest interplanar spacing (i.e. lowest Miller indices).162  A crystalline lattice is often 
weakest coplanar with one of its largest faces, as high d-spacing correlates with weak 
interplanar bonding, establishing these as the most likely sites for plastic deformation to 
occur.163  The interphase boundary in a eutectic solid represents the source of its weakest 
intermolecular interactions.  If it is assumed that the interphase boundary has comparable 
mechanical implications to weak interplanar bonding in single crystal systems, then these 
interphase regions become likely sites for mechanical failure to occur.  If it is further 
assumed that this boundary becomes weaker as the interlamellar spacing (λ) increases, 
then experimental parameters affecting the interlamaller spacing also affect the 
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 mechanical properties of the material.  A binary system co-solidified at its eutectic 
composition will display a growth rate (v): 
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where λ is the interlamellar spacing, k2 is a proportionality constant, D is the liquid 
diffusivity, λ*  is the minimum possible lamellar spacing and ΔT is the degree of 
undercooling below Te.16 Therefore, exacting control over the temperature at which a 
eutectic solid is grown holds implications for the interlamellar spacing and mechanical 
properties of the material. 
 As addressed above, the eutectic composition (χe) represents the specific 
mole/mass fraction concentrations of two mutually miscible liquids at which co-
solidification without prior phase separation will result in a microstructure that melts at a 
lower temperature than the Tm of either pure component.  In Figure A.2, a typical 
temperature-composition (T-χ) binary phase diagram is shown.  Compositions falling to 
the left or right of χe will result in a product having a mixed microstructure, where the 
excess phase, will solidify prior to cooling below Te (Figure A.2b).    In order to 
maximize predictable physicochemical benefits afforded by the unique microstructure, 
explicit control of growth parameters at χe and Te is essential, although not easily 
established.   
 168
  
Figure A.2.  A T–χ diagram for a mixture of two mutually miscible liquids α and β. a) 
Cooling the homogeneous mixture along this trajectory results in eutectic solidification 
below Te, resulting in lamellar microstructure (1). b) For χ≠χe, cooling the 
homogeneous liquid mixture (2) along the trajectory indicated results in precipitation of β 
(3). Continued cooling allows growth of crystalline β (4). At T≤Te, the remaining liquid 
(χ=χe) solidifies as eutectic (5) resulting in a mixed microstructure 
 
 Currently, χe for simple binary systems is determined empirically, first requiring 
assessment of the compatibility of the two components.  Eutectic formation requires 
complete miscibility of the two components in the liquid state and immiscibility in the 
solid state.  In the traditional method employed for χe determination, samples spanning 
the entire concentration range of the two materials are co-solidified, employing the 
fusion-based method discussed above.  Samples are subjected to thermal analysis (i.e., 
DSC, hot stage microscopy, etc.,) and the fusion temperature(s) of the co-solidified 
mixture is determined and plotted as a function of composition, thereby creating the T- χ 
phase diagram.  This is where prior characterization of thermal interactions becomes 
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 critical, as this may affect the accuracy in determination of the true melting 
temperature.164  The thermal interactions between components upon heating may 
complicate the signal from thermal analysis of mixtures, thus warranting care when 
interpreting data.  Further, phase-purity must be considered, as this will also affect the 
fusion temperature.     
 Two problematic issues associated with eutectic composition determination via T- 
χ phase diagram construction are anticipated: (1) the process of creating a T- χ phase 
diagram is laborious and (2) phase diagram construction requires the sacrifice of 
relatively large amounts of both components.  Considering the amount of material 
typically available during the early stages of investigating a NCE, determining the 
eutectic point via phase diagram is often prohibitive.  As a result, a great deal of current 
research focuses on the development of methods aimed at determining eutectic 
compatibility and eutectic composition in few-to-no experiments.   
 Law et al.,165 developed a dimensionless index (Ic) used as a screening tool for 
predicting PEG-drug eutectic composition based on the van’t Hoff equation: 
f
d
f
d
f
p
f
d
c HTR
TT
I
Δ/)( 2
-
=
 (A.2)
 
where Tdf is the fusion temperature of the drug, Tpf is the fusion temperature of the 
polymer, R is the ideal gas constant, and ΔHdf is the enthalpy of fusion of the drug.  
Though the authors claim to have successfully predicted the eutectic composition for 
eight model drug compounds, the index only provided an estimate of χe ± 10-15%.  
Further, this index does not consider racemization, phase transitions, decomposition, 
incompatibility, etc., as these characteristics would affect the co-solidification process.  
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 Approximation of χe is, however, not without merit.  First, the approach adopted by Law 
et al.,165 accurately predicted whether or not a eutectic would form between two 
components.  During eutectic development, T- χ phase diagrams are created for two 
components which occasionally are not able to form a eutectic.  The index, therefore, 
prevents this costly and time-consuming event from occurring.  Also, when the 
approximate eutectic point is known, an abbreviated T- χ phase diagram may be prepared, 
thereby decreasing initial material requirements.   
 Two additional details concerning the aforementioned index deserve some 
attention: (1) the order of material structure of the carrier PEG and (2) applications of the 
van’t Hoff equation.  Much of the pharmaceutical literature reports the formation of 
eutectics between a drug and the water soluble, synthetic polymer PEG, as is the case in 
this example.  From a structural standpoint, the formation of a classic eutectic 
microstructure between these two components may be difficult to envision, owing to the 
fact that the long-chain PEG molecules do not crystallize in the rigorous sense of the 
word.  Furthermore, the considerable size difference between PEG and any small 
molecule is expected to result in significant dimensional mismatch.  To visualize the 
formation of a eutectic microstructure between PEG and a small molecule drug 
compound, PEG needs to be considered in terms of both micro- and macroscopic 
structural features.  In the solid state PEG molecules are arranged as repeating lamellar 
units bridged by tie molecules (molecules arranged in a disordered state).  Therefore, 
PEGs exhibit a defined Tg due to the tie molecules, as well as having repeating ordered 
regions, termed spherulites, which may be conceptualized as a crystalline.  Consequently, 
PEGs are considered “semicrystalline,” where the relative amount of crystallinity is 
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 determined by the molecular weight of the PEG chain.166  The crystal lattice for PEG is 
often defined as encompassing only portions of the polymeric chains, where the unit cell 
dimensions are proportional to that of medicinal organic molecular crystals.   
 The second issue identified above considers that the index is constructed using the 
van’t Hoff equation as its foundation.  Models incorporating this equation are typically 
bounded by assumptions that may not be rigorously true for real systems (i.e., equivalent 
interactions, no change in volume, etc.).  The highly idealized assumption of equality of 
interactions is invalidated when the incoherent phase boundaries between layers of the 
eutectic structure are considered.  These boundaries are less thermodynamically stable 
relative to bulk lattice regions, specifically due to the difference in interactions between 
unlike components across the solid-solid interface.  These difficulties may ultimately 
detract from the practicality of such tools, limiting their universal application.   
 The financial and raw material resources required to determine the eutectic 
composition appear to represent deterrents of eutectic application in pharmaceutical 
systems.  Therefore, a key avenue for future eutectics research should include 
development of methods designed to decrease the amount of experimentation necessary 
for determination of χe and Te, as well as moving towards accurate, predictive 
determination of these parameters.  Analytical tools used to characterize drug:carrier 
compatibility and models designed to predict compatibility are paramount to minimizing 
experimental consumption of API, thereby making this strategy more attractive as an 
early development tool.  Further, as a better understanding of the relationship between 
eutectic microstructure and material function is gained, more efficient methodologies for 
predicting eutectic composition may result.  Characterization of the incoherent 
 172
 boundaries formed in eutectics may aide in achieving a better understanding of the 
aforementioned relationship.  Through characterization, some questions concerning this 
boundary need to be investigated: 1) What is the composition at this boundary (i.e. a 
single layer of molecules of each phase, multiple, interspersed layers)? 2) Is the boundary 
both macroscopically and microscopically isotropic, or does anisotropy exist? and 3) 
Does the boundary become increasingly isotropic as the eutectic composition is 
approached?  If these interfacial boundaries can be modeled structurally through defining 
specific intermolecular orientations and interactions, it may enable the macroscopic 
composition to be determined theoretically.   
A.3 Physical Stability 
 Eutectics are the most thermodynamically stable of the binary composite 
materials covered in this dissertation.  Structurally, eutectics are crystalline; the increased 
free energy, enthalpy, and entropy are manifestations of the incoherent phase boundaries 
formed upon solidification.  At χe, the number of incoherent, higher energy regions is 
maximized.  As explained previously, this is the source from which the enhanced 
aqueous solubility of these materials is derived.  These high energy regions also result in 
the decreased melting temperature that is observed relative to those of each individual 
component.  If Te is close to ambient temperatures, a limit of physical stability is 
represented where the system disproportionates into a mixture of individual phases (i.e., 
phase separation).  On the contrary, a lower temperature limit of stability may also be 
observed in eutectic solids.  In this case, eutectics held at temperatures well below the 
eutectic temperature decompose into a mixture of the two phases.167  This most likely 
results from the higher energy associated with the interphase boundaries.  These regions, 
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 over a period of time, are likely to proceed from a metastable state to a more ordered 
phase.  As a result, the eutectic decomposes into a mixture of the two individual phases.  
Both sources of physical instability may ultimately alter the physicochemical properties 
of the product, thereby negating the enhanced aqueous solubility that provided the 
impetus to engineer the eutectic at the outset of development.  Unfortunately, there is a 
paucity of literature sources pertaining to the stabilization of eutectics, which may be due 
to: (1) the increased thermodynamic stability of eutectics relative to other solid binary 
composite systems results in rare occurrences of the aforementioned routes of instability, 
(2) traditional stabilizing methods are not applicable to eutectics and alternative 
techniques do not exist, (3) research concerning eutectic-based pharmaceutical 
formulations is limited relative to their solid-dispersion counterparts, or (4) a combination 
of the preceding points. 
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Appendix B: PXRD and PDF Analyses 
 All powder X-ray diffraction (PXRD) patterns were obtained using an X’Pert Pro 
MPD system (PANalytical B.V., Almelo, the Netherlands) equipped with a copper anode 
(λ = 1.5406 Å), an auxiliary elliptical mirror, and X’CeleratorTM detector.  The 
operational voltage and amperage were set to 45.0 kV and 40.0 mA, respectively.  
Diffraction patterns were acquired on intact samples, sandwiched between two layers of 
Kapton® film and subsequently placed on a spinning vertical sample stage (16 rpm).  
Experimental parameters include an irradiation time of 51.04 seconds per step and an 
angular step size of 0.017° 2θ over a 2-100° 2θ range.  From raw powder patterns, if co-
solidified products displayed Bragg diffraction peaks, no PDF analysis was carried out 
due to the obvious indication of partial crystallinity.  Indexed PXRD patterns only are 
shown for compounds exhibiting this level of phase separation. 
 A number of corrections are made to raw diffraction data to obtain a structure 
function consistent with those outlined by Egami and Billinge.38  All intensity corrections 
and PDF calculations were performed using software developed in-house in the Matlab 
programming environment (v7.1, MathWorks, Natick, MA) based on published equations.  
The PDF transforms were optimized using the Glow quality criterion introduced by 
Peterson, et al.41
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Figure B.1. The PDF assessment for felodpine:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: (top to 
bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of 
illustration is the actual analysis, as labeled.  Due to the lack of agreement between the calculated PDF and co-solidified product PDF 
as evidenced by the high R-value, drug and polymer concentration values that deviate from theory, and the regions in r where zero is 
not contained in the confidence interval, felodipine and PVPva are concluded to be completely miscible. 
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Figure B.2. The PDF assessment for indomethacin:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: 
(top to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of 
illustration is the actual analysis, as labeled.  Due to the lack of agreement between the calculated PDF and co-solidified product PDF 
as evidenced by drug and polymer concentration values that deviate from theory and the regions in r where zero is not contained in the 
confidence interval, indomethacin and PVPva are concluded to be completely miscible. 
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Figure B.3. The PDF assessment for ketoconazole:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: 
(top to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of 
illustration is the actual analysis, as labeled.  Due to the lack of agreement between the calculated PDF and co-solidified product PDF 
as evidenced by the high R-value, drug and polymer concentration values that deviate from theory, and the regions in r where zero is 
not contained in the confidence interval, ketoconazole and PVPva are concluded to be completely miscible.
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Figure B.4.  Raw powder X-ray diffraction pattern for the itraconazole:PVPva co-
solidified product.  Black delta peaks are indicative of the referenced Bragg intensity 
values for itraconazole (CSD reference code: TEHZIP).  The PXRD pattern of the co-
solidified product does not contain any Bragg peaks attributable to crystalline 
itraconazole.  Since the PDF analysis was not performed due to inability to produce 
amorphous itraconazole, conclusions were made from PXRD and DSC data (Appendix 
C) only. Itraconazole was concluded to be completely miscible with PVPva due to lack 
of detectable crystallinity in PXRD data and a single detectable Tg from DSC. 
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Figure B.5. The PDF assessment for tolbutamide:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: (top 
to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of 
illustration is the actual analysis, as labeled.  Due to the lack of agreement between the calculated PDF and co-solidified product PDF 
as evidenced by the high R-value and the regions in r where zero is not contained in the confidence interval, tolbutamide and PVPva 
are concluded to be completely miscible. 
 
 
Figure B.6. The PDF assessment for chlorpropamide:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: 
(top to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of 
illustration is the actual analysis, as labeled.  Due to the lack of agreement between the calculated PDF and co-solidified product PDF 
as evidenced by the high R-value, drug and polymer concentration values that deviate from theory, and the regions in r where zero is 
not contained in the confidence interval, chlorpropamide and PVPva are concluded to be completely miscible.
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Figure B.7. Raw powder X-ray diffraction pattern for the nifedipine:PVPva co-solidified 
product.  Blue delta peaks are indicative of the referenced Bragg intensity values for 
crystalline nifedipine (ICDD reference code: 00-052-2175).  As shown, detectable partial 
crystallinity attributable to crystalline nifedipine is present in the co-solidified product.
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Figure B.8. The PDF assessment for quinidine:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: (top to 
bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of 
illustration is the actual analysis, as labeled.  Due to the agreement between the calculated PDF and co-solidified product PDF as 
evidenced by the low R-value, drug and polymer concentration values that are close to theory, and confidence intervals that contain 
zero for all values of r, quinidine and PVPva are concluded to be phase-separated.
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Figure B.9.  Raw powder X-ray diffraction pattern for the propranolol:PVPva co-
solidified product.  Black delta peaks are indicative of the referenced Bragg intensity 
values for dl-propranolol hydrochloride (ICDD reference code: 00-051-2107).  As shown, 
detectable partial crystallinity attributable to crystalline propranolol is present in the co-
solidified product. 
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Figure B.10.  Raw powder X-ray diffraction pattern for the cloperastine:PVPva co-
solidified product.  Black delta peaks are indicative of the referenced Bragg intensity 
values for crystalline cloperastine hydrochloride (ICDD reference code: 00-046-1967).  
As shown, detectable partial crystallinity, although not indexed to the crystal structure 
shown,  is present in the co-solidified product.
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Figure B.11. The PDF assessment for terfenadine:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: 
(top to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of 
illustration is the actual analysis, as labeled.  Due to the agreement between the calculated PDF and co-solidified product PDF as 
evidenced by the low R-value, drug and polymer concentration values that are close to theory, and confidence intervals that contain 
zero for all values of r, terfenadine and PVPva are concluded to be phase-separated.
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Figure B.12. Raw powder X-ray diffraction pattern for the sulfanilamide:PVPva co-
solidified product.  Black delta peaks are indicative of the referenced Bragg intensity 
values for α-sulfanilamide (ICDD reference code: 00-038-1709) and blue delta peaks are 
for γ-sulfanilamide (ICDD reference code: 00-038-1710).  As shown, detectable partial 
crystallinity attributable to crystalline sulfanilamide is present in the co-solidified product.
α-form 
γ-form 
 188 
 
Figure B.13.  The PDF assessment for cimetidine:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: (top 
to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of 
illustration is the actual analysis, as labeled.  Although the larger R-value and regions in r where zero is not contained in the 
confidence interval may indicate a poor fit between the calculated PDF and co-solidified product PDF, the portion of the PDF likely to 
contain information pertaining to structure (i.e. r ≥ 5Å) exhibits a good fit between the two PDFs and therefore leads to the conclusion 
that terfenadine and PVPva are phase-separated. 
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Figure B.14.  The PDF assessment for melatonin:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: (top 
to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of 
illustration is the actual analysis, as labeled.  Due to the agreement between the calculated PDF and co-solidified product PDF as 
evidenced by the low R-value, drug and polymer concentration values that are close to theory, and confidence intervals that contain 
zero for all values of r, melatonin and PVPva are concluded to be phase-separated. 
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Figure B.15. The PDF assessment for bicalutamide:PVPva co-solidified product; left three graphs are corrected PXRD patterns for: 
(top to bottom) drug, polymer, and co-solidified product; center three graphs are the respective PDF transformations; right portion of 
illustration is the actual analysis, as labeled.  Due to the lack of agreement between the calculated PDF and co-solidified product PDF 
as evidenced by the high R-value, drug and polymer concentration values that deviate from theory, and the regions in r where zero is 
not contained in the confidence interval, bicalutamide and PVPva are concluded to be completely miscible.
  191
Appendix C: DSC Analyses 
 
 Glass transition temperatures (Tg) for amorphous pure components and co-
solidified samples were measured using a TA Q100 DSC (TA Instruments, New Castle, 
DE) under constant nitrogen purge (~50mL/min).  A three-point enthalpy and 
temperature calibration was performed at 20°C/min using o-terphenyl, indium, and tin 
standards.  In an attempt to avoid artifacts arising from grinding samples, approximately 
5 mg intact “sample chips” were hermetically sealed in aluminum pans.  To normalize 
thermal history, samples were first heated at 20 °C/min to 105 °C, held isothermally for 2 
minutes, and subsequently cooled to -20°C at 20 °C/min.  Samples were then cycled 
through Tg events at 20 °C/min for temperature determination.  In each of the following 
thermograms, the Tg event for each pure component and Tg for the co-solidified product is 
shown.  For the co-solidified products, only a single cycle is shown, unless otherwise 
noted.  The ideal Tg as calculated using the Couchman-Karasz equation,85 Tg,CK, is given 
in the figure captions where applicable.
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Figure C.1. The DSC thermograms of felodpine:PVPva systems showing the glass transition event for the individual components and 
co-solidified product (as labeled), where Tg,CK = 63.4 °C.  The presence of a single Tg in the co-solidified product is indicative of 
miscibility between felodpine and PVPva. 
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Figure C.2.  The DSC thermograms of indomethacin:PVPva systems showing the glass transition event for the individual components 
and co-solidified product (as labeled) , where Tg,CK = 66.9 °C.  The presence of a single Tg in the co-solidified product is indicative of 
miscibility between indomethacin and PVPva.
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Figure C.3.  The DSC thermograms of ketoconazole:PVPva systems showing the glass transition event for the individual components 
and co-solidified product (as labeled) , where Tg,CK = 63.4 °C.  The single, detectable Tg in the co-solidified product is similar to that 
of amorphous ketoconazole and therefore, not definitively interpretable. 
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Figure C.4. The DSC thermograms of itraconazole:PVPva systems showing the glass transition event for the individual components 
and co-solidified product (as labeled) , where Tg,CK = 72.2 °C.  The single, detectable Tg in the co-solidified product is similar to that 
of amorphous itraconazole and therefore, not definitively interpretable.  Due to the inability to perform a PDF analysis, the 
repeatability of the Tg across three preparations combined with the lack of detectable Bragg peaks in PXRD patterns provides basis for 
concluding miscibility between itraconazole and PVPva.
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Figure C.5.  The DSC thermograms of tolbutamide:PVPva systems showing the glass transition event for the individual components 
and co-solidified product (as labeled) , where Tg,CK = 34.0 °C.  The presence of a single, detectable Tg in the co-solidified product is 
indicative of miscibility between tolbutamide and PVPva. 
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Figure C.6.  The DSC thermograms of chlorpropamide:PVPva systems showing the glass transition event for the individual 
components and co-solidified product (as labeled) , where Tg,CK = 41.7 °C.  The presence of a single, detectable Tg in the co-solidified 
product is indicative of miscibility between chlorpropamide and PVPva. 
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Figure C.7.  The DSC thermograms of nifedipine:PVPva systems showing the glass transition event for the individual components 
and co-solidified product (as labeled) , where Tg,CK = 65.4 °C.  The presence of a single, detectable Tg in the co-solidified product is 
indicative of miscibility between chlorpropamide and PVPva; however, the PXRD pattern of the co-solidified product (Appendix B) 
revealed detectable crystallinity attributable to nifedipine. 
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Figure C.8. The DSC thermograms of quinidine:PVPva systems showing the glass transition event for the individual components and 
co-solidified product (as labeled) , where Tg,CK = 76.8 °C.  The presence of two Tg  events in the co-solidified product is indicative of 
phase separation. 
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Figure C.9.  The DSC thermograms of propranolol:PVPva systems showing the glass transition event for the individual components 
and co-solidified product (as labeled) , where Tg,CK = 60.5 °C.  The lack of a detectable Tg in the co-solidified product is indicative 
undetectable amorphous phase. 
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Figure C.10. The DSC thermograms of cloperastine:PVPva systems showing the glass transition event for the individual components 
and co-solidified product (as labeled) , where Tg,CK = 53.6 °C.  The lack of a detectable Tg in the co-solidified product is indicative 
undetectable amorphous phase. 
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Figure C.11. The DSC thermograms of terfenadine:PVPva systems showing the glass transition event for the individual components 
and co-solidified product (as labeled) , where Tg,CK = 77.2 °C.  The single, detectable Tg in the co-solidified product is similar to that 
of amorphous terfenadine and therefore, not definitively interpretable. 
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Figure C.12. The DSC thermograms of sulfanilamide:PVPva systems showing the glass transition event for the individual 
components and co-solidified product (as labeled) , where Tg,CK = not obtainable.  A thermogram for amorphous sulfanilamide is not 
shown due to the inability to produce the amorphous phase.  The two Tg events in the co-solidified product is indicative of phase 
separation in the amorphous component of the system.  Additionally, detectable crystallinity indexed to sulfanilamide was observed in 
the PXRD pattern (Appendix B) of the co-solidified product. 
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Figure C.13.  The DSC thermograms of cimetidine:PVPva systems showing the glass transition event for the individual components 
and co-solidified product (as labeled) , where Tg,CK = 69.9 °C.  The single, detectable Tg in the co-solidified product is similar to that 
of amorphous cimetidine and therefore, not definitively interpretable. 
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Figure C.14.  The DSC thermograms of melatonin:PVPva systems showing the glass transition event for the individual components 
and co-solidified product (as labeled) , where Tg,CK = 47.6 °C.  The single, detectable Tg in the co-solidified product is similar to that 
of amorphous melatonin and therefore, not definitively interpretable 
 
  
Figure C.15.  The DSC thermograms of bicalutamide:PVPva systems showing the glass transition event for the individual 
components and co-solidified product (as labeled) , where Tg,CK = 70.3 °C.  The single, detectable Tg in the co-solidified product is 
similar to that of amorphous bicalutamide and therefore, not definitively interpretable
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